
<html lang="en"     class="pb-page"  data-request-id="ec3fd967-7987-4066-bc9c-a78a426bc8c8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.5b01995;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2016.59.issue-7;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates" /></meta><meta name="dc.Creator" content="Mihirbaran  Mandal" /></meta><meta name="dc.Creator" content="Yusheng  Wu" /></meta><meta name="dc.Creator" content="Jeffrey  Misiaszek" /></meta><meta name="dc.Creator" content="Guoqing  Li" /></meta><meta name="dc.Creator" content="Alexei  Buevich" /></meta><meta name="dc.Creator" content="John P.  Caldwell" /></meta><meta name="dc.Creator" content="Xiaoxiang  Liu" /></meta><meta name="dc.Creator" content="Robert D.  Mazzola" /></meta><meta name="dc.Creator" content="Peter  Orth" /></meta><meta name="dc.Creator" content="Corey  Strickland" /></meta><meta name="dc.Creator" content="Johannes  Voigt" /></meta><meta name="dc.Creator" content="Hongwu  Wang" /></meta><meta name="dc.Creator" content="Zhaoning  Zhu" /></meta><meta name="dc.Creator" content="Xia  Chen" /></meta><meta name="dc.Creator" content="Michael  Grzelak" /></meta><meta name="dc.Creator" content="Lynn A.  Hyde" /></meta><meta name="dc.Creator" content="Reshma  Kuvelkar" /></meta><meta name="dc.Creator" content="Prescott T.  Leach" /></meta><meta name="dc.Creator" content="Giuseppe  Terracina" /></meta><meta name="dc.Creator" content="Lili  Zhang" /></meta><meta name="dc.Creator" content="Qi  Zhang" /></meta><meta name="dc.Creator" content="Maria S.  Michener" /></meta><meta name="dc.Creator" content="Brad  Smith" /></meta><meta name="dc.Creator" content="Kathleen  Cox" /></meta><meta name="dc.Creator" content="Diane  Grotz" /></meta><meta name="dc.Creator" content="Leonard  Favreau" /></meta><meta name="dc.Creator" content="Kaushik  Mitra" /></meta><meta name="dc.Creator" content="Irina  Kazakevich" /></meta><meta name="dc.Creator" content="Brian A.  McKittrick" /></meta><meta name="dc.Creator" content="William  Greenlee" /></meta><meta name="dc.Creator" content="Matthew E.  Kennedy" /></meta><meta name="dc.Creator" content="Eric M.  Parker" /></meta><meta name="dc.Creator" content="Jared N.  Cumming" /></meta><meta name="dc.Creator" content="Andrew W.  Stamford" /></meta><meta name="dc.Description" content="We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrroli..." /></meta><meta name="Description" content="We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrroli..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="March 22, 2016" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.5b01995" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2016 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01995" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.5b01995" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.5b01995" /></link>
        
    
    

<title>Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.5b01995" /></meta><meta property="og:title" content="Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0016.jpeg" /></meta><meta property="og:description" content="We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold. Employing structure-based design, truncation of the cyanophenyl group of 6 that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in S1 was pursued. Optimization of the pyrimidine substituent that binds in the S2′–S2″ pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogues in this series and imparted high BACE1 affinity. These efforts resulted in the discovery of difluorophenyl analogue 9 (MBi-4), which robustly lowered CSF and cortex Aβ40 in both rats and cynomolgus monkeys following a single oral dose. Compound 9 represents a unique molecular shape among BACE inhibitors reported to potently lower central Aβ in nonrodent preclinical species." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.5b01995"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.5b01995">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.5b01995&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.5b01995&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.5b01995&amp;href=/doi/10.1021/acs.jmedchem.5b01995" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2016</span><span class="cit-fg-volume">, 59</span><span class="cit-fg-issue">, 7</span><span class="cit-fg-pageRange">, 3231-3248</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/59/7" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.5b01984" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.5b01998" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mihirbaran++Mandal">Mihirbaran Mandal</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yusheng++Wu">Yusheng Wu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jeffrey++Misiaszek">Jeffrey Misiaszek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guoqing++Li">Guoqing Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexei++Buevich">Alexei Buevich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+P.++Caldwell">John P. Caldwell</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxiang++Liu">Xiaoxiang Liu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robert+D.++Mazzola">Robert D. Mazzola</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Orth">Peter Orth</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Corey++Strickland">Corey Strickland</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johannes++Voigt">Johannes Voigt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hongwu++Wang">Hongwu Wang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhaoning++Zhu">Zhaoning Zhu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xia++Chen">Xia Chen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Grzelak">Michael Grzelak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lynn+A.++Hyde">Lynn A. Hyde</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reshma++Kuvelkar">Reshma Kuvelkar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Prescott+T.++Leach">Prescott T. Leach</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Giuseppe++Terracina">Giuseppe Terracina</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Lili++Zhang">Lili Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Qi++Zhang">Qi Zhang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Maria+S.++Michener">Maria S. Michener</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brad++Smith">Brad Smith</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathleen++Cox">Kathleen Cox</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Diane++Grotz">Diane Grotz</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Leonard++Favreau">Leonard Favreau</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kaushik++Mitra">Kaushik Mitra</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Kazakevich">Irina Kazakevich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian+A.++McKittrick">Brian A. McKittrick</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William++Greenlee">William Greenlee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Matthew+E.++Kennedy">Matthew E. Kennedy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric+M.++Parker">Eric M. Parker</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jared+N.++Cumming">Jared N. Cumming</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Andrew+W.++Stamford">Andrew W. Stamford</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Department of Global Chemistry, <sup>‡</sup>Department of Neuroscience, <sup>§</sup>Department of Safety Assessment and Laboratory Animal Research, <sup>∥</sup>Department of Discovery Pharmaceutical Sciences, and <sup>⊥</sup>Department of Pharmacokinetics, Pharmacodynamics, and Drug Metabolism, Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div><div class="corresp-info"><strong>*</strong>For A.W.S.: phone, +1 732-594-1960; E-mail, <a href="/cdn-cgi/l/email-protection#6d0c03091f081a431e190c000b021f092d00081f0e06430e0200"><span class="__cf_email__" data-cfemail="0b6a656f796e7c25787f6a666d64796f4b666e79686025686466">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For J.N.C.: phone +1 908-740-4049; E-mail: <a href="/cdn-cgi/l/email-protection#e28883908786cc81978f8f8b8c85a28f87908189cc818d8f"><span class="__cf_email__" data-cfemail="94fef5e6f1f0baf7e1f9f9fdfaf3d4f9f1e6f7ffbaf7fbf9">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01995&amp;href=/doi/10.1021%2Facs.jmedchem.5b01995" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2016</span></span><span class="cit-volume">, 59</span><span class="cit-issue">, 7</span><span class="cit-pageRange">, 3231–3248</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 3, 2016</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 December 2015</li><li><span class="item_label"><b>Published</b> online</span>22 March 2016</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 April 2016</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.5b01995" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01995</a></div><div class="article_header-article-copyright"><strong>Copyright © 2016 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3231%26pageCount%3D18%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMihirbaran%2BMandal%252C%2BYusheng%2BWu%252C%2BJeffrey%2BMisiaszek%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D59%26issueNum%3D7%26contentID%3Dacs.jmedchem.5b01995%26title%3DStructure-Based%2BDesign%2Bof%2Ban%2BIminoheterocyclic%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE%2529%2BInhibitor%2Bthat%2BLowers%2BCentral%2BA%25CE%25B2%2Bin%2BNonhuman%2BPrimates%26numPages%3D18%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3248%26publicationDate%3DApril%2B2016">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.5b01995"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3395</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">28</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.5b01995" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Based Design of an Iminoheterocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aβ in Nonhuman Primates&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mihirbaran&quot;,&quot;last_name&quot;:&quot;Mandal&quot;},{&quot;first_name&quot;:&quot;Yusheng&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Jeffrey&quot;,&quot;last_name&quot;:&quot;Misiaszek&quot;},{&quot;first_name&quot;:&quot;Guoqing&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Alexei&quot;,&quot;last_name&quot;:&quot;Buevich&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;P. Caldwell&quot;},{&quot;first_name&quot;:&quot;Xiaoxiang&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;D. Mazzola&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Orth&quot;},{&quot;first_name&quot;:&quot;Corey&quot;,&quot;last_name&quot;:&quot;Strickland&quot;},{&quot;first_name&quot;:&quot;Johannes&quot;,&quot;last_name&quot;:&quot;Voigt&quot;},{&quot;first_name&quot;:&quot;Hongwu&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Zhaoning&quot;,&quot;last_name&quot;:&quot;Zhu&quot;},{&quot;first_name&quot;:&quot;Xia&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Grzelak&quot;},{&quot;first_name&quot;:&quot;Lynn&quot;,&quot;last_name&quot;:&quot;A. Hyde&quot;},{&quot;first_name&quot;:&quot;Reshma&quot;,&quot;last_name&quot;:&quot;Kuvelkar&quot;},{&quot;first_name&quot;:&quot;Prescott&quot;,&quot;last_name&quot;:&quot;T. Leach&quot;},{&quot;first_name&quot;:&quot;Giuseppe&quot;,&quot;last_name&quot;:&quot;Terracina&quot;},{&quot;first_name&quot;:&quot;Lili&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Qi&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Maria&quot;,&quot;last_name&quot;:&quot;S. Michener&quot;},{&quot;first_name&quot;:&quot;Brad&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;Kathleen&quot;,&quot;last_name&quot;:&quot;Cox&quot;},{&quot;first_name&quot;:&quot;Diane&quot;,&quot;last_name&quot;:&quot;Grotz&quot;},{&quot;first_name&quot;:&quot;Leonard&quot;,&quot;last_name&quot;:&quot;Favreau&quot;},{&quot;first_name&quot;:&quot;Kaushik&quot;,&quot;last_name&quot;:&quot;Mitra&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Kazakevich&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;A. McKittrick&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;Greenlee&quot;},{&quot;first_name&quot;:&quot;Matthew&quot;,&quot;last_name&quot;:&quot;E. Kennedy&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;M. Parker&quot;},{&quot;first_name&quot;:&quot;Jared&quot;,&quot;last_name&quot;:&quot;N. Cumming&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;W. Stamford&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2016&quot;,&quot;month&quot;:&quot;03&quot;,&quot;day&quot;:&quot;22&quot;,&quot;issue&quot;:&quot;7&quot;,&quot;volume&quot;:&quot;59&quot;,&quot;pages&quot;:&quot;3231-3248&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.5b01995&quot;},&quot;abstract&quot;:&quot;We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by 6 that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold. Employing structure-based design, truncation of the cyanophenyl group of 6 that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in S1 was pursued. Optimization of the pyrimidine substituent that binds in the S2′–S2″ pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogues in this series and imparted high BACE1 affinity. These efforts resulted in the discovery of difluorophenyl analogue 9 (MBi-4), which robustly lowered CSF and cortex Aβ40 in both rats and cynomolgus monkeys following a single oral dose. Compound 9 represents a unique molecular shape among BACE inhibitors reported to potently lower central Aβ in nonrodent preclinical species.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01995&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01995" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01995&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01995" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.5b01995&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01995" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.5b01995&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.5b01995&amp;href=/doi/10.1021/acs.jmedchem.5b01995" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.5b01995" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.5b01995" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.5b01995%26sid%3Dliteratum%253Aachs%26pmid%3D26937601%26genre%3Darticle%26aulast%3DMandal%26date%3D2016%26atitle%3DStructure-Based%2BDesign%2Bof%2Ban%2BIminoheterocyclic%2B%25CE%25B2-Site%2BAmyloid%2BPrecursor%2BProtein%2BCleaving%2BEnzyme%2B%2528BACE%2529%2BInhibitor%2Bthat%2BLowers%2BCentral%2BA%25CE%25B2%2Bin%2BNonhuman%2BPrimates%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D59%26issue%3D7%26spage%3D3231%26epage%3D3248%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/59/7" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/jmcmar.2016.59.issue-7/20160414-01/jmcmar.2016.59.issue-7.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We describe successful efforts to optimize the in vivo profile and address off-target liabilities of a series of BACE1 inhibitors represented by <b>6</b> that embodies the recently validated fused pyrrolidine iminopyrimidinone scaffold. Employing structure-based design, truncation of the cyanophenyl group of <b>6</b> that binds in the S3 pocket of BACE1 followed by modification of the thienyl group in S1 was pursued. Optimization of the pyrimidine substituent that binds in the S2′–S2″ pocket of BACE1 remediated time-dependent CYP3A4 inhibition of earlier analogues in this series and imparted high BACE1 affinity. These efforts resulted in the discovery of difluorophenyl analogue <b>9</b> (MBi-4), which robustly lowered CSF and cortex Aβ<sub>40</sub> in both rats and cynomolgus monkeys following a single oral dose. Compound <b>9</b> represents a unique molecular shape among BACE inhibitors reported to potently lower central Aβ in nonrodent preclinical species.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects an estimated 5.3 million people in the United States and is responsible for 60–80% of all dementias, of which there were nearly 47 million worldwide in 2015.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> In addition to the emotional and social burden that AD exerts on patients and their families, the economic burden is enormous. In the U.S. alone, the total cost of care for patients with AD and other dementias was approximately US $226 billion in 2015.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> It is expected that the number of people with AD will triple by 2050, resulting in a public health crisis unless disease modifying agents become available.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1, 2)</a> Because current AD medications, the acetylcholine esterase inhibitors and the <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor antagonist, memantine, only produce modest and transient improvements in cognitive function,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> there is an urgent medical need to discover an agent that slows the underlying neurodegenerative process. Major advances in the fields of genetics, cell biology, biochemistry, and neuroscience have provided some level of understanding of the pathophysiology of AD.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Two major neuropathological hallmarks of AD are extracellular amyloid plaques and intracellular neurofibrillary tangles which are found predominantly in the cortex and hippocampus. Amyloid plaques are composed of oligomerized and fibrillar β-amyloid (Aβ) peptides, primarily 42 amino acid residues in length, which are derived from amyloid precursor protein (APP) through sequential cleavage of APP by the β-site APP cleaving enzyme 1 (BACE1) followed by γ-secretase.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> According to the amyloid hypothesis, accumulation of Aβ peptides in the brain is causative of the underlying neurodegenerative process of AD. Therefore, inhibition of Aβ peptide synthesis is a potentially disease-modifying approach to the treatment of AD.</div><div class="NLM_p">Over recent years, BACE1 inhibition has emerged as the primary small molecule approach for blocking Aβ peptide synthesis given the mechanism-based toxicity that attends γ-secretase inhibition, resulting in dose-limiting side effects.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Complementary approaches targeting central Aβ via anti-Aβ monoclonal antibodies have also been tested in the clinic, but the effects on cognitive improvement reported thus far either did not meet their target end points or, if they were significant, represented only a minimal effect and require further trials.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Taken together, the clinical data generated to-date with both γ-secretase inhibitors and anti-Aβ antibodies do not reflect a definitive or even robust vetting of the amyloid hypothesis.</div><div class="NLM_p">In support of a focus on BACE1 inhibition to ultimately test this hypothesis, BACE1 knockout (KO) mice do not produce Aβ peptides,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> and a cross between these knockout mice and a transgenic mouse model of early onset Alzheimer’s disease showed significant improvement in the overall disease phenotype in regard to both reduction of amyloid levels and decreased memory deficits.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> BACE1 KO mice were initially reported to possess no overt negative phenotype,<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> but more recently loss of BACE1 function in these animals has been shown to result in subtle morphological and behavioral alterations, and physiological non-APP substrates of BACE1 have been identified.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Among the best characterized of these substrates is neuregulin 1, both type III and type I. Phenotypes associated with reduced proteolytic processing of these two substrates in BACE1 KO mice are a reduction of peripheral nerve myelination<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and a reduction in muscle spindle formation,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> respectively. Importantly, these and many phenotypes in homozygous BACE1 KO mice are not seen in BACE1 heterozygous mice and are not replicated in adult wild-type mice given selective BACE inhibitors. While our understanding of BACE1 biology continues to evolve, and careful monitoring of safety in BACE1 inhibitor clinical trials is critical, the sum total of current data offers the potential for partial pharmacological inhibition of BACE1 in adult patients to be a safe approach to disease modification in Alzheimer’s disease.</div><div class="NLM_p">Because BACE1 is an aspartyl protease, the early phase of BACE1 inhibitor design was dominated by substrate-based peptidic and peptidomimetic approaches<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> that had been successful in the design of inhibitors of related aspartyl proteases such as HIV protease and renin. These efforts resulted in many potent inhibitors, but these generally lacked suitable molecular properties to achieve significant brain penetration and in vivo CNS Aβ lowering activity at appropriate pharmacological doses.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Therefore, focus shifted to nonpeptidic BACE1 inhibitors that would be more likely to possess properties conducive to CNS activity.</div><div class="NLM_p">As shown in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>, our work in this area began with the identification of isothiourea <b>1</b> through a fragment-based approach,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and we have disclosed the progression of this fragment via lead compound <b>2</b><a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> to high affinity brain penetrant and bioavailable inhibitors belonging to two distinct chemical series, iminohydantoins (e.g., <b>3</b>)<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and iminopyrimidinones (e.g., <b>4</b> and <b>5</b>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> These efforts,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> independent of others achieved through HTS and fragment-based approaches,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> involved significant de novo design elements with extensive application of X-ray crystallography and molecular modeling. In the iminopyrimidinone series, additional SAR development that focused on structural diversity and conformational constraint led to design of a novel bicyclic iminopyrimidinone scaffold represented by compounds <b>6</b>, <b>7</b><a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>8</b> (<a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Discovery of bicyclic iminopyrimidinones <b>6</b>, <b>7</b>, and <b>8</b> from fragment <b>1</b> by rational design and SAR development through iminohydantoins <b>2</b> and <b>3</b> and iminopyrimidinone <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>6</b> reduced cortex Aβ<sub>40</sub> in Sprague–Dawley rats (−42% compared to vehicle) after administration of a single dose (30 mg/kg, PO).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Unfortunately, it had relatively high PSA that likely contributed to modest brain penetration (brain/plasma 0.1), was a potent time dependent CYP3A4 inhibitor, and showed significant <i>h</i>ERG inhibition (70% @ 1 μM). To overcome these issues, we investigated truncation of the cyanophenyl moiety of <b>6</b> that binds in the BACE1 S3 pocket (shown schematically in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>). We concurrently explored SAR of the fluoropyrimidine group of <b>6</b> that binds in the S2–S2″ pockets to rescue the associated loss of affinity and to address the time-dependent CYP3A4 inhibition. Subsequent modification of the aryl group in S1 was pursued to further improve the affinity and selectivity of the series. These efforts culminated in discovery of inhibitor <b>9</b> (MBi-4; <a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>), which showed robust pharmacodynamic Aβ lowering activity in rats and monkeys. It is worth noting that the vast majority of published small molecule BACE inhibitors that lower Aβ in monkey and/or dog, including all that have entered clinical trials, have substituents that occupy the S3 subsite of BACE, and none of these structures occupy the S2″ subsite (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In this way, our present work validates a novel molecular shape, a fused pyrrolidine iminopyrimidinone, that only occupies S1 and S2′–S2″, and thus achieves a similar overall profile with unique structural diversity. The discovery and characterization of compound <b>9</b> will be the central focus of this article.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative published BACE inhibitors that lower central Aβ in monkeys and/or dogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Synthetic routes to P1 thiophene analogues <b>10</b>–<b>17</b> are shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. Bromothiophene core <b>26</b> was prepared following our previously described synthetic route<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and was debrominated under standard hydrogenation conditions to provide thiophene <b>27</b> as a versatile intermediate. Bromination of compound <b>27</b> with <i>N</i>-bromosuccinimide (NBS) afforded isomeric bromothiophene <b>28</b> that was subjected to palladium-mediated cyanation using Zn/ZnCN<sub>2</sub> followed by removal of the 2,2,2-trichloroethoxycarbonyl (Teoc) group with tetrabutylammonium fluoride (TBAF) to provide pyrrolidine <b>29</b>. To generate the analogous pyrrolidine with a P1 chlorothiophene <b>31</b>, intermediate <b>27</b> was chlorinated using <i>N</i>-chlorosuccinimide (NCS) to afford compound <b>30</b> that was subsequently treated with TBAF. Compounds <b>29</b> and <b>31</b> were used for preparation of compounds <b>10</b>–<b>17</b> in two steps: palladium-mediated <i>N</i>-heteroarylation with a variety of heteroaryl halides followed by treatment of the resulting products with TFA to remove the <i>tert</i>-butoxycarbonyl (Boc) protecting group.</div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of P1 Thiophene Analogues <b>10</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 10% Pd/C, H<sub>2</sub>, methanol, rt, 92%; (b) NBS, DMF, rt, 60%; (c) Zn(CN)<sub>2</sub>, Zn, PdCl<sub>2</sub>(dppf), DMA, 80 °C, then Et<sub>3</sub>N, (Boc)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 71%; (d) TBAF, THF, 0 °C to rt, 80%; (e) heteroaryl halide, tris(dibenzylideneacetone)dipalladium(0), Na-O<i>t</i>Bu, (2-biphenylyl)di-<i>tert</i>-butylphosphine (JohnPhos), toluene, 70 °C, 5–60%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (g) NCS, DMF, 50 °C, 80%.</p></p></figure><div class="NLM_p">Synthesis of compound <b>9</b> is depicted in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> as a representative example for the approach to P1 phenyl analogues <b>18</b>–<b>22</b>. Commercially available 2-(2,4-difluorophenyl)acetonitrile <b>32</b> was condensed with aqueous glyoxylic acid using potassium carbonate, and product <b>33</b> spontaneously precipitated from the reaction mixture. Hydrolysis of the nitrile moiety of <b>33</b> using a mixture of sulfuric and formic acid produced, after dehydrative cyclization, anhydride <b>34</b>. In contrast to our previous efforts,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> anhydride <b>34</b> was not hydrolyzed to the corresponding diacid but rather was used directly in the dipolar cycloaddition with commercially available <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine <b>35</b>. After the cycloaddition reaction was complete, removal of the solvent and treatment of the crude residue with methanol resulted in precipitation of methyl ester <b>36</b> as a single regioisomer from solvolysis of the initial cycloaddition product. The carboxylic acid moiety of <b>36</b> was converted to an amine via diphenylphosphoryl azide (DPPA)-mediated Curtius rearrangement using 2-(trimethylsilyl)ethanol as the isocyanate trapping agent followed by unmasking the free amine by treatment with HCl to give intermediate <b>37</b>. Boc-protected iminopyrimidinone core <b>38</b> was formed by coupling between <b>37</b> and <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> The enantiomers of compound <b>38</b> were separated using chiral HPLC to provide desired isomer <b>39</b> and its enantiomer <b>40</b>. Removal of the benzyl group of <b>39</b> followed by palladium mediated coupling of pyrrolidine <b>41</b> with 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine and subsequent treatment of the resulting intermediate with TFA provided compound <b>9</b>.</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2,4-Difluorophenyl Analogue <b>9</b><sup>a</sup> and Related Analogues <b>18</b>–<b>22</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glyoxylic acid (50% (w/w) in water), K<sub>2</sub>CO<sub>3</sub>, MeOH, 70 °C, 89%; (b) 7% conc H<sub>2</sub>SO<sub>4</sub> in formic acid, reflux, 94%; (c) cat. TFA in THF, 0 °C to rt, concentration then dilution with MeOH, rt, 57%; (d) DPPA, Et<sub>3</sub>N, toluene, 66 °C then acetic acid, TMS–ethanol, reflux, 48%; (e) 4 N HCl in dioxane, rt; (f) <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate, EDCI, DIEA, DMF, 30 °C, 63%; (g) HPLC, AD column; (h) H<sub>2</sub>, 20% Pd(OH)<sub>2</sub>/C, MeOH, rt, 91%; (i) 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine, Pd(OAc)<sub>2</sub>, Na-O<i>t</i>Bu, toluene, 2′-(di-<i>tert</i>-butylphosphino)-<i>N</i>,<i>N</i>-dimethyl-[1,1′-biphenyl]-2-amine, 100 °C; (j) TFA, DCM, 58% from <b>41</b>.</p></p></figure><div class="NLM_p">Preparation of analogues <b>23</b>–<b>25</b> required changes to the synthetic route due to perturbation of the stereoelectronics of the neighboring carbons imposed by 2,6-difluoro substitution. <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a> shows this modified synthetic route for compound <b>23</b>. Note that the pyrrolidine intermediates analogous to compound <b>46</b> en route to analogues <b>24</b> and <b>25</b> were made by a slightly different sequence as shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a> for intermediate <b>56</b>.</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2,6-Difluorophenyl Analogue <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, AcOH, dioxane, 80 °C, 34%; (b) LiOH·H<sub>2</sub>O, THF, 40 °C; (c) acetic anhydride, 90 °C, 99%; (d) cat. TFA in THF, 0 °C to rt, concentration then dilution with premixed MeOH/Et<sub>3</sub>N, −60 °C to rt, 56%; (e) 20% Pd(OH)<sub>2</sub> on carbon, H<sub>2</sub>, MeOH, rt; (f) CbzCl, Et<sub>3</sub>N, THF, dioxane, rt, 64% from <b>45</b>; (g) DPPA, Et<sub>3</sub>N, toluene, 75 °C, then TMS–ethanol, 110 °C, 67%; (h) 4 N HCl in dioxane, rt; (i) <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate, EDCI, DIEA, DMF, rt, 57%; (j) HPLC, AD column; (k) 20% Pd(OH)<sub>2</sub> on carbon, H<sub>2</sub>, MeOH, rt, 98%; (l) 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine, tris(dibenzylideneacetone)dipalladium(0), Na-O<i>t</i>Bu, (2-biphenylyl)di-<i>tert</i>-butylphosphine (JohnPhos), toluene, 65 °C, 46%; (m) TFA, DCM, 63%.</p></p></figure><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrrolidine Intermediate En Route to 2,3,6-Trifluorophenyl Analogue <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCN, EtOH, H<sub>2</sub>O, reflux, 79%; (b) glyoxalic acid monohydrate, K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 °C to rt; (c) 10% conc H<sub>2</sub>SO<sub>4</sub> in formic acid, 100 °C; (d) 5% conc H<sub>2</sub>SO<sub>4</sub> in MeOH, reflux, 41%; (e) <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine, cat. TFA, THF, 0 °C to rt, 100%; (f) 15% conc H<sub>2</sub>SO<sub>4</sub> in water, reflux; (g) Ac<sub>2</sub>O, 90 °C, concentration then dilution with premixed MeOH/Et<sub>3</sub>N, −78 °C to rt; (h) Pd(OH)<sub>2</sub>, MeOH, rt; (i) CbzCl, Et<sub>3</sub>N, THF, 0 °C to rt, 79%.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76301" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76301" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Our previous SAR studies generated three optimized lead compounds <b>6</b>, <b>7</b>,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and <b>8</b> from the iminopyrimidinone series with BACE1 <i>K</i><sub>i</sub> values of 3.5, 5.6, and 0.9 nM, respectively (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>). Despite their similar structures and affinities, X-ray cocrystal structures with BACE1 showed that these molecules each exhibit unique binding features in S2′–S2″ (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). The fluoropyrimidine moiety of compound <b>6</b> binds in an open hydrophobic space near S2’ and establishes a hydrogen bonding network with Trp<sup>76</sup> through a highly conserved water molecule (not shown) in the S2″ subpocket. While the pyridine substituent of analogue <b>7</b> overlays with the pyrimidine of compound <b>6</b> very well, it projects the cyano substituent into S2″ to displace the conserved water molecule and forms a direct hydrogen bond with Trp<sup>76</sup>. In sharp contrast to the two modes above, the methoxypyrimidine moiety of <b>8</b> shifted roughly 2 Å relative to the other analogues to displace two conserved waters and displaying the methoxy group deep in the S2″ binding pocket.</div><figure id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Superimposed X-ray conformation of iminopyrimidinone <b>6</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0">5hd0</a>), <b>7</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g">4h3g</a>), and <b>8</b> (magenta, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>) in the active site of BACE1 with red surface showing the location of catalytic aspartic acids. (b) Structures of <b>6</b>, <b>7</b>, and <b>8</b> with their respective BACE1 <i>K</i><sub>i</sub>, CYP3A4 IC<sub>50</sub> (pre), CatD/BACE1 selectivity, and calculated properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The different arrangements of the pyridine and pyrimidine moieties offered several potential strategies for further optimization of the overall inhibitor profiles. At the outset, however, we were cognizant that optimization of <b>6</b>, <b>7</b>, and <b>8</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) should avoid the incorporation of additional molecular weight and lipophilicity because this could result in profiles unsuitable for a CNS agent and would likely only exacerbate critical off target liabilities (e.g., <i>h</i>ERG). Therefore, our strategy was to remove the P3 cyanophenyl moiety to afford lower molecular weight scaffolds that occupy two binding sites (S1 and S2″), from which we could pursue SAR to rescue any intrinsic potency loss while fine-tuning physicochemical properties (cLogP, PSA) into CNS drug-like ranges. Such inhibitors would be structurally differentiated from the majority of optimized amidine-based analogues that occupy the S1–S3 pockets.<a onclick="showRef(event, 'cit22a cit22b cit22c cit22d cit22e cit22f ref23'); return false;" href="javascript:void(0);" class="ref cit22a cit22b cit22c cit22d cit22e cit22f ref23">(22a-22f, 23)</a> Additionally, we envisaged that optimization based on <b>6</b> and <b>8</b> would necessitate modification of their fluoropyrimidine moieties. It was hypothesized that the time-dependent CYP3A4 inhibition observed with <b>6</b> and <b>8</b> (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b) was a result of bioactivation of the fluoropyrimidine moiety to generate a reactive intermediate. Evidence for this was provided by incubation of <b>6</b> with recombinant CYP3A4, supplemented with glutathione, which led to the formation of a product of <i>m</i>/<i>z</i> 751.2104, corresponding to a glutathione adduct of <b>6</b> with concomitant loss of fluoride.</div><div class="NLM_p">Implementation of this strategy using <b>6</b> and <b>7</b> as starting points failed to provide an inhibitor with an acceptable overall profile. On the other hand, compound <b>8</b> presented some potential advantages as a starting point including higher BACE1 affinity and similar or better selectivity for BACE1 over cathepsin D (CatD) compared to <b>6</b> and <b>7</b>. The importance of achieving substantial selectivity for BACE1 over CatD has been highlighted by the recent report of ocular toxicity and neurodegeneration in rats that was attributed to CatD inhibition with the modestly selective BACE1 inhibitor LY-2811376.<a onclick="showRef(event, 'cit22a'); return false;" href="javascript:void(0);" class="ref cit22a">(22a)</a></div><div class="NLM_p">Truncation of the P3 cyanophenyl group of compound <b>8</b> to P1 cyanothiophene analogue <b>10</b> led to a 40-fold drop in BACE1 affinity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Introduction of a methyl group at the 6-position of the pyrimidine gave compound <b>11</b>, resulting in a 4-fold gain of BACE1 affinity. Replacement of the P1 5-cyano substituent of <b>11</b> with chloro (<b>12</b>) resulted in similar affinity and cellular potency for Aβ<sub>40</sub> lowering. On the other hand, further increase in lipophilicity resulting from replacement of the pyrimidine methyl substituent of <b>12</b> with ethyl (<b>13</b>) or <i>n</i>-propyl (<b>14</b>) was detrimental to cellular potency. The X-ray crystal structure of <b>11</b> complexed with BACE1 showed that truncation and subsequent pyrimidine substitution did not affect the overall binding mode of this series. The methoxy group of the pyrimidine remains deep in the S2″ binding pocket, while the methyl group projects toward the S2′ binding site as designed (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>). Selectivity for BACE1 over CatD for the truncated analogues was generally maintained or eroded relative to <b>8</b>, with the exception of <b>15</b>, which appeared to be highly BACE1 selective (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). In the absence of a crystal structure of <b>15</b> and its analogues in complex with CatD, a convincing explanation for the observed high selectivity of <b>15</b> is not readily apparent. A recent publication disclosing inhibitors that bind a region of BACE1 similar to that for the inhibitors described herein attributed the observed CatD selectivity to be a result of interactions between the inhibitors and Tyr<sup>78</sup> and Trp<sup>40</sup> of CatD.<a onclick="showRef(event, 'cit22g'); return false;" href="javascript:void(0);" class="ref cit22g">(22g)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR Investigation of Truncated Thiophene Analogues<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0013.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="(" /></col><col align="center" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup><b>1</b></sup></th><th class="colsep0 rowsep0" align="center">R<sup><b>2</b></sup></th><th class="colsep0 rowsep0" align="center">R<sup><b>3</b></sup></th><th class="colsep0 rowsep0" align="center" char="(">MW (ClogP)</th><th class="colsep0 rowsep0" align="center">BACE1 <i>K</i><sub>i</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">HEK293 Aβ<sub>40</sub> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">LE</th><th class="colsep0 rowsep0" align="center">CatD/BACE1</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="(">468 (2.8)</td><td class="colsep0 rowsep0" align="center">1.4</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="center">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">401 (1.0)</td><td class="colsep0 rowsep0" align="center">57</td><td class="colsep0 rowsep0" align="char" char=".">238</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="center">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">416 (1.5)</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="char" char=".">40</td><td class="colsep0 rowsep0" align="char" char=".">0.46</td><td class="colsep0 rowsep0" align="center">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">435 (2.7)</td><td class="colsep0 rowsep0" align="center">10</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="center">70</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">439 (3.2)</td><td class="colsep0 rowsep0" align="center">11</td><td class="colsep0 rowsep0" align="char" char=".">203</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">Cl</td><td class="colsep0 rowsep0" align="left"><i>n</i>Pr</td><td class="colsep0 rowsep0" align="left">OMe</td><td class="colsep0 rowsep0" align="char" char="(">453 (3.8)</td><td class="colsep0 rowsep0" align="center">15</td><td class="colsep0 rowsep0" align="char" char=".">190</td><td class="colsep0 rowsep0" align="char" char=".">0.35</td><td class="colsep0 rowsep0" align="center">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">OEt</td><td class="colsep0 rowsep0" align="char" char="(">430 (2.0)</td><td class="colsep0 rowsep0" align="center">48</td><td class="colsep0 rowsep0" align="char" char=".">361</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td><td class="colsep0 rowsep0" align="center"> >2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">SMe</td><td class="colsep0 rowsep0" align="char" char="(">432 (2.0)</td><td class="colsep0 rowsep0" align="center">45</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="center">5.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">NHMe</td><td class="colsep0 rowsep0" align="char" char="(">414 (1.6)</td><td class="colsep0 rowsep0" align="center">336</td><td class="colsep0 rowsep0" align="char" char=".">157</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="center">66</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Protocols for determination of inhibitor <i>K</i><sub>i</sub> values against purified human BACE1 and cathepsin D, as well as for cellular BACE1 IC<sub>50</sub> values, have been previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div></div></div><figure id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Superimposition of X-ray crystal structures of <b>11</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>) and <b>8</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>) complexed with BACE1. Red surface represents the catalytic dyad Asp<sup>32</sup> and Asp<sup>228</sup>. (b) Overlay of X-ray crystal structures of <b>11</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>), <b>15</b> (blue, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx">5hdx</a>), <b>16</b> (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz">5hdz</a>) and <b>17</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5">5he5</a>). The red ball represents the bridging water molecule between the Trp<sup>76</sup> and the nitrogen of the pyrimidine of <b>15</b>, <b>16</b>, and <b>17</b>. Pyrimidine moieties of <b>15</b>, <b>16</b>, and <b>17</b> have shifted almost 1.9 Å toward S2′ binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To probe if methoxy was optimal for binding in S2″, the methoxy group of <b>11</b> was homologated to the ethoxy analogue <b>15</b> which resulted in a 3-fold loss in BACE1 affinity and a similar loss of cellular potency. We next examined the isosteric aminomethyl and thiomethyl replacements. Thiomethyl substitution was tolerated with affinity similar to that of the ethoxy analogue (<b>16</b>, BACE1 <i>K</i><sub>i</sub> = 45 nM). In contrast, aminomethyl analogue <b>17</b> displayed a significant drop in affinity (BACE1 <i>K</i><sub>i</sub> = 336 nM). Interestingly, the X-ray structures of <b>15, 16</b>, and <b>17</b> complexed with BACE1 showed that the pyrimidine moiety had flipped to orient the ethoxy, thiomethyl and aminomethyl moieties toward the S2′ binding pocket and that the pyrimidine ring had shifted from the S2″ binding site by approximately 1.9 Å, engaging in an interaction with Trp<sup>76</sup> through conserved water molecules mimicking the binding modes of compound <b>6</b> (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b). Whereas the in-plane <i>anti</i>-oriented methoxy group of the pyrimidine ring of <b>11</b> is positioned optimally in the S2″ pocket, larger groups such as ethoxy and thiomethyl (e.g., <b>15</b> and <b>16</b>), or groups that lack the energetics to adopt preferentially the <i>anti</i>-orientation such as the aminomethyl group (e.g., <b>17</b>), occupy the relatively larger S2′ binding site.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> S1 SAR with Optimized S2′–S2″ Moiety</h3><div class="NLM_p">The SAR explorations described above demonstrated that truncation from S3 and optimization of the substituents in S2′ and S2″ could generate potent, ligand-efficient analogues relative to their higher molecular weight precursors. In fact, the optimal S2′–S2″ substituent, 4-methoxy-5-fluoro-6-methylpyrimidine, present in analogues <b>11</b> and <b>12</b>, imparted excellent affinity with minimal (methyl) occupancy of S2′, and both of these analogues gratifyingly showed reduced time-dependent inhibition of CYP3A4 compared to starting compound <b>8</b> (IC<sub>50</sub> 2 μM for <b>8</b> vs 24 μM and 18 μM for <b>11</b> and <b>12</b>, respectively). We attribute the reduced time-dependent CYP3A4 inhibition of <b>11</b> and <b>12</b> to the increased steric demand of the newly introduced methyl substituent, reducing the rate of oxidation of the pyrimidine moiety and/or redirecting metabolism to the methyl group itself.</div><div class="NLM_p">Given that the S1 thienyl moiety was originally installed to provide an optimal vector for the now absent aryl substituent into the S3 pocket, we next chose to replace this group with phenyl in combination with the optimized S2′–S2″ pyrimidine substituent. In this regard, compound <b>18</b> was well tolerated with a BACE1 <i>K</i><sub>i</sub> of 36 nM and whole cell potency of 58 nM (<a class="ref internalNav" href="#tbl3" aria-label="Table 2">Table 2</a>). A series of mono- and polyfluorinated phenyl analogues was also prepared to assess SAR related to in vitro potency, selectivity, and rat PK parameters. As shown in <a class="ref internalNav" href="#tbl3" aria-label="Table 2">Table 2</a>, introduction of fluorine to the P1 phenyl was generally beneficial, imparting improved <i>K</i><sub>i</sub> values (e.g., <b>9</b>, <b>19</b>–<b>22</b>). The improvement in potency may be due to general hydrophobic contacts within the lipophilic S1 site or may be driven by electrostatic interactions of the fluorine with the phenyl rings of Trp<sup>115</sup> and with the hydroxyl group of flap Tyr<sup>71</sup> as suggested by the X-ray cocrystal structure of the 2,4-difluorophenyl analogue <b>9</b> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>a).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> The exception to the potency improvements with fluorine addition are the 2,6-difluoro-containing analogues <b>23</b>–<b>25</b>. These analogues are all slightly less active than their 2-fluoro-6-proteophenyl counterparts (analogues <b>9</b>, <b>19</b>–<b>22</b>), possibly due to a weakly negative interaction with carbonyl of Gly<sup>230</sup> and carbonyl of the side chain carboxylic acid of Asp<sup>32</sup> (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>b).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR Investigation of Fluorophenyl Substitution in the Presence of the 4-Methoxy-5-fluoro-6-methylpyrimidinyl Substituent<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0014.gif" alt="" id="GRAPHIC-d257e1876-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0015.gif" alt="" id="GRAPHIC-d257e1877-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">Protocols for determination of inhibitor <i>K</i><sub>i</sub> values against purified human BACE1 and cathepsin D, as well as for cellular BACE1 IC<sub>50</sub> values, have been previously described.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">Concentration in brain homogenate 6h post 10 mpk PO dosing.</p></div></div><div></div></div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>9</b> complexed with BACE1. The hydroxyl moiety of Tyr<sup>71</sup> of the flap is 2.9 Å away from the 2-fluorine of 2,4-difluorophenyl group of compound <b>9</b>. (b) Superimposition of X-ray crystal structures of <b>9</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he7">5he7</a>) and a racemic sample of <b>23</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4">5he4</a>) complexed with BACE1. The 6-fluorine of the bound enantiomer of <b>23</b> is 3.1 Å away from the backbone carbonyl of Gly<sup>230</sup> and is 3.4 Å away from the carbonyl of the side chain carboxylic acid of Asp<sup>32</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Importantly, in all cases, the addition of fluorine did not significantly erode the cell Aβ<sub>40</sub> IC<sub>50</sub> values relative to the <i>K</i><sub>i</sub> values of these analogues, and compounds <b>9</b>, <b>19</b>, and <b>20</b> showed cell IC<sub>50</sub> values of less than 20 nM. In addition, all of these analogues showed at least 100-fold selectivity over CatD and did not show significant inhibition of CYP3A4 under preincubation conditions. Of these, the 2,4-difluorophenyl analogue <b>9</b> was selected for further profiling based on its favorable overall profile with respect to BACE1 affinity, cell potency, and 460-fold selectivity over CatD.</div><div class="NLM_p">Compound <b>9</b> displayed good selectivity for BACE1 over the human aspartic proteases pepsin (>20000×), renin (6820×), and cathepsin E (648×) but was not selective versus the closely related BACE1 homologue BACE2 (0.5×). Expressed predominantly in the periphery, BACE2 processes the melanocyte structural protein PMEL17 required for proper pigmentation in rodents.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> BACE2 is also expressed in pancreatic β-cells, and loss of BACE2 function has been associated with glucose homeostasis.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> While knowledge of BACE2 mediated biological processes continues to evolve, current understanding mitigates concerns related to BACE2 inhibition for development of a therapeutic agent. In a counterscreen of a panel of human receptors, enzymes, and ion channels, <b>9</b> did not show significant off-target activity with the exception of histamine H2 (<i>K</i><sub>i</sub> = 4.9 μM), melatonin MT1 (<i>K</i><sub>i</sub> = 2.9 μM), and motilin (<i>K</i><sub>i</sub> = 19 μM) receptors.</div><div class="NLM_p">Compound <b>9</b> did not significantly inhibit human CYPs 1A2, 2C8, 2C9, 2C19, 2D6, and 3A4 at concentrations below 20 μM and thus has minimal risk of interaction with drugs that are metabolized by the major human CYPs, demonstrating a marked improvement over its progenitor <b>6</b>. Inhibition of the <i>h</i>ERG channel by <b>9</b> (IC<sub>50</sub> = 1.9 μM) was also reduced relative to <b>6</b>.</div><div class="NLM_p">The pharmacokinetic parameters of <b>9</b> are shown in <a class="ref internalNav" href="#tbl4" aria-label="Table 3">Table 3</a>. Oral bioavailability of <b>9</b> was low in rats and dogs and moderate in monkeys, consistent with the high Cl<sub>int</sub> observed in hepatocytes of the respective species. In vivo total clearance exceeded liver blood flow in rats and dogs, indicating that clearance pathways other than hepatic extraction contribute to total clearance. In this regard, <b>9</b> was unstable in rat and dog plasma, suggesting that its plasma instability may constitute a significant extrahepatic clearance pathway in these species. In cynomolgus monkeys, total in vivo clearance of <b>9</b> was moderate and in concert with the moderate volume of distribution resulted in higher plasma exposure and a longer half-life in vivo. The compound achieves substantial total brain concentrations in rats and monkeys (brain/plasma ratios of 0.8 and 3.2, respectively). The improved brain penetration of <b>9</b> compared to <b>6</b>, which had a brain/plasma ratio in rats of 0.1,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> is consistent with the reduction in calculated PSA achieved during optimization (PSA 94 Å<sup>2</sup> vs 109 Å<sup>2</sup>, respectively). While instability of <b>9</b> in plasma from rat, dog, and monkey precluded accurate determination of plasma protein binding values, the compound is more stable in human plasma (95% bound). In human hepatocytes, <b>9</b> exhibited low intrinsic clearance (1.8 μL/min/10<sup>6</sup> cells), in contrast with the high hepatocyte clearance observed in rat, dog, and monkey hepatocytes (<a class="ref internalNav" href="#tbl4" aria-label="Table 3">Table 3</a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Rat, Dog, And Monkey Pharmacokinetic Parameters of <b>9</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center" char=".">dose (mg/kg)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>(0–∞)</sub> (μM·h)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">%<i>F</i></th><th class="colsep0 rowsep0" align="center" char=".">Hep Cl<sub>int</sub> (μL/min/10<sup>6</sup> cells)</th><th class="colsep0 rowsep0" align="center" char=".">in vivo clearance (mL/min/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub>,ss (L/kg)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.30</td><td class="colsep0 rowsep0" align="char" char=".">0.1</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dog</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.39</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">8.2</td><td class="colsep0 rowsep0" align="char" char=".">73</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">monkey</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">0.49</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">7.3</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">Oral.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">Intravenous (3 mg/kg for rat and 1 mg/kg for dog and monkey).</p></div></div></div><div class="NLM_p">Compound <b>9</b> was evaluated to assess its ability to lower Aβ<sub>40</sub> in the plasma, brain, and CSF of rats (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>). Dose related increases in exposure of <b>9</b> in plasma, brain, and CSF were seen across the dose range of 0.3–300 mg/kg, and dose responsive lowering of Aβ<sub>40</sub> was observed in all three compartments. The lowest dose of 0.3 mg/kg of <b>9</b> lowered Aβ<sub>40</sub> in plasma to 40% of the control levels corresponding to an ED<sub>50</sub> for Aβ<sub>40</sub> lowering of 0.5 mg/kg in plasma. On the other hand, potency for CSF and cortex Aβ<sub>40</sub> lowering was considerably shifted rightward with ED<sub>50</sub> values of 5.2 and 12.7 mg/kg, respectively. Notably, levels of <b>9</b> in the CSF were below the limit of quantitation at the 3 mg/kg dose, a dose at which significant CSF Aβ<sub>40</sub> lowering was observed. Consistent with this observation, <b>9</b> was determined to be a rat Pgp substrate in an MDCK cell line overexpressing MDR1 (efflux ratio >30; <i>P</i><sub>app</sub> 41 × 10<sup>–6</sup> cm/s), indicating that CSF levels of <b>9</b> cannot be considered a reliable predictor of its free brain concentration.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Measured total concentration of <b>9</b> in plasma (<i>C</i><sub>P</sub>), CSF (<i>C</i><sub>CSF</sub>), and brain (<i>C</i><sub>B</sub>) of rats at doses ranging from 0.3 mg/kg to 300 mg/kg. (b) Effect of acute oral administration of compound <b>9</b> on the reduction of plasma, CSF, and cortical Aβ<sub>40</sub> levels in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The pharmacodynamic profile of <b>9</b> was also determined in nonhuman primates. Single doses of compound <b>9</b> (10, 30, and 100 mg/kg) were orally administered to cisterna magna ported rhesus monkeys, enabling evaluation of its effect on the temporal dynamics of BACE1-related biomarkers in CSF and plasma. Plasma and CSF samples were collected at 2, 4, 6, 8, 12, 24, and 48 h post dose to analyze compound and Aβ<sub>40</sub> levels. In addition, Aβ<sub>42</sub> and sAPPβ were analyzed at each time point in the samples from CSF. A dose dependent increase in exposure of <b>9</b> was observed in plasma and CSF (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a). Correspondingly, dose- and time-dependent reduction of CSF Aβ<sub>40</sub> was observed with profound peak reduction (−77% relative to baseline) observed at 24 h following the high dose (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>d). The maximum lowering of plasma Aβ<sub>40</sub> at each dose was not differentiated, with apparent plateauing at 50–60% reduction as a result of the limited window of quantification by the plasma Aβ<sub>40</sub> assay. However, a dose-dependent effect on the duration of plasma Aβ<sub>40</sub> inhibition was observed which correlated with plasma exposures of <b>9</b> (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>c). Peak reductions of CSF Aβ<sub>40</sub> occurred at time points that were significantly delayed relative to the timing (<i>T</i><sub>max</sub>) of the plasma and CSF <i>C</i><sub>max</sub> concentrations of <b>9</b>, with the delay (∼6 h) more pronounced at the lower doses (cf. <a class="ref internalNav" href="#fig7" aria-label="Figures 7">Figures 7</a>a,d). Reductions of Aβ<sub>42</sub> and sAPPβ in the CSF followed a temporal pattern very similar to that of Aβ<sub>40</sub> (<a class="ref internalNav" href="#fig7" aria-label="Figures 7">Figures 7</a>e,f). This hysteresis effect is likely related to the kinetics of central Aβ turnover and transit to the CSF from within the brain.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Acute PK/PD profile of compound <b>9</b> in cisterna magna ported rhesus monkeys. Plasma and CSF samples were collected at 2, 4, 6, 8, 12, 24, and 48 h after oral administration of <b>9</b> (10, 30, or 100 mg/kg) and analyzed for both compound concentrations and Aβ<sub>40</sub> levels. (a) Plasma and CSF concentrations of <b>9</b> over time. (b) Pharmacokinetic parameters of <b>9</b>. (c) Plasma Aβ<sub>40</sub> levels. (d) CSF Aβ<sub>40</sub> levels. (e) CSF Aβ<sub>42</sub> levels. (f) CSF sAPPβ levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The acute effect of <b>9</b> on the reduction of CSF and cortex Aβ<sub>40</sub> was investigated in cynomolgus monkeys (<a class="ref internalNav" href="#fig8" aria-label="Figure 8">Figure 8</a>). Acute oral administration of <b>9</b> at 10 mg/kg resulted in 58% reduction of Aβ<sub>40</sub> in cortex compared with the vehicle control group when evaluated at 4 h post dose. Interestingly, CSF Aβ<sub>40</sub> reduction (35% relative to control) was not as pronounced as that observed in cortex at the same time point.</div><div class="NLM_p">The greater reduction of cortex Aβ<sub>40</sub> compared to CSF Aβ<sub>40</sub> at the 4 h time point is thought to be a manifestation of the dynamics of Aβ<sub>40</sub> transit and turnover under the conditions of acute administration of <b>9</b>. A close temporal relationship between BACE1 inhibition of Aβ<sub>40</sub> synthesis and the magnitude of Aβ<sub>40</sub> inhibition would be expected in cortex where Aβ<sub>40</sub> is directly produced. In contrast, the degree of reduction of Aβ<sub>40</sub> in the CSF under nonsteady state conditions of acute inhibitor administration is dependent on the kinetics of Aβ<sub>40</sub> clearance from CSF and of transit of newly synthesized Aβ into the CSF compartment from the primary sites of synthesis in the brain.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> This hypothesis is consistent with the observed delay to maximum CSF Aβ<sub>40</sub> lowering of 12–24 h post dosing in rhesus monkeys (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>d).</div><figure id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute effect of compound <b>9</b> (10 mg/kg) on CSF and cortical Aβ<sub>40</sub> levels in cynomolgus monkeys (*<i>p</i> = 0.0014, **<i>p</i> < 0.0007).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Design and development of potent BACE1 inhibitors for advanced clinical studies have been challenging due to the intrinsic nature of the BACE1 active site and the localization of the enzyme within intracellular compartments of the brain. To achieve high affinity, inhibitors require polar functionality to interact with the active site catalytic aspartic acids complemented by lipophilic groups that bind in the adjacent specificity pockets. Successful inhibitor development requires an appropriate balance of properties to achieve cell and brain penetration while minimizing off-target liabilities. Our earlier work employing the novel bicyclic iminopyrimidinone scaffold clearly illustrated these challenges, resulting in the potent BACE1 inhibitor <b>6</b> which suffered from significant CYP3A4 and <i>h</i>ERG inhibition and suboptimal brain exposure. Using <b>6</b> as a starting point, improvement of the ancillary profile and CNS properties was achieved by truncation of the P3 moiety and optimization of the pyrimidine moiety binding in the S2′–S2″ region, delivering <b>11</b>. Subsequent optimization of the P1 aryl group of <b>11</b> to improve affinity and selectivity delivered 2,4-difluorophenyl analogue <b>9</b>, which is structurally diverse from previously reported S1–S3 binding inhibitors and afforded robust central Aβ reduction in rats and monkeys.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38862" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38862" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Procedures for X-ray crystallography, aspartyl protease <i>K</i><sub>i</sub> determination, cell Aβ<sub>40</sub> IC<sub>50</sub> determination, and determination of Aβ levels in rat brain and CSF samples were conducted as previously described.<a onclick="showRef(event, 'ref15 ref16 ref18'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref18">(15, 16, 18)</a></div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Synthesis</h3><div class="NLM_p">Unless otherwise mentioned, all the reagents and solvents were obtained from commercial sources and used without further purification. Air sensitive chemistries were performed under an atmosphere of nitrogen or argon. Purification of the final compounds to >95% purity were carried out either using a prepacked silica gel cartridge (Analogix or Biotage or ISCO) or a reverse phase C18 column (mobile phase, A = 0.05% TFA in water and B = 0.05% TFA in acetonitrile, gradient = 10% to 95% B over 10 min). All NMR data unless otherwise specified were collected at 400 MHz on Varian or Bruker instruments. Chemical shifts are reported in ppm relative to the residual solvent peak in the indicated solvent, and for <sup>1</sup>H NMR, multiplicities, coupling constants in hertz and numbers of protons are indicated parenthetically. Microwave assisted reactions were performed in a Smith synthesizer from Personal Chemistry. Purity and MS information was obtained via LC-electrospray-mass spectroscopy with a C18 column using a gradient of 5–95% MeCN in water with 0.05% TFA as the mobile phase. The purity of the samples was assessed using a UV detector at 254 nm. An additional analytical reverse phase HPLC system was used to assess the purity of final compounds using an ELSD detector and a UV detector monitoring both 220 and 254 nm.</div><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> <i>tert</i>-Butyl ((4a<i>R</i>,7a<i>R</i>)-7a-(5-Cyanothiophen-2-yl)-3-methyl-4-oxohexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2(3<i>H</i>)-ylidene)carbamate (<b>29</b>)</h4><div class="NLM_p">To a solution of <b>26</b> (1.8 g, 3.1 mmol) in methanol (40 mL) was added 10% palladium on carbon (0.9 g), and the resulting mixture was stirred under an atmosphere of H<sub>2</sub> at rt for 1.5 h. The reaction mixture was filtered, the filtrate was concentrated, and the residue was purified by silica gel chromatography using 0–100% ethyl acetate in hexanes to provide <b>27</b> (1.41 g, 92%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.4 (m, 1H), 7.31 (m, 1H), 6.97–6.99 (m, 2H), 4.20 (m, 2H), 3.68–4.06 (m, 4H), 3.50 (m, 1H), 3.30 (s, 3H), 1.53 (s, 9H), 1.01 (m, 2H), 0.03 (s, 9H).</div><div class="NLM_p">To a solution of <b>27</b> (1.41 g, 2.8 mmol) in DMF (15 mL) was added NBS (0.6 g, 3.4 mmol), and the resulting mixture was stirred at rt for 12 h. The reaction mixture was diluted with ethyl acetate (100 mL) and washed with brine and then with water. The organic layer was dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated. The crude product was purified by silica gel chromatography using 0–100% ethyl acetate in hexanes to provide <b>28</b> (0.96 g, 60%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.39 (m, 1H), 6.94 (d, <i>J</i> = 4.0 Hz, 1H), 6.76 (m, 1H), 4.20 (m, 2H), 3.68–4.04 (m, 4H), 3.43 (m, 1H), 3.29 (s, 3H), 1.53 (s, 9H), 1.01 (m, 2H), 0.03 (s, 9H).</div><div class="NLM_p last">To a solution of <b>28</b> (1.0 g, 1.7 mmol) in DMA (3 mL) were added PdCl<sub>2</sub>(dppf) (0.13 g, 0.17 mmol), Zn(CN)<sub>2</sub> (0.20 g, 1.7 mmol), and Zn powder (0.11 g, 1.7 mmol). The resulting solution was degassed and heated at 80 °C for 4 h. The reaction mixture was then diluted with ethyl acetate and passed through a silica gel plug. The filtrate was evaporated, and to a solution of the resulting material in dichloromethane (5 mL) was added Et<sub>3</sub>N (0.5 mL, 3.5 mmol) and (Boc)<sub>2</sub>O (0.57 g, 2.6 mmol). The resulting solution was stirred at rt for 12 h and then evaporated to dryness. The crude product was purified via silica gel chromatography eluting with 25% ethyl acetate in hexanes to provide a Teoc-protected precursor to cyanothiophene core <b>29</b> (0.628 g, 71%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.47 (m, 1H), 7.51 (d, <i>J</i> = 4.5 Hz, 1H), 7.04 (m, 1H), 4.16–4.20 (m, 2H), 3.71–4.04 (m, 4H), 3.46–3.49 (m, 1H), 3.26 (s, 3H), 1.50 (s, 9H), 0.98 (m, 2H), 0.01 (s, 9H). To a solution of this intermediate (1.0 g, 1.9 mmol) in THF (2 mL) was added a solution of 1 M TBAF in THF (5.7 mL, 5.7 mmol) at 0 °C, and the resulting solution was warmed to rt over period of 30 min and then stirred for additional 3 h. The reaction mixture was evaporated to dryness and was directly loaded into silica gel column and purified using 100% ethyl acetate to provide <b>29</b> (0.56 g, 80%).</div></div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Procedure A for <i>N</i>-Arylation and Subsequent Boc Removal</h3><div class="NLM_p">To a solution of the pyrrolidine intermediate (1 equiv) and heteroaryl halide (1.2 equiv) in toluene (5 mL/mmol of pyrroldine) were added tris(dibenzylidene-acetone)dipalladium(0) (0.1 equiv), (2-biphenylyl)di-<i>tert</i>-butylphosphine (JohnPhos, 0.15 equiv), and Na-O<i>t</i>Bu (2.2 equiv). The resulting solution was degassed and heated at 70 °C for 3 h, then cooled to room temperature, filtered through a pad of Celite, and the crude material was purified via silica gel chromatography using ethyl acetate in hexanes as the eluant to give an <i>N</i>-arylated product. The Boc protecting group was removed through treament of this material with 20% TFA/CH<sub>2</sub>Cl<sub>2</sub> (2.5 mL/mmol). The deprotected compounds were purified by reverse phase HPLC (C18) using 0–90% water/acetonitrile with 0.05% TFA.</div><div id="sec5_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 5-((4a<i>R</i>,7a<i>R</i>)-6-(5-Fluoro-4-methoxypyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-7a-yl)thiophene-2-carbonitrile (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared from compound <b>29</b> (38 mg, 0.10 mmol) and 2-chloro-5-fluoro-4-methoxypyrimidine following general procedure A (2.2 mg, 5%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.05 (d, <i>J</i> = 3.3 Hz, 1H), 7.76 (d, <i>J</i> = 4.0 Hz, 1H), 7.33 (d, <i>J</i> = 4.0 Hz, 1H), 4.41 (d, <i>J</i> = 12.4 Hz, 1H), 4.10 (m, 4H), 4.02 (s, 3H), 3.33 (s, 3H). <i>m</i>/<i>z</i>: 402.2.</div></div><div id="sec5_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 5-((4a<i>R</i>,7a<i>R</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-7a-yl)thiophene-2-carbonitrile (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared from compound <b>29</b> (40 mg, 0.11 mmol) and 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine following general procedure A (26 mg, 60%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 4.0 Hz, 1H), 7.32 (d, <i>J</i> = 4.0 Hz, 1H), 4.88 (s, 3H), 4.40 (d, <i>J</i> = 12.9 Hz, 1H), 4.08 (m, 4H), 3.98 (s, 3H), 3.33 (s, 3H), 2.28 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 416.2.</div></div><div id="sec5_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> <i>tert</i>-Butyl ((4a<i>R</i>,7a<i>R</i>)-7a-(5-Chlorothiophen-2-yl)-3-methyl-4-oxohexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-2(3<i>H</i>)-ylidene)carbamate (<b>31</b>)</h4><div class="NLM_p">To a solution of <b>27</b> (1.0 g, 1.9 mmol) in DMF (15 mL) was added NCS (0.26 g, 4.5 mmol), and the resulting mixture was stirred at 50 °C for 2 h and then cooled to room temperature. The reaction mixture was diluted with water and extracted with ethyl acetate (3 × 50 mL). The organic layers were combined, dried with Na<sub>2</sub>SO<sub>4</sub> and concentrated, and the residue was purified via silica gel chromatography using 25% ethyl acetate in hexanes to provide 5-chlorothiophene <b>30</b> (0.846 g, 80%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.39 (m, 1H), 6.78 (m, 2H), 4.19–4.21 (m, 2H), 3.71–4.04 (m, 4H), 3.43 (m, 1H), 3.29 (s, 3H), 1.52 (s, 9H), 1.0 (m, 2H), 0.03 (s, 9H).</div><div class="NLM_p last">To a solution of <b>30</b> (0.846 g, 1.6 mmol) in THF (2 mL) was added a solution of 1 M TBAF in THF (4.8 mL, 4.8 mmol) at 0 °C, and the resulting solution was warmed to rt over period of 30 min and then stirred for additional 3 h. The reaction mixture was evaporated to dryness and was loaded onto silica gel column and purified using 100% ethyl acetate to provide <b>31</b> (0.417 g, 75%).</div></div><div id="sec5_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> (4a<i>R</i>,7a<i>R</i>)-7a-(5-Chlorothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared from compound <b>31</b> (20 mg, 0.052 mmol) and 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine following general procedure A (10 mg, 48%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.03 (d, <i>J</i> = 3.9 Hz, 1H), 6.97 (d, <i>J</i> = 3.9 Hz, 1H), 4.36 (d, <i>J</i> = 12.3 Hz, 1H), 4.07 (m, 4H), 3.98 (s, 3H), 3.33 (s, 3H), 2.29 (d, <i>J</i> = 3.0 Hz, 3H). <i>m</i>/<i>z</i>: 425.2.</div></div><div id="sec5_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (4a<i>R</i>,7a<i>R</i>)-7a-(5-Chlorothiophen-2-yl)-6-(4-ethyl-5-fluoro-6-methoxypyrimidin-2-yl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared from compound <b>31</b> (20 mg, 0.052 mmol) and 2-chloro-4-ethyl-5-fluoro-6-methoxypyrimidine following general procedure A (10 mg, 46%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.03 (d, <i>J</i> = 3.9 Hz, 1H), 6.97 (d, <i>J</i> = 3.9 Hz), 4.34 (d, <i>J</i> = 12.4 Hz, 1H), 4.08 (m, 4H), 3.98 (s, 3H), 3.33 (s, 3H), 2.65 (qq, <i>J</i> = 2.5 Hz, 7.6 Hz, 2H), 1.22 (t, <i>J</i> = 7.5 Hz, 3H). <i>m</i>/<i>z</i>: 439.2.</div></div><div id="sec5_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> (4a<i>R</i>,7a<i>R</i>)-7a-(5-Chlorothiophen-2-yl)-6-(5-fluoro-4-methoxy-6-propylpyrimidin-2-yl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared from compound <b>31</b> (20 mg, 0.052 mmol) and 2-chloro-5-fluoro-4-methoxy-6-propylpyrimidine following general procedure A (11 mg, 48%). <sup>1</sup>H NMR (CD<sub>3</sub>OD) δ 7.03 (d, <i>J</i> = 4.0 Hz, 1H), 6.97 (d, <i>J</i> = 3.9 Hz, 1H), 4.36 (d, <i>J</i> = 12.2 Hz, 1H), 4.22–4.07 (m, 1H), 4.07–4.00 (m, 2H), 3.99 (s, 3H), 3.32 (s, 3H), 2.67–2.54 (m, 2H), 1.70 (h, <i>J</i> = 7.4 Hz, 2H), 0.95 (t, <i>J</i> = 7.4 Hz, 3H). <i>m</i>/<i>z</i>: 453.2.</div></div><div id="sec5_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-((4a<i>R</i>,7a<i>R</i>)-6-(4-Ethoxy-5-fluoro-6-methylpyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-7a-yl)thiophene-2-carbonitrile (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared from compound <b>29</b> (60 mg, 0.16 mmol) and 2-chloro-4-ethoxy-5-fluoro-6-methylpyrimidine following general procedure A (14 mg, 20%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.75 (d, <i>J</i> = 4.0 Hz, 1H), 7.32 (d, <i>J</i> = 4.0 Hz, 1H), 4.48–4.42 (q, <i>J</i> = 7.1 Hz, 2H), 4.40 (d, <i>J</i> = 12.3 Hz, 1H), 4.15 (dd, <i>J</i> = 8.7, 7.0 Hz, 1H), 4.11–3.98 (m, 4H), 3.32 (s, 3H), 2.28 (d, <i>J</i> = 3.0 Hz, 3H), 1.39 (t, <i>J</i> = 7.1, 3H). <i>m</i>/<i>z</i>: 430.2.</div></div><div id="sec5_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-((4a<i>R</i>,7a<i>R</i>)-6-(5-Fluoro-4-methyl-6-(methylthio)pyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-7a-yl)thiophene-2-carbonitrile (<b>16</b>)</h4><div class="NLM_p last">To a solution of compound <b>29</b> (90 mg, 0.24 mmol) in toluene (3 mL) was added tris(dibenzylidene-acetone)dipalladium(0)·CHCl<sub>3</sub> (27 mg, 0.026 mmol), 2-cyclohexylphosphino-2′-(<i>N</i>,<i>N</i>-dimethylamino)biphenyl (24 mg, 0.068 mmol), and sodium <i>tert</i>-butoxide (74 mg, 0.77 mmol), and the vial was degassed with nitrogen (evacuate/flush, 3×) and 2-chloro-5-fluoro-4-methyl-6-(methylthio)pyrimidine (63 mg, 0.33 mmol) was added as a solution in toluene (0.2 mL). The reaction mixture was heated at 60 °C for 16 h, then cooled to room temperature, filtered through a pad of Celite, and concentrated. The crude material was purified by flash chromatography using 0–60% ethyl acetate in hexanes to afford an <i>N</i>-arylated product that was treated with 20% TFA/CH<sub>2</sub>Cl<sub>2</sub> (2 mL) to remove the Boc-protecting group. This material was purified by reverse phase HPLC (C18, 35 mL/min, 10–95% MeCN/H<sub>2</sub>O, 0.05% TFA) to provide compound <b>16</b> (46 mg, 45%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.77–7.72 (m, <i>J</i> = 3.3 Hz, 1 H), 7.33 (d, <i>J</i> = 4.0 Hz, 1 H), 4.53–4.42 (m, 1 H), 4.25–4.14 (m, 1 H), 4.14–4.01 (m, 3 H), 3.33 (s, 3 H), 2.53 (s, 3 H), 2.29 (d, <i>J</i> = 2.2 Hz, 3 H).</div></div><div id="sec5_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-((4a<i>R</i>,7a<i>R</i>)-6-(5-Fluoro-4-methyl-6-(methylamino)pyrimidin-2-yl)-2-imino-3-methyl-4-oxooctahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-7a-yl)thiophene-2-carbonitrile (<b>17</b>)</h4><div class="NLM_p last">Compound <b>17</b> was prepared from compound <b>29</b> (53 mg, 0.14 mmol) and <i>tert</i>-butyl (2-chloro-5-fluoro-6-methylpyrimidin-4-yl) (methyl)carbamate following general procedure A (21 mg, 38%, yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.76 (d, <i>J</i> = 3.9 Hz, 1H), 7.35 (d, <i>J</i> = 4.0 Hz, 1H), 4.27–4.08 (m, 3H), 3.31 (s, 3H), 3.03 (s, 3H), 2.33 (d, <i>J</i> = 3.1 Hz, 3H). <i>m</i>/<i>z</i>: 415.2.</div></div><div id="sec5_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> (4a<i>R</i>,7a<i>S</i>)-7a-(2,4-Difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyloctahydro-4<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4-one (<b>9</b>)</h4><div class="NLM_p">To a solution of 2-(2,4-difluorophenyl)acetonitrile <b>32</b> (75 g, 0.49 mol) in MeOH (3 L) was added glyoxylic acid (50% (w/w) in water, 81.8 mL, 0.735 mol). The resulting reaction mixture was cooled to 0 °C and then K<sub>2</sub>CO<sub>3</sub> (169 g, 1.2 mol) was added in several portions. After the addition of K<sub>2</sub>CO<sub>3</sub>, the reaction mixture was heated at 70 °C overnight and then was allowed to cool to room temperature. The resulting white precipitate was collected by filtration and washed with cold water and with methanol to afford <b>33</b> as a white solid after drying in a vacuum oven (108 g, 89%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (m, 1H), 7.34 (m, 1H), 7.15 (m, 1H), 6.84 (s, 1H).</div><div class="NLM_p">To a mixture of concentrated sulfuric acid (0.630 L) and 99% formic acid (8.36 L) at rt was added <b>33</b> (1424 g, 5.76 mol) in several portions over 15 min. The resulting solution was heated at reflux for 3 h and allowed to cool to rt overnight. The precipitated solid was collected by vacuum filtration and redissolved in toluene (1.5 L). The resulting solution was concentrated under reduced pressure to provide <b>34</b> (568 g, 47%) as a white solid. The filtrate from the reaction was then extracted with toluene (3 × 4 L) and the combined extracts concentrated under reduced pressure to afford additional <b>34</b> (569 g, 47%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.43 (m, 1H), 7.21 (d, 1H), 7.08 (m, 1H), 7.02 (m, 1H).</div><div class="NLM_p">A solution of <b>34</b> (252 g, 1.20 mol) in THF (800 mL) was cooled to 0–5 °C, and trifluoroacetic acid (20 mL, 0.260 mol) was then added. To the resulting mixture was added a solution of <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl)benzylamine <b>35</b> (80% pure, 455 g, 1.50 mol) in THF (300 mL) dropwise over 2 h. The internal temperature was monitored and kept below 15 °C. Upon completion of the addition, the cold bath was removed, the reaction mixture was warmed to rt and stirred for 18 h, and then the solvents were removed under reduced pressure. Methanol (1.1 L) was added, and the reaction mixture was stirred overnight. The precipitated solid was collected by vacuum filtration, washed with methanol (400 mL) and then with diethyl ether (500 mL), and dried to give <b>36</b> (257 g, 57%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.63 (m, 1H), 7.30–7.06 (m, 7H), 3.73 (m, 3H), 3.54 (s, 3H), 3.31 (m, 1H), 3.09 (m, 2H), 2.97 (m, 1H). <i>m</i>/<i>z</i>: 376.1.</div><div class="NLM_p">To a slurry of <b>36</b> (250 g, 0.666 mol) in anhydrous toluene (2.22 L) was added triethylamine (67.4 g, 0.666 mol). The resulting suspension was stirred at rt for 10 min and then DPPA (202 g, 0.733 mol) was added. The reaction mixture was heated at 66 °C for 30 min and then was cooled to 40–50 °C, and to this mixture was added acetic acid (40.0 g, 0.666 mol) followed by 2-(trimethylsilyl)ethanol (118 g, 0.998 mol). The resulting mixture was heated at gentle reflux overnight. The reaction mixture was cooled to room temperature, concentrated under reduced pressure, diluted with ethyl acetate (1 L), and the suspension washed with saturated aqueous sodium bicarbonate (2 × 800 mL). The combined aqueous layers were back extracted with ethyl acetate (400 mL). The organic layers were combined, washed with brine (600 mL), dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The resulting residue was purified by flash column chromatography (silica gel, 15% EtOAc/heptane) to afford a Teoc protected Curtius product (155 g, 48%) as a light-yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (m, 1H), 7.32 (m, 5H), 6.82 (m, 3H), 4.08 (m, 2H), 3.76 (d, 2H), 3.71 (s, 3H), 3.61 (m, 1H), 3.40 (m, 1H), 3.36 (m, 1H), 3.01 (m, 2H), 0.98 (m, 1H), 0.02 (s, 9H). <i>m</i>/<i>z</i>: 491.1.</div><div class="NLM_p">A solution of HCl (4 M in 1,4-dioxane, 313 mL, 1.25 mol) was added to a portion of the above material (68.0 g, 0.139 mol). The resulting solution was stirred at rt overnight. At this time, the reaction mixture was concentrated under reduced pressure to a syrup and then basified to pH 9 by slow addition of saturated aqueous sodium carbonate. The resulting suspension was extracted with ethyl acetate (4 × 300 mL). The combined extracts were dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was further dried under high vacuum for 30 min to give amine <b>37</b> as a crude mixture that was used directly in the next step. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.31 (m, 1H), 7.43 (m, 5H), 7.90 (m, 2H), 6.19 (m, 1 H), 4.43 (m, 2H), 4.17 (m, 2H), 4.00 (m, 2H), 3.71 (s, 3H). To a solution of this crude amine <b>37</b> in anhydrous DMF (700 mL) was added DIEA (97.0 mL, 0.556 mol), <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (33.6 g, 0.177 mol), and EDCI (42.4 g, 0.221 mol). The resulting mixture was stirred at 30 °C for 24 h. At this time, the reaction mixture was cooled to rt, diluted with ethyl acetate (1.5 L), and washed sequentially with water (4 × 800 mL) and brine (500 mL). The organic layer was dried over anhydrous sodium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by flash column chromatography (silica gel, 15% ethyl acetate/heptane) to afford racemic <b>38</b> as a white solid (41.1 g, 63%). The enantiomers were separated using chiral HPLC (Chiralpak AD column, 20 μm, 5 cm × 50 cm, 40 mL/min, 95% hexane/2-propanol) to afford desired enantiomer <b>39</b> (slower eluting, <i>t</i><sub><i>R</i></sub> = 65 min) and undesired enantiomer <b>40</b> (faster eluting, <i>t</i><sub><i>R</i></sub> = 34 min). <sup>1</sup>H NMR for <b>39</b> (400 MHz, CDCl<sub>3</sub>) δ 7.39 (m, 5H), 7.31 (m, 1H), 6.99 (m, 2H), 3.86 (s, 2H), 3.79 (m, 1H), 3.38 (s, 3H), 3.36 (m, 3H), 3.20 (m, 1H), 1.63 (s, 9H). <i>m</i>/<i>z</i>: 471.1.</div><div class="NLM_p">To a solution of <b>39</b> (3.57 g, 7.44 mmol) in methanol (30 mL) was added 20% Pd(OH)<sub>2</sub> on carbon (0.97 g), and the resulting mixture was degassed under vacuum and purged with N<sub>2</sub>.  The reaction mixture was then stirred under an atmosphere of H<sub>2</sub> at rt overnight and then filtered through Celite. The Celite was washed with MeOH, and the combined filtrate and washings were evaporated to give <b>41</b> (2.63 g, 91%), which was used without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (m, 1H), 7.00 (m, 2H), 4.03 (m, 1 H), 3.91 (m, 2H), 3.72 (m, 1H), 3.58 (m, 1H), 3.35 (s, 3H), δ 1.60 (s, 9H). <i>m</i>/<i>z</i>: 381.2.</div><div class="NLM_p last">To a flame-dried and N<sub>2</sub> purged flask was added 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine (765 mg, 4.33 mmol), 2′-(di-<i>tert</i>-butylphosphino)-<i>N</i>,<i>N</i>-dimethylbiphenyl-2-amine (63 mg, 0.18 mmol), Pd(OAc)<sub>2</sub> (37 mg, 0.167 mmol), and sodium <i>tert</i>-butoxide (705 mg, 7.33 mmol) in one portion. To this mixture was then added a solution of <b>41</b> (1.27 g, 3.33 mmol) in anhydrous toluene (10 mL). The reaction mixture was heated at 100 °C in an oil bath with stirring for 30 min and then cooled to rt. The reaction mixture was diluted with CH<sub>2</sub>Cl<sub>2</sub> (100 mL) and acidified with 5% aqueous citric acid. The aqueous layer was extracted with CH<sub>2</sub>Cl<sub>2</sub> (50 mL). The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude mixture was purified by silica gel chromatography (gradient from 0% to 15% EtOAc/hexanes) to afford the corresponding <i>N</i>-arylated product (1.30 g, 75% yield). This material was stirred with 20% TFA/DCM (10 mL) at rt for 4 h and then concentrated. The residue was purified by reverse phase HPLC (Novapak HR-C18, 25 mm × 100 mm, 6 μm) gradient from 10% to 90% MeCN/H<sub>2</sub>O with 0.1% HCOOH, 35 mL/min) to give <b>9</b> (0.57 g, 78%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.40 (m, 1H), 7.18 (m, 1H), 7.07 (m, 1H), 4.55 (dd, <i>J</i> = 3.2 Hz, 12.5 Hz, 1H,), 4.21 (m, 2H), 3.98 (s, 1H), 3.29 (s, 3H), 2.29 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 421.1.</div></div><div id="sec5_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyl-7a-phenylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">Compound <b>18</b> was prepared from 3-phenylfuran-2,5-dione according to the procedures for compound <b>9</b> beginning from the [3 + 2] cycloaddition step with <b>35</b> and using general procedure A for the <i>N</i>-arylation and final deprotection. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.51–7.38 (m, 5H), 4.32 (d, <i>J</i> = 12.2 Hz, 1H), 4.17 (dd, <i>J</i> = 10.4, 8.7 Hz, 1H), 4.07 (t, <i>J</i> = 8.4 Hz, 1H), 3.97 (m, 5H), 3.27 (s, 3H), 2.28 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 385.2</div></div><div id="sec5_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-7a-(2-fluorophenyl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was prepared from 2-(2-fluorophenyl)acetonitrile according to the procedures for compound <b>9</b> and using general procedure A for the <i>N</i>-arylation and final deprotection. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.17–7.04 (m, 4H), 4.48 (dd, <i>J</i> = 2.0 Hz, 12.4 Hz, 1H), 4.33 (dd, <i>J</i> = 10.0 Hz, 10.5 Hz, 1H), 4.09 (t, <i>J</i> = 9.3 Hz, 1H), 4.02 (d, <i>J</i> = 12.4 Hz, 1H), 3.96 (s, 3H), 3.81 (t, <i>J</i> = 10.4 Hz, 1H), 3.36 (s, 3 H), 2.29 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 403.2.</div></div><div id="sec5_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-7a-(4-fluorophenyl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last">Compound <b>20</b> was prepared from 3-(4-fluorophenyl)furan-2,5-dione according to the procedures for compound <b>9</b> beginning from the [3 + 2] cycloaddition step with <b>35</b> and using general procedure A for the <i>N</i>-arylation and final deprotection. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.56–7.48 (m, 2H), 7.25–7.18 (m, 2H), 4.32 (d, <i>J</i> = 12.3 Hz, 1H), 4.14 (dd, <i>J</i> = 9.9, 8.3 Hz, 1H), 4.10–4.03 (m, 1H), 4.02–3.94 (m, 5H), 3.29 (s, 3H), 2.28 (d, <i>J</i> = 3.0 Hz, 3H). <i>m</i>/<i>z</i>: 403.2.</div></div><div id="sec5_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> (4a<i>R</i>,7a<i>S</i>)-7a-(2,5-Difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>21</b>)</h4><div class="NLM_p last">Compound <b>21</b> was prepared from 2-(2,5-difluorophenyl)acetonitrile according to the procedures for compound <b>9</b> and using general procedure A for the <i>N</i>-arylation and final deprotection. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.37–7.21 (m, 2H), 7.14 (m, 1H), 4.54 (dd, <i>J</i> = 12.3, 3.1 Hz, 1H), 4.31–4.16 (m, 2H), 4.02–3.90 (m, 5H), 3.30 (s, 3H), 2.30–2.28 (m, 3H). <i>m</i>/<i>z</i>: 421.2.</div></div><div id="sec5_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyl-7a-(2,4,5-trifluorophenyl)hexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">Compound <b>22</b> was prepared from 2-(2,4,5-trifluorophenyl)acetonitrile according to the procedures for compound <b>9</b> and using general procedure A for the <i>N</i>-arylation and final deprotection. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.37–7.17 (m, 2H), 4.24 (d, <i>J</i> = 11.4 Hz, 1H), 4.14 (t, <i>J</i> = 9.7 Hz, 1H), 3.96 (s, 3H), 4.00–3.84 (m, 2H), 3.78–3.66 (m, 1H), 3.22 (s, 3H), 2.27 (s, 3H). <i>m</i>/<i>z</i>: 439.2.</div></div><div id="sec5_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> (4a<i>R</i>,7a<i>S</i>)-7a-(2,6-Difluorophenyl)-6-(5-fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methylhexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p">A flask was charged sequentially with diethylacetylene dicarboxylate <b>42</b> (5.0 g, 29 mmol), 2,6-difluorophenylboronic acid <b>43</b> (5.57 g, 35.3 mmol), 1,4-dioxane (90 mL), tetrakis(triphenylphosphine)palladium(0) (1.36 g, 1.18 mmol), and acetic acid (0.167 mL, 2.94 mmol). The resulting mixture was degassed by evacuation and backfilled with N<sub>2</sub> (3×) and was then immersed in an 80 °C oil bath. After 16 h, the reaction was diluted with water and extracted twice with EtOAc. The combined organic portions were washed with satd aq NaHCO<sub>3</sub> and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude sample was subjected to column chromatography (330 g silica, 90 mL/min, 0–35% EtOAc/hexanes) to give diethyl 2-(2,6-difluorophenyl)maleate (2.85 g, 34%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.32 (m, 1H) 6.94 (m, 2H), 6.45 (s, 1H), 4.30 (t, <i>J</i> = 12.2 Hz, 2H) overlapping 4.26 (t, <i>J</i> = 12.2 Hz, 2H), 1.32 (q, <i>J</i> = 12.2 Hz, 3H) overlapping 1.30 (q, <i>J</i> = 12.2 Hz, 3H).</div><div class="NLM_p">To a solution of diethyl 2-(2,6-difluorophenyl)maleate (1.34 g, 4.71 mmol) in mixture of THF (100 mL) and water (35 mL) was added lithium hydroxide monohydrate (0.99 g, 34 mmol). The resulting mixture was immersed in a 40 °C oil bath and stirred vigorously. After 18 h at 40 °C, the reaction was cooled, diluted with 1 N HCl, and extracted twice with THF/EtOAc (1/3). The combined organic portions were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. This material was dissolved in acetic anhydride (35 mL, 260 mmol) and immersed in a 90 °C oil bath. After 90 min, the mixture was concentrated to a semisolid and dried azeotropically with toluene (50 mL) to give 3-(2,6-difluorophenyl)furan-2,5-dione <b>44</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.53 (m, 1H), 7.09 (m, 3H).</div><div class="NLM_p">To a solution of <b>44</b> (46.8 g, 180 mmol) in THF (400 mL) was added <i>N</i>-benzyl-<i>N</i>-methoxymethyl-<i>N</i>-(trimethylsilyl)methylamine <b>35</b> (64.5 mL, 352 mmol) and then trifluoroacetic acid (1.39 mL, 18.0 mmol) at 0 °C. The cooling bath was removed, and the mixture was allowed to stir at rt. After 75 min, the reaction mixture was immersed in a bath at −60 °C, and a premixed solution of triethylamine (50.2 mL, 360 mmol) in methanol (180 mL) was added via dropping funnel over 15 min. The resulting mixture was allowed to warm to rt and stirred for 2.5 days. The precipitated solid was collected via filtration, and the filtrate was partially concentrated causing additional solid to precipitate that was isolated by filtration. A third batch of solid was obtained by filtration after the mother liquor was allowed to stand for 1 week. The combined yield for the three crops of <b>45</b> was 48.4 g (56% as the triethylammonium salt). A portion of this material was converted to its HCl salt by treatment with 4 N HCl/dioxane. <i>m</i>/<i>e</i> = 376.</div><div class="NLM_p">To a solution of compound <b>45</b> (8.5 g, 18 mmol) in MeOH (350 mL) was added 4 N HCl in dioxane (100 mL) and then concentrated. The resulting residue was then redissolved in MeOH (350 mL) and 20% palladium hydroxide on carbon (4.0 g) was added in two batches. The mixture was stirred vigorously, and the flask was evacuated and backfilled with H<sub>2</sub> from a balloon (3×). The reaction was then kept under the atmosphere of H<sub>2</sub> for 3 h. At that time, the flask was evacuated and backfilled with N<sub>2</sub> (2×), and the mixture was filtered through a Celite pad with copious MeOH washes. The filtrate was concentrated to give a crude product that was dissolved in THF (200 mL) and treated with triethylamine (6.2 mL, 44 mmol). Dioxane (100 mL) was added, followed by benzyl chloroformate (3.0 mL, 21 mmol). After 1 h, the reaction was diluted with 1 N HCl and was extracted with 1:1 THF:EtOAc (3×). The organic portions were combined, washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude sample was taken up in toluene (100 mL), reconcentrated, and subjected to column chromatography (330 g silica, 80 mL/min, 0–10% MeOH/DCM) to give <b>46</b> (4.8 g, 64%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (m, 4H), 7.31 (m, 2H), 6.89 (m, 2H), 5.15 (dq, <i>J</i><sub>q</sub> = 12.0 Hz, <i>J</i><sub>d</sub> = 4.0 Hz, 2H), 4.63–4.51 (m, 1H), 3.98 (m, 2H), 3.86 (m, 1H), 3.77 (dd, <i>J</i> = 16.0, 2.8 Hz, 1H), 3.71 (m, 3H).</div><div class="NLM_p">A round bottomed flask was charged with <b>46</b> (4.8 g, 11 mmol), toluene (35 mL), triethyl amine (3.19 mL, 22.9 mmol), and DPPA (3.21 mL, 14.9 mmol). The mixture was immersed in a 75 °C oil bath. After 3 h at 75 °C, 2-(trimethylsilyl)ethanol (6.56 mL, 45.8 mmol) was added and the resulting mixture was heated at 110 °C for 2 h. Then the reaction mixture was cooled to rt and concentrated. The crude sample was subjected to column chromatography (330 g silica, 100 mL/min, 0–50% EtOAc/hexanes) to give a Teoc protected amine (4.1 g, 67%). This material was mixed with 4.0 M of HCl in dioxane (38 mL) and allowed to stir at rt for 20 h. The reaction mixture was concentrated to viscous gum to provide <b>47</b>, which was taken to next step without further purification. <i>m</i>/<i>e</i> = 391.</div><div class="NLM_p">To a mixture of <b>47</b> (3.5 g, 8.2 mmol) and DMF (40 mL) was added DIEA (5.71 mL, 32.8 mmol), <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> (1.95 g, 10.3 mmol), and EDCI (2.36 g, 12.3 mmol). The resulting mixture stirred at room temperature for 6.5 days. At that time, the reaction mixture was diluted with water and EtOAc and stirred vigorously until both phases cleared. The phases were seaprated, and the aqueous layer was extracted with EtOAc (2×). The combined organic layers were washed with saturated aqueous NaHCO<sub>3</sub> (3×) and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated to a light-brown oil. This crude sample was subjected to column chromatography (120 g silica, 0–40% EtOAc/hexanes, 60 mL/min,) to give <b>48</b> (2.4 g, 57%). The enantiomers of <b>48</b> were separated by chiral HPLC (AD column, 15% i-PrOH/hexanes, 80 mL/min) to give undesired enantiomer <b>49</b> (faster eluting, <i>t</i><sub>R</sub> ∼25 min) and desired enantiomer <b>50</b> (slower eluting, <i>t</i><sub>R</sub> ∼ 40 min). <sup>1</sup>H NMR for <b>50</b>: (400 MHz, CDCl<sub>3</sub>) δ 10.57–10.48 (m, 1H), 7.42–7.26 (m, 6H), 6.95 (tq, <i>J</i> = 8.3, 2.8, 2.4 Hz, 2H), 5.24–5.14 (m, 1H), 5.17–5.06 (m, 1H), 4.57 (dt, <i>J</i> = 12.3, 3.0 Hz, 0.5H), 4.46 (dt, <i>J</i> = 12.2, 3.0 Hz, 0.5 H), 4.20–3.94 (m, 2H), 3.76 (dd, <i>J</i> = 12.3, 6.5 Hz, 1H), 3.63 (td, <i>J</i> = 10.3, 7.5 Hz, 1H), 3.27 (d, <i>J</i> = 6.0 Hz, 3H), 1.50 (d, <i>J</i> = 1.8 Hz, 10H).</div><div class="NLM_p">Compound <b>50</b> (1.2 g, 2.3 mmol) was dissolved in MeOH (15 mL) and 20% palladium hydroxide on carbon (1:4, palladium hydroxide:carbon black, 0.5 g) was added. The mixture was evacuated and backfilled with H<sub>2</sub> from a balloon (5×) and then allowed to stir under the H<sub>2</sub> atmosphere. After 5 h, the reaction mixture was filtered through a Celite plug. The filtrate was concentrated to give compound <b>51</b> that was carried forward without further purification. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.30 (s, 1H), 7.36–7.22 (m, 1H), 6.99–6.85 (m, 2H), 3.94 (dt, <i>J</i> = 12.8, 3.1 Hz, 1H), 3.76–3.67 (m, 1H), 3.70–3.51 (m, 1H), 3.29 (s, 3H), 3.40–3.22 (m, 2H), 1.51 (s, 9H).</div><div class="NLM_p last">A microwave vial was charged with <b>51</b> (180 mg, 0.473 mmol), 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine (125 mg, 0.708 mmol), 2-(di-<i>tert</i>-butylphosphino)biphenyl (21 mg, 0.070 mmol), tris(dibenzylideneacetone)dipalladium(0) (27 mg, 0.029 mmol), toluene (2.5 mL), and sodium <i>tert</i>-butoxide (100 mg, 1.041 mmol). The resulting solution was degassed and backfilled with nitrogen (3×). The reaction was then sealed and immersed in an oil bath and heated at 65 °C for 4 h. After cooling to rt, the reaction mixture was diluted with water and ethyl acetate and stirred vigorously until both phases cleared. The phases were separated, and the aqueous portion was extracted with ethyl acetate. The combined organic portions were washed with brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was subjected to column chromatography (40 g silica, 40 mL/min, 0–50% ethyl acetate in hexanes) to give the corresponding <i>N</i>-arylated product (112 mg, 46%). This material was dissolved in DCM (5 mL) and treated with trifluoroacetic acid (1.5 mL). The resulting mixture was allowed to stand at rt for 3 h and was then concentrated and subjected to reverse phase HPLC (C18, 35 mL/mim, 10–95% MeCN/H<sub>2</sub>O, 0.1% HCO<sub>2</sub>H) to afford compound <b>23</b> (83 mg, 63%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.50 (tt, <i>J</i> = 8.4, 6.2 Hz, 1H), 7.17–7.08 (m, 2H), 4.92 (m, 1H), 4.35 (t, <i>J</i> = 9.2 Hz, 1H), 4.26–4.15 (m, 1H), 3.99 (s, 3H), 3.95–3.82 (m, 2H), 3.30 (s, 3H), 2.29 (d, <i>J</i> = 2.9, 3H). <i>m</i>/<i>z</i>: 421.2.</div></div><div id="sec5_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1-((Benzyloxy)carbonyl)-4-(methoxycarbonyl)-3-(2,3,6-trifluorophenyl)pyrrolidine-3-carboxylic Acid (<b>56</b>)</h4><div class="NLM_p">To a solution of 2-(bromomethyl)-1,3,4-trifluorobenzene <b>52</b> (68 g, 292 mmol) in ethanol (80 mL) and water (20 mL) was added NaCN (25 g, 526 mmol), and the resulting solution was heated at reflux for 12 h. The reaction mixture was cooled to rt and extracted with ethyl acetate. The organic layer was dried with MgSO<sub>4</sub> and purified using 0–100% ethyl acetate in hexanes to provide 2-(2,3,6-trifluorophenyl)acetonitrile (44 g, 79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.22–7.12 (m, 1H), 6.95–6.88 (m, 1H), 3.74 (t, <i>J</i> = 1.2 Hz, 2H).</div><div class="NLM_p">To a solution of 2-(2,3,6-trifluorophenyl)acetonitrile (33 g, 198 mmol) in methanol (200 mL) was added glyoxalic acid monohydrate (27 g, 297 mmol), and the resulting mixture was cooled to 0 °C. Solid K<sub>2</sub>CO<sub>3</sub> (68 g, 495 mmol) was added in several portions while cooling the reaction mixture at 0 °C. The reaction mixture was slowly warmed to rt, then stirred for 4 h. It was filtered, and the filtrate was evaporated to yield a solid mass, which was dissolved carefully in 10% conc H<sub>2</sub>SO<sub>4</sub> in formic acid (500 mL) and was heated at 100 °C for 12 h. The reaction mixture was diluted with water and extracted with ethyl acetate to yield the crude 2-(2,3,6-trifluorophenyl)maleic acid. This diacid was dissolved in 5% conc H<sub>2</sub>SO<sub>4</sub> in methanol (500 mL) and heated at reflux for 12 h. The resulting mixture was evaporated to dryness, and then it was diluted with water, extracted with ethyl acetate, the organic layer dried with MgSO<sub>4</sub>, concentrated, and purified using 0–100% ethyl acetate in hexanes to provide dimethyl 2-(2,3,6-trifluorophenyl)maleate <b>53</b> (21 g, 41%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.23–7.12 (m, 1H), 6.89 (tddd, <i>J</i> = 9.2, 3.8, 2.2, 0.7 Hz, 1H), 6.47 (t, <i>J</i> = 0.8 Hz, 1H), 3.83 (t, <i>J</i> = 1.2 Hz, 3H), 3.81 (t, <i>J</i> = 0.9 Hz, 3H).</div><div class="NLM_p">To a solution of dimethyl 2-(2,3,6-trifluorophenyl)maleate <b>53</b> (20 g, 72 mmol) in THF (200 mL) was added <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine <b>35</b> (26 g, 109 mmol) at 0 °C followed by catalytic amount of trifluoroacetic acid (0.4 mL, 7.2 mmol). The reaction mixture was slowly warmed to rt and stirred for 4 h. The resulting solution was evaporated to dryness and purified via silica gel chromatography using 0–100% ethyl acetate in hexanes to provide dimethyl 1-benzyl-3-(2,3,6-trifluorophenyl)pyrrolidine-3,4-dicarboxylate (29 g, 100%). <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>) δ 7.35–7.19 (m, 6H), 7.06 (qd, <i>J</i> = 9.0, 4.8 Hz, 1H), 6.79 (dddd, <i>J</i> = 11.4, 9.2, 4.1, 2.3 Hz, 1H), 3.84–3.78 (m, 1H), 3.75 (s, 2H), 3.71 (s, 3H), 3.65 (s, 3H), 3.46–3.36 (m, 2H), 3.19 (d, <i>J</i> = 8.8 Hz, 2H). A solution of this dimethyl 1-benzyl-3-(2,3,6-trifluorophenyl)pyrrolidine-3,4-dicarboxylate (30 g) in 15% conc H<sub>2</sub>SO<sub>4</sub> in water (300 mL) was heated under reflux for 24 h. The reaction mixture was cooled to room temperature, and the pH of the solution was adjusted to 3 using 6N NaOH. Compound <b>54</b> precipitated from this mixture and was collected, dried and taken to the next step.</div><div class="NLM_p">A solution of 1-benzyl-3-(2,3,6-trifluorophenyl)pyrrolidine-3,4-dicarboxylic acid <b>54</b> (30 g, 79 mmol) in acetic anhydride (100 mL) was heated at 90 °C for 1 h. The resulting mixture was evaporated to dryness to obtain the anhydride, which was dissolved in dichloromethane (200 mL) and treated with a mixture of methanol (30 mL) and triethylamine (16.5 mL) at −78 °C. The resulting mixture was slowly warmed to rt over 12 h. The reaction mixture was evaporated to dryness, and the crude product <b>55</b> was taken directly to the next step.</div><div class="NLM_p last">To a solution of the above crude 1-((benzyloxy)carbonyl)-4-(methoxycarbonyl)-3-(2,3,6-trifluorophenyl)pyrrolidine-3-carboxylic acid <b>55</b> (assumed to be 79 mmol) in methanol (400 mL) was added Pd(OH)<sub>2</sub> (7.5 g, 10% by wt.), and the resulting mixture was stirred under 1 atm of H<sub>2</sub> at rt for 3 h. The solution was then filtered through a pad of Celite, and the filtrate was evaporated to dryness to obtain the corresponding free amine. To this crude amine in THF (1000 mL) at 0 °C was added benzyl chloroformate (25 mL, 122 mmol) followed by triethylamine (20 mL, 143 mmol). The resulting mixture was warmed to rt over 30 min and stirred for 12 h. The reaction mixture was diluted with ethyl acetate and washed with 1 N HCl. The organic layer was separated, dried with MgSO<sub>4</sub>, concentrated, and purified via silica gel chromatography using 10% methanol in dichloromethane to provide compound <b>56</b> (25 g, 79%) <sup>1</sup>H NMR (600 MHz, CDCl<sub>3</sub>,) δ 7.37–7.25 (m, 5H), 7.15–7.05 (m, 1H), 6.98 (dddd, <i>J</i> = 11.6, 7.6, 3.9, 2.3 Hz, 1H), 5.13 (s, 2H), 4.43 (ddt, <i>J</i> = 10.3, 4.9, 2.6 Hz, 1H), 4.12 (dt, <i>J</i> = 15.8, 9.2 Hz, 1H), 3.94–3.71 (m, 3H), 3.67 (d, <i>J</i> = 3.7 Hz, 3H).</div></div><div id="sec5_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyl-7a-(2,3,6-trifluorophenyl)hexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared from compound <b>56</b> according to the procedures outlined for compound <b>23</b> beginning from the Curtius rearrangement step. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.49–7.38 (m, 1H), 7.18–7.08 (m, 1H), 4.89–4.85 (m, 1H), 4.39 (t, <i>J</i> = 9.7 Hz, 1H), 4.22 (t, <i>J</i> = 10.5 Hz, 1H), 3.98 (s, 3H), 3.96–3.85 (m, 2H), 3.28 (s, 3H), 2.28 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 439.5.</div></div><div id="sec5_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (4a<i>R</i>,7a<i>S</i>)-6-(5-Fluoro-4-methoxy-6-methylpyrimidin-2-yl)-2-imino-3-methyl-7a-(2,3,4,6-tetrafluorophenyl)hexahydro-1<i>H</i>-pyrrolo[3,4-<i>d</i>]pyrimidin-4(4a<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">Compound <b>25</b> was prepared from 2-(bromomethyl)-1,3,4,5-tetrafluorobenzene according to the procedures described for compounds <b>56</b> and <b>24</b>. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.35–7.23 (m, 1H), 4.88–4.84 (m, 1H), 4.38 (t, <i>J</i> = 9.7 Hz, 1H), 4.24 (dd, <i>J</i> = 9.8 Hz, 10.7 Hz, 1H), 4.01 (s, 3H), 3.97–3.86 (m, 2H), 3.30 (s, 3H), 2.31 (d, <i>J</i> = 2.9 Hz, 3H). <i>m</i>/<i>z</i>: 457.3.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01995">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36215" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36215" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.5b01995" class="ext-link">10.1021/acs.jmedchem.5b01995</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Synthetic procedures for preparation of the pyrimidine reagents used to make compounds <b>8</b>–<b>25</b>, the synthesis of compound <b>8</b>, procedures for incubation of compound <b>6</b> with CYP3A4 in the presence and absence of glutathione, methods for determination of rhesus monkey plasma, CSF and cortical Aβ<sub>40</sub>, Aβ<sub>42</sub>, and sAPPβ levels, and methods for determination of cynomolgus monkey CSF and cortical Aβ<sub>40</sub> levels (<a href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">(<a href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_001.pdf">jm5b01995_si_001.pdf (520.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_002.csv">jm5b01995_si_002.csv (1.59 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for BACE1/inhibitor complexes will be deposited at the Protein Data Bank. Authors will release the atomic coordinates and experimental data upon article publication. PDB codes: <b>6</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0">5hd0</a>; <b>7</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g">4h3g</a>; <b>8</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>; <b>11</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>; <b>15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx">5hdx</a>; <b>16</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz">5hdz</a>; <b>17</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5">5he5</a>; <b>23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4">5he4</a>.</p><div class="testing" data-doi="10.1021/acs.jmedchem.5b01995" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jared N. Cumming</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#355f544750511b564058585c5b5275585047565e1b565a58"><span class="__cf_email__" data-cfemail="fd979c8f9899d39e88909094939abd90988f9e96d39e9290">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew W. Stamford</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f4959a90869183da87809599929b8690b4999186979fda979b99"><span class="__cf_email__" data-cfemail="9afbf4fee8ffedb4e9eefbf7fcf5e8fedaf7ffe8f9f1b4f9f5f7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihirbaran Mandal</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yusheng Wu</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jeffrey Misiaszek</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guoqing Li</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexei Buevich</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John P. Caldwell</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxiang Liu</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert D. Mazzola</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Orth</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Corey Strickland</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johannes Voigt</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hongwu Wang</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhaoning Zhu</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xia Chen</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Grzelak</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lynn A. Hyde</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reshma Kuvelkar</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Prescott T. Leach</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Giuseppe Terracina</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lili Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Qi Zhang</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Maria S. Michener</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brad Smith</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathleen Cox</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Diane Grotz</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leonard Favreau</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kaushik Mitra</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Kazakevich</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian A. McKittrick</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William Greenlee</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Matthew E. Kennedy</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric M. Parker</span> - <span class="hlFld-Affiliation affiliation">†Department of Global Chemistry, ‡Department of Neuroscience, §Department of Safety Assessment and
Laboratory Animal Research, ∥Department of Discovery Pharmaceutical Sciences, and ⊥Department of
Pharmacokinetics, Pharmacodynamics, and Drug Metabolism,  Merck Research Laboratories, 2015 Galloping Hill Road, Kenilworth, New Jersey 07033, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d257e4404-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34430" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34430" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank T.-M. Chan for his help in compound characterization and Qin Jiang, Laura M. Rossiter, Sarah K. Zeile, and Meagan M. Ryan (Albany Molecular Research Inc.) for their contributions to synthesis. Li-Kang Zhang, Junling Gao, and Charles Ross are thanked for their help in LCMS analysis of the compounds. Use of the IMCA-CAT beamline 17-ID (or 17-BM) at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with Hauptman-Woodward Medical Research Institute. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> Abbreviations Used</h2><tr><td class="NLM_term">CatD</td><td class="NLM_def"><p class="first last">cathepsin D</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DPPA</td><td class="NLM_def"><p class="first last">diphenylphosphoryl azide</p></td></tr><tr><td class="NLM_term">EDCI</td><td class="NLM_def"><p class="first last">1-ethyl-3-(3-(dimethylamino)propyl)carbodiimide hydrochloride</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">Gly</td><td class="NLM_def"><p class="first last">glycine</p></td></tr><tr><td class="NLM_term">IPA</td><td class="NLM_def"><p class="first last">isopropyl alcohol</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>d</sub></td><td class="NLM_def"><p class="first last">dissociation constant</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney epithelial cell line</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance protein 1</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability coefficient</p></td></tr><tr><td class="NLM_term">Teoc</td><td class="NLM_def"><p class="first last">2,2,2-trichloroethoxycarbonyl</p></td></tr><tr><td class="NLM_term">Trp</td><td class="NLM_def"><p class="first last">tryptophan</p></td></tr><tr><td class="NLM_term">Tyr</td><td class="NLM_def"><p class="first last">tyrosine</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80035" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80035" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 28 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span>Alzheimer’s Disease Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.alz.org/facts/downloads/facts_figures_2015.pdf" class="extLink">http://www.alz.org/facts/downloads/facts_figures_2015.pdf</a> (accessed February 13, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2015%3B+http%3A%2F%2Fwww.alz.org%2Ffacts%2Fdownloads%2Ffacts_figures_2015.pdf+%28accessed+February+13%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span>World Alzheimer Report; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><a href="http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a> (accessed February 13, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report%3B+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2015%2C+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf+%28accessed+February+13%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Alzheimer%2520Report%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span> </span><span class="NLM_article-title">Current treatment for Alzheimer disease and future prospects</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S105</span><span class="NLM_x">–</span> <span class="NLM_lpage">S113</span><span class="refDoi"> DOI: 10.1097/00002093-200307004-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F00002093-200307004-00005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=S105-S113&author=P.+N.+Tariotauthor=H.+J.+Federoff&title=Current+treatment+for+Alzheimer+disease+and+future+prospects&doi=10.1097%2F00002093-200307004-00005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1097%2F00002093-200307004-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002093-200307004-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DCurrent%2520treatment%2520for%2520Alzheimer%2520disease%2520and%2520future%2520prospects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2003%26volume%3D17%26spage%3DS105%26epage%3DS113%26doi%3D10.1097%2F00002093-200307004-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nordberg, A.</span><span> </span><span class="NLM_article-title">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span><span class="refDoi"> DOI: 10.1097/01.wad.0000213804.59187.2d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F01.wad.0000213804.59187.2d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16772751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=S12-S18&author=A.+Nordberg&title=Mechanisms+behind+the+neuroprotective+actions+of+cholinesterase+inhibitors+in+Alzheimer+disease&doi=10.1097%2F01.wad.0000213804.59187.2d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S12-S18</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme acetylcholinesterase (AChE) are presently used as long-term symptomatic treatments for patients with Alzheimer's disease (AD), as they enhance central levels of synaptic acetylcholine.  The accumulation of evidence implicating AChE in the pathogenesis of AD raises the question of whether, in addn. to their palliative actions, inhibitors of this enzyme are able to act as disease-modifying agents.  In addn. to their catalytic effects, there is a suggestion that AChE inhibitors may influence expression of AChE isoforms and increase expression of nicotinic receptors, both of which correlate with cognitive improvements in AD patients.  The neuroprotective effect of nicotine, presumably mediated via nicotinic receptors, against β-amyloid (Aβ) toxicity and its effect on amyloid precursor protein (APP) and Aβ prodn. has previously been established.  It has also been shown that AChE inhibitors influence APP processing and attenuate Aβ-induced toxicity via mechanisms including interruption of the prodn. of Aβ, alteration of the levels of Aβ 1-50 and 1-52, and formation of the sol. form of APP.  Some of these effects seem to occur independently of nicotinic receptors, however.  If such exptl. in vitro observations can be extrapolated into clin. neuroprotective properties, AChE inhibitors could pos. modulate the disease course of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_vn_esJ9_SLVg90H21EOLACvtfcHk0ljGI-K5NOpxpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D&md5=367c676ee4a4c2f1e6eb1985f5f7a556</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000213804.59187.2d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000213804.59187.2d%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DMechanisms%2520behind%2520the%2520neuroprotective%2520actions%2520of%2520cholinesterase%2520inhibitors%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3DS12%26epage%3DS18%26doi%3D10.1097%2F01.wad.0000213804.59187.2d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bullock, R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1097/01.wad.0000201847.29836.a5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F01.wad.0000201847.29836.a5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16493232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=23-29&author=R.+Bullock&title=Efficacy+and+safety+of+memantine+in+moderate-to-severe+Alzheimer+disease%3A+the+evidence+to+date&doi=10.1097%2F01.wad.0000201847.29836.a5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of memantine in moderate-to-severe Alzheimer's disease: the evidence to date</span></div><div class="casAuthors">Bullock, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Memantine, a moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist, is currently the only agent approved for moderately severe to severe Alzheimer disease (AD) in Europe and for moderate-to-severe Alzheimer disease in the United States.  In clin. trials, memantine has consistently demonstrated a reduced rate of deterioration on global, cognitive, functional, and behavioral measures, across a range of outcome measures compared with usual care.  Notably, improvements vs. placebo were seen in individual activities of daily living and behavior, particularly agitation.  Efficacy was demonstrated in patients with newly diagnosed Alzheimer disease, patients previously or currently receiving acetylcholinesterase inhibitors, and both institutionalized and community-dwelling Alzheimer disease patients.  Memantine has a tolerability profile similar to placebo.  This review presents the results of key clin. trials, and includes clin. relevant analyses, such as nos.-needed-to-treat and effect sizes.  Increased dependency and institutionalization are significant cost drivers in Alzheimer disease.  Memantine is able to reduce dependency, caregiver time required, and mean monthly caregiver and societal costs.  Recent studies of the relationship between Alzheimer disease progression, caregiver burden, and health-care costs emphasize the need for treatments such as memantine that can slow the rate of decline in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoek-h3moVHKrVg90H21EOLACvtfcHk0liUMq9eD5HjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D&md5=4c1ef99e957070d2f300d2e6b5c48de8</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000201847.29836.a5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000201847.29836.a5%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520memantine%2520in%2520moderate-to-severe%2520Alzheimer%2520disease%253A%2520the%2520evidence%2520to%2520date%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3D23%26epage%3D29%26doi%3D10.1097%2F01.wad.0000201847.29836.a5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lambert, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouyel, P.</span><span> </span><span class="NLM_article-title">Genetics of Alzheimer’s disease: new evidences for an old hypothesis?</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1016/j.gde.2011.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.gde.2011.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=295-301&author=J.-C.+Lambertauthor=P.+Amouyel&title=Genetics+of+Alzheimer%E2%80%99s+disease%3A+new+evidences+for+an+old+hypothesis%3F&doi=10.1016%2Fj.gde.2011.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2011.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2011.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.-C.%26aulast%3DAmouyel%26aufirst%3DP.%26atitle%3DGenetics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520new%2520evidences%2520for%2520an%2520old%2520hypothesis%253F%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2011%26volume%3D21%26spage%3D295%26epage%3D301%26doi%3D10.1016%2Fj.gde.2011.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaether, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">The cell biology of Alzheimer’s disease: uncovering the secrets of secretases</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1016/S0959-4388(00)00253-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2FS0959-4388%2800%2900253-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=585-590&author=J.+Walterauthor=C.+Kaetherauthor=H.+Steinerauthor=C.+Haass&title=The+cell+biology+of+Alzheimer%E2%80%99s+disease%3A+uncovering+the+secrets+of+secretases&doi=10.1016%2FS0959-4388%2800%2900253-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0959-4388%2800%2900253-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-4388%252800%252900253-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKaether%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DThe%2520cell%2520biology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520uncovering%2520the%2520secrets%2520of%2520secretases%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2001%26volume%3D11%26spage%3D585%26epage%3D590%26doi%3D10.1016%2FS0959-4388%2800%2900253-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stege, G. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosman, G. J. C. G. M.</span><span> </span><span class="NLM_article-title">The biochemistry of Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.2165/00002512-199914060-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.2165%2F00002512-199914060-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10408742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADyaK1MXktFShu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=437-446&author=G.+J.+J.+Stegeauthor=G.+J.+C.+G.+M.+Bosman&title=The+biochemistry+of+Alzheimer%E2%80%99s+disease&doi=10.2165%2F00002512-199914060-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemistry of Alzheimer's disease</span></div><div class="casAuthors">Stege, Gerard J. J.; Bosman, Giel J. C. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-446</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review, with 106 refs.  In the course of the biochem. efforts devoted to elucidation of the cause(s) and mechanism(s) of neurodegeneration in Alzheimer's disease (AD), much attention has been given to the processes by which amyloid is generated from amyloid precursor protein, notwithstanding the finding that mutations in 2 other proteins, presenilin 1 and 2, are assocd. with early-onset, familial AD in the majority of patients.  In addn., the reason why the apolipoprotein E ε4 allele is over-represented in patients with the sporadic form of AD is unknown.  Furthermore, the degree of dementia is clearly assocd. more with the degree of neurofibrillary pathol. than with the amyloid plaque burden.  In general, amyloid formation may very well be at the end of a pathophysiol. cascade, set in motion by many different triggers.  This cascade could involve excessive apoptosis, followed by necrosis and inflammation.  In this process, microglia as well as astrocytes are involved.  Disturbance of 1 or more crit. signal transduction processes, esp. at the level of the plasma membrane, may be an important trigger.  The pathogenesis of AD is complicated, but further identification of the processes of neurodegeneration will also lead to identification of the factors that make specific neurons vulnerable and, hopefully, point the way to a means to prevent neuronal degeneration at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoXf6nWiFmPrVg90H21EOLACvtfcHk0liUMq9eD5HjeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFShu74%253D&md5=bc21e459622864bedc5977c50e4480dc</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.2165%2F00002512-199914060-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199914060-00004%26sid%3Dliteratum%253Aachs%26aulast%3DStege%26aufirst%3DG.%2BJ.%2BJ.%26aulast%3DBosman%26aufirst%3DG.%2BJ.%2BC.%2BG.%2BM.%26atitle%3DThe%2520biochemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D1999%26volume%3D14%26spage%3D437%26epage%3D446%26doi%3D10.2165%2F00002512-199914060-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Neuroscience: Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1038/461895a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2F461895a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=19829367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=895-897&author=L.+Mucke&title=Neuroscience%3A+Alzheimer%E2%80%99s+disease&doi=10.1038%2F461895a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroscience: Alzheimer's disease</span></div><div class="casAuthors">Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7266</span>),
    <span class="NLM_cas:pages">895-897</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The neurodegenerative disorder Alzheimer's disease is becoming more prevalent in aging populations worldwide.  The identification of effective treatments will require a better understanding of the physiol. mechanisms involved, and innovative approaches to drug development and evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphIaMIviIdeLVg90H21EOLACvtfcHk0ljl-rz77TTQHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KntLrK&md5=602e450d267d313e11ef2ef9d0152cd2</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2F461895a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F461895a%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DNeuroscience%253A%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D895%26epage%3D897%26doi%3D10.1038%2F461895a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span><span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0ljl-rz77TTQHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljl-rz77TTQHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+Amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0lhgUwFqkm3Ceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1016/j.jalz.2007.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.jalz.2007.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=18631966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslKgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=176-178&author=A.+D.+Korczyn&title=The+amyloid+cascade+hypothesis&doi=10.1016%2Fj.jalz.2007.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis</span></div><div class="casAuthors">Korczyn, Amos D.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">176-178</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The amyloid deposits in the brains of patients with Alzheimer's disease have attracted attention and are now considered not only an essential requirement for pathol. diagnosis but also an important clue to the pathogenesis of the disease.  This article looks critically at the basis of the "amyloid cascade hypothesis" to conclude that there are many issues that need to be resolved since they are inconsistent with the hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrra1GCUOJiJLVg90H21EOLACvtfcHk0lhgUwFqkm3Ceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslKgsbw%253D&md5=0f450f43d608598b2e0ccb59075ec981</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D176%26epage%3D178%26doi%3D10.1016%2Fj.jalz.2007.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Has the amyloid cascade hypothesis for Alzheimer’s been proved?</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.2174/156720506775697098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.2174%2F156720506775697098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16472206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=71-73&author=J.+Hardy&title=Has+the+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+been+proved%3F&doi=10.2174%2F156720506775697098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Has the amyloid cascade hypothesis for Alzheimer's disease been proved?</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-73</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  After much initial debate for and against the role of amyloid in Alzheimer's disease (AD), mutations on the amyloid precursor protein (APP) and processing pathways that increase levels of the amyloid β peptide of 42 residues (Aβ42) have established that faulty function or processing of these proteins are responsible for AD pathogenesis.  Given the neurotoxicity of aggregates of Ab42, the central role of this peptide in AD pathogenesis is self evident.  In this article, I summarize the major pieces of evidence adduced to support the amyloid cascade hypothesis and point out their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6iEcNF7UI7Vg90H21EOLACvtfcHk0lhgUwFqkm3Ceg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVant7o%253D&md5=08292f72462f6b494734c7380c7ca744</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.2174%2F156720506775697098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506775697098%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DHas%2520the%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520been%2520proved%253F%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D71%26epage%3D73%26doi%3D10.2174%2F156720506775697098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Selkoe, D.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: genes, proteins, and therapy</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=741-766&author=D.+Selkoe&title=Alzheimer%E2%80%99s+disease%3A+genes%2C+proteins%2C+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520genes%252C%2520proteins%252C%2520and%2520therapy%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D741%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Archer, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeatman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M. N.</span><span> </span><span class="NLM_article-title">Amyloid load and cerebral atrophy in Alzheimer’s disease: a 11C-BIP positron emission tomography study</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1002/ana.20889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2Fana.20889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16802294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A280%3ADC%252BD28vms1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=145-147&author=H.+A.+Archerauthor=P.+Edisonauthor=D.+J.+Brooksauthor=J.+Barnesauthor=C.+Frostauthor=T.+Yeatmanauthor=N.+C.+Foxauthor=M.+N.+Rossor&title=Amyloid+load+and+cerebral+atrophy+in+Alzheimer%E2%80%99s+disease%3A+a+11C-BIP+positron+emission+tomography+study&doi=10.1002%2Fana.20889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study</span></div><div class="casAuthors">Archer Hilary A; Edison Paul; Brooks David J; Barnes Jo; Frost Chris; Yeatman Tom; Fox Nick C; Rossor Martin N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-7</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">To determine the relationship between cerebral amyloid plaque load and rates of cerebral atrophy in Alzheimer's disease. (11)C-PIB((11)C-6-OH benzothiazole)PET (positron emission tomography) findings were correlated with volumetric magnetic resonance imaging (MRI) measurements in nine subjects with mild to moderate AD.  Analysis revealed a positive correlation between rates of whole brain atrophy and whole brain (p = 0.019) and regional (11)C-PIB uptake.  This provides support for the central role of amyloid deposition in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrBNwOByLjIAqdek-gHSrIfW6udTcc2eYvD7Chzy2T-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vms1entg%253D%253D&md5=9979e03c8fa101fe3e5ed7777b696f7c</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1002%2Fana.20889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20889%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DH.%2BA.%26aulast%3DEdison%26aufirst%3DP.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DC.%26aulast%3DYeatman%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26atitle%3DAmyloid%2520load%2520and%2520cerebral%2520atrophy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252011C-BIP%2520positron%2520emission%2520tomography%2520study%26jtitle%3DAnn.%2520Neurol.%26date%3D2006%26volume%3D60%26spage%3D145%26epage%3D147%26doi%3D10.1002%2Fana.20889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A Phase 3 trial of semagacestat for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+Phase+3+trial+of+semagacestat+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0ljy5ue4U-Z3dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520Phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DeStrooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed γ-secretase Alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+DeStrooper&title=Lessons+from+a+failed+%CE%B3-secretase+Alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDeStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520%25CE%25B3-secretase%2520Alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reardon, S.</span><span> </span><span class="NLM_article-title">Alzheimer antibody drugs show questionable potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1038/nrd4709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnrd4709" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=591-592&author=S.+Reardon&title=Alzheimer+antibody+drugs+show+questionable+potential&doi=10.1038%2Fnrd4709"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4709%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26atitle%3DAlzheimer%2520antibody%2520drugs%2520show%2520questionable%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D591%26epage%3D592%26doi%3D10.1038%2Fnrd4709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0ljUcSykNwuPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Prins, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1186/alzrt220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1186%2Falzrt220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=56-61&author=N.+D.+Prinsauthor=P.+Scheltens&title=Treating+Alzheimer%E2%80%99s+disease+with+monoclonal+antibodies%3A+current+status+and+outlook+for+the+future&doi=10.1186%2Falzrt220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future</span></div><div class="casAuthors">Prins, Niels D.; Scheltens, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">56/1-56/6, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In the past decade, Alzheimer's disease drug discovery has been directed at 'disease modifying drugs' that are able to counteract the progression of Alzheimer's disease by intervening in specific parts of its neuropathol. process.  Passive immunization with monoclonal antibodies (mAbs) may be able to clear toxic amyloid-β species either directly or through microglia or complement activation, thereby halting the amyloid cascade and preventing neurodegeneration and cognitive and functional decline.  Thus far, results from two large phase 3 trial programs with bapineuzumab and solaneuzumab, resp., have brought rather disappointing results.  Possible explanations could be that these compds. were either targeting the wrong amyloid-β species, or were given too late in the disease process.  Several new mAbs targeting various amyloid-β epitopes are now being tested in ongoing phase 2 and 3 clin. trials.  The present review discusses the various mAbs aimed at amyloid-β, summarizes trial results and provides an outlook for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTG2QS0c-0zbVg90H21EOLACvtfcHk0ljUcSykNwuPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlWqur4%253D&md5=dae320be2b99baeab5d5f01d6f05b62a</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1186%2Falzrt220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt220%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DN.%2BD.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DTreating%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoclonal%2520antibodies%253A%2520current%2520status%2520and%2520outlook%2520for%2520the%2520future%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2013%26volume%3D5%26spage%3D56%26epage%3D61%26doi%3D10.1186%2Falzrt220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/85059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.+C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta+secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation&doi=10.1038%2F85059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0ljUcSykNwuPwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta%2520secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232%26doi%3D10.1038%2F85059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damore, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">BACE1 (beta secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/S0969-9961(03)00104-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2FS0969-9961%2803%2900104-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=13678669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1amt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=81-88&author=Y.+Luoauthor=B.+Bolonauthor=M.+A.+Damoreauthor=D.+Fitzpatrickauthor=H.+Liuauthor=J.+Zhangauthor=Q.+Yanauthor=R.+Vassarauthor=M.+Citron&title=BACE1+%28beta+secretase%29+knockout+mice+do+not+acquire+compensatory+gene+expression+changes+or+develop+neural+lesions+over+time&doi=10.1016%2FS0969-9961%2803%2900104-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Damore, Michael A.; Fitzpatrick, Dan; Liu, Hantao; Zhang, Jianhua; Yan, Qiao; Vassar, Robert; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The formation of Alzheimer's Aβ peptide is initiated when the amyloid precursor protein (APP) is cleaved by the enzyme β-secretase (BACE1); inhibition of this cleavage has been proposed as a means of treating Alzheimer's disease. (AD) We have previously shown that young BACE1 knockout mice (BACE1 KO) do not generate Aβ but in other respects appear normal.  Here we have extended this anal. to include both gene expression profiling and phenotypic assessment of older BACE1 KO animals to evaluate the impact of chronic Aβ deficiency.  We did not detect global compensatory changes in neural gene expression in young BACE1 KO mice.  In particular, expression of the β-secretase homolog BACE2 was not upregulated.  Furthermore, we found no structural alterations in any organ, including all central and peripheral neural tissues, of BACE1 KO mice up to 14 mo of age.  Aged BACE1 KO mice engineered to overexpress human APP (BACE1 KO/APPtg) did not develop amyloid plaques.  These data provide evidence that neither β-secretase nor Aβ plays a vital role in mouse physiol. and that chronic β-secretase inhibition could be a useful approach in treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov3-UtSwdlHrVg90H21EOLACvtfcHk0ljTVS0bhtIP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1amt7g%253D&md5=69eac3e7707d9abc8e85fd082053b91e</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FS0969-9961%2803%2900104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-9961%252803%252900104-9%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DDamore%26aufirst%3DM.%2BA.%26aulast%3DFitzpatrick%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBACE1%2520%2528beta%2520secretase%2529%2520knockout%2520mice%2520do%2520not%2520acquire%2520compensatory%2520gene%2520expression%2520changes%2520or%2520develop%2520neural%2520lesions%2520over%2520time%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2003%26volume%3D14%26spage%3D81%26epage%3D88%26doi%3D10.1016%2FS0969-9961%2803%2900104-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">26326</span><span class="NLM_x">–</span> <span class="NLM_lpage">26334</span><span class="refDoi"> DOI: 10.1074/jbc.M611687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1074%2Fjbc.M611687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=17616527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson-Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice&doi=10.1074%2Fjbc.M611687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span></div><div class="casAuthors">McConlogue, Lisa; Buttini, Manuel; Anderson, John P.; Brigham, Elizabeth F.; Chen, Karen S.; Freedman, Stephen B.; Games, Dora; Johnson-Wood, Kelly; Lee, Michael; Zeller, Michelle; Liu, Weiqun; Motter, Ruth; Sinha, Sukanto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">26326-26334</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates processing of amyloid precursor protein (APP) into amyloid β (Aβ) peptide, the major component of Alzheimer disease (AD) plaques.  To det. the role that BACE1 plays in the development of Aβ-driven AD-like pathol., we have crossed PDAPP mice, a transgenic mouse model of AD overexpressing human mutated APP, onto mice with either a homozygous or heterozygous BACE1 gene knockout.  Anal. of PDAPP/BACE(-/-) mice demonstrated that BACE1 is absolutely required for both Aβ generation and the development of age-assocd. plaque pathol.  Furthermore, synaptic deficits, a neurodegenerative pathol. characteristic of AD, were also reversed in the bigenic mice.  To det. the extent of BACE1 redn. required to significantly inhibit pathol., PDAPP mice having a heterozygous BACE1 gene knock-out were evaluated for Aβ generation and for the development of pathol.  Although the 50% redn. in BACE1 enzyme levels caused only a 12% decrease in Aβ levels in young mice, it nonetheless resulted in a dramatic redn. in Aβ plaques, neuritic burden, and synaptic deficits in older mice.  Quant. analyses indicate that brain Aβ levels in young APP transgenic mice are not the sole determinant for the changes in plaque pathol. mediated by reduced BACE1.  These observations demonstrate that partial redns. of BACE1 enzyme activity and concomitant Aβ levels lead to dramatic inhibition of Aβ-driven AD-like pathol., making BACE1 an excellent target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolXkPkhLFworVg90H21EOLACvtfcHk0ljTVS0bhtIP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D&md5=5cd1df8e7c16473d8116de3226c78cd4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611687200%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334%26doi%3D10.1074%2Fjbc.M611687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F. J.</span><span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.-H.+Kuhnauthor=Ch.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+J.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+BACE+proteases%3A+current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0ljTVS0bhtIP_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DHaass%26aufirst%3DCh.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%2BJ.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520BACE%2520proteases%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the β-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1126/science.1132341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1126%2Fscience.1132341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+%CE%B2-secretase+BACE1&doi=10.1126%2Fscience.1132341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132341%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520%25CE%25B2-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666%26doi%3D10.1126%2Fscience.1132341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macklin, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapp, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Bace1 modulates myelination in the central and peripheral nervous system</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1520</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.1038/nn1797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnn1797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=17099708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1520-1525&author=X.+Huauthor=C.+W.+Hicksauthor=W.+Heauthor=P.+Wongauthor=W.+B.+Macklinauthor=B.+D.+Trappauthor=R.+Yan&title=Bace1+modulates+myelination+in+the+central+and+peripheral+nervous+system&doi=10.1038%2Fnn1797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 modulates myelination in the central and peripheral nervous system</span></div><div class="casAuthors">Hu, Xiangyou; Hicks, Caitlin W.; He, Wanxia; Wong, Philip; Macklin, Wendy B.; Trapp, Bruce D.; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1520-1525</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the β-secretase site.  Apart from this cleavage, the functional importance of Bace1 in other physiol. events is unknown.  We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves.  In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination.  Bace1-null mice also showed altered neurol. behaviors such as elevated pain sensitivity and reduced grip strength.  Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice.  Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice.  Furthermore, phosphorylated Akt was also reduced.  Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWcMnd4xVWrVg90H21EOLACvtfcHk0lhT4zK0M2yWig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cns7nP&md5=a8df10ae9c3e3243e564a017288a57c6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnn1797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1797%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHicks%26aufirst%3DC.%2BW.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DMacklin%26aufirst%3DW.%2BB.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DBace1%2520modulates%2520myelination%2520in%2520the%2520central%2520and%2520peripheral%2520nervous%2520system%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1520%26epage%3D1525%26doi%3D10.1038%2Fnn1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span><span class="refDoi"> DOI: 10.1038/emboj.2013.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Femboj.2013.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23792428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles&doi=10.1038%2Femboj.2013.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 and neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span></div><div class="casAuthors">Cheret, Cyril; Willem, Michael; Fricker, Florence R.; Wende, Hagen; Wulf-Goldenberg, Annika; Tahirovic, Sabina; Nave, Klaus-Armin; Saftig, Paul; Haass, Christian; Garratt, Alistair N.; Bennett, David L.; Birchmeier, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2015-2028</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Secretase 1 (Bace1) was identified through its crit. role in prodn. of amyloid-β peptides (Aβ), the major component of amyloid plaques in Alzheimer's disease.  Bace1 is considered a promising target for the treatment of this pathol., but also processes addnl. substrates, among them neuregulin-1 (Nrg1).  The authors' biochem. anal. indicated that Bace1 processed the Ig-contg. β1 Nrg1 (IgNrg1β1) isoform.  The authors found that a graded redn. in IgNrg1 signal strength in vivo resulted in increasingly severe deficits in the formation and maturation of muscle spindles, a proprioceptive organ crit. for muscle coordination.  Further, it was shown that Bace1 was required for formation and maturation of the muscle spindle.  Finally, pharmacol. inhibition and conditional mutagenesis in adult animals demonstrated that Bace1 and Nrg1 were essential to sustain muscle spindles and to maintain motor coordination.  The results assigned to Bace1 a role in the control of coordinated movement through its regulation of muscle spindle physiol., and implicated IgNrg1-dependent processing as a mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp74BUA5mCeAbVg90H21EOLACvtfcHk0lhT4zK0M2yWig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVersr8%253D&md5=7cf5ecb44dd55bca5096792720638560</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.146%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028%26doi%3D10.1038%2Femboj.2013.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6765</span><span class="NLM_x">–</span> <span class="NLM_lpage">6813</span><span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhaQJB1P5IUpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine+and+piperidine-based+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2007.10.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417%26doi%3D10.1016%2Fj.bmcl.2007.10.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2007.10.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+McHughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor&doi=10.1016%2Fj.bmcl.2007.10.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422%26doi%3D10.1016%2Fj.bmcl.2007.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowrie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Rational design of novel potent piperazinone and imidazolidinone BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3236</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2008.04.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3236-3241&author=J.+N.+Cummingauthor=T.+X.+Leauthor=S.+Babuauthor=C.+Carrollauthor=X.+Chenauthor=L.+Favreauauthor=P.+Gaspariauthor=T.+Guoauthor=D.+W.+Hobbsauthor=Y.+Huangauthor=U.+Iserlohauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=G.+Liauthor=J.+Lowrieauthor=N.+A.+McHughauthor=L.+Ozgurauthor=J.+Panauthor=E.+M.+Parkerauthor=K.+Saionzauthor=A.+W.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Wangauthor=Y.+Wuauthor=L.+Zhangauthor=Q.+Zhang&title=Rational+design+of+novel+potent+piperazinone+and+imidazolidinone+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLe%26aufirst%3DT.%2BX.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGaspari%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLowrie%26aufirst%3DJ.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DRational%2520design%2520of%2520novel%2520potent%2520piperazinone%2520and%2520imidazolidinone%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3236%26epage%3D3241%26doi%3D10.1016%2Fj.bmcl.2008.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span><span class="refDoi"> DOI: 10.1021/jm300119p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid&doi=10.1021%2Fjm300119p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024%26doi%3D10.1021%2Fjm300119p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-Site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9025</span><span class="NLM_x">–</span> <span class="NLM_lpage">9044</span><span class="refDoi"> DOI: 10.1021/jm300118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9025-9044&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+synthesis+of+potent%2C+orally+efficacious+hydroxyethylamine+derived+%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors&doi=10.1021%2Fjm300118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14eR"><div class="casContent"><span class="casTitleNuber">14e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span></div><div class="casAuthors">Dineen, Thomas A.; Weiss, Matthew M.; Williamson, Toni; Acton, Paul; Babu-Khan, Safura; Bartberger, Michael D.; Brown, James; Chen, Kui; Cheng, Yuan; Citron, Martin; Croghan, Michael D.; Dunn, Robert T.; Esmay, Joel; Graceffa, Russell F.; Harried, Scott S.; Hickman, Dean; Hitchcock, Stephen A.; Horne, Daniel B.; Huang, Hongbing; Imbeah-Ampiah, Ronke; Judd, Ted; Kaller, Matthew R.; Kreiman, Charles R.; La, Daniel S.; Li, Vivian; Lopez, Patricia; Louie, Steven; Monenschein, Holger; Nguyen, Thomas T.; Pennington, Lewis D.; San Miguel, Tisha; Sickmier, E. Allen; Vargas, Hugo M.; Wahl, Robert C.; Wen, Paul H.; Whittington, Douglas A.; Wood, Stephen; Xue, Qiufen; Yang, Bryant H.; Patel, Vinod F.; Zhong, Wenge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9025-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compds. (e.g., 1, I) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing.  In this article, we describe further modifications of the Ph ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS.  Several of these compds. caused robust redn. of Aβ levels in rat CSF and brain following oral dosing, and compd. II exhibited an improved cardiovascular safety profile relative to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqApKWBnTeHErVg90H21EOLACvtfcHk0li3qOJvO-lbpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D&md5=1c6ad4a5aa1583864bd778715e1453ea</span></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520efficacious%2520hydroxyethylamine%2520derived%2520%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9025%26epage%3D9044%26doi%3D10.1021%2Fjm300118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Wang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nechuta, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span> </span><span class="NLM_article-title">Application of fragment-based NMR screening, X-ray crystallography, structure- based design, and focused chemical library design to identify novel μM leads for the development of nM BACE-1 (β-site APP cleaving enzyme 1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1021/jm901472u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901472u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=942-950&author=Y.-S.+Wangauthor=C.+Stricklandauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=B.+M.+Beyerauthor=M.+M.+Seniorauthor=E.+M.+Smithauthor=T.+L.+Nechutaauthor=V.+S.+Madisonauthor=M.+Czarnieckiauthor=B.+A.+McKittrickauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=W.+J.+Greenleeauthor=D.+F.+Wyss&title=Application+of+fragment-based+NMR+screening%2C+X-ray+crystallography%2C+structure-+based+design%2C+and+focused+chemical+library+design+to+identify+novel+%CE%BCM+leads+for+the+development+of+nM+BACE-1+%28%CE%B2-site+APP+cleaving+enzyme+1%29+inhibitors&doi=10.1021%2Fjm901472u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901472u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901472u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-S.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DSenior%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNechuta%26aufirst%3DT.%2BL.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520fragment-based%2520NMR%2520screening%252C%2520X-ray%2520crystallography%252C%2520structure-%2520based%2520design%252C%2520and%2520focused%2520chemical%2520library%2520design%2520to%2520identify%2520novel%2520%25CE%25BCM%2520leads%2520for%2520the%2520development%2520of%2520nM%2520BACE-1%2520%2528%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D942%26epage%3D950%26doi%3D10.1021%2Fjm901472u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Discovery of cyclic acylguanidines as highly potent and selective β-site amyloid cleaving enzyme (BACE) inhibitors: part I; inhibitor design and validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1021/jm901408p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901408p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=951-965&author=Z.+Zhuauthor=Z.-Y.+Sunauthor=Y.+Yeauthor=J.+Voigtauthor=C.+Stricklandauthor=E.+M.+Smithauthor=J.+Cummingauthor=L.+Wangauthor=J.+Wongauthor=Y.-S.+Wangauthor=D.+F.+Wyssauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=E.+Parkerauthor=B.+A.+McKittrickauthor=A.+Stamfordauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=J.+C.+Hunter&title=Discovery+of+cyclic+acylguanidines+as+highly+potent+and+selective+%CE%B2-site+amyloid+cleaving+enzyme+%28BACE%29+inhibitors%3A+part+I%3B+inhibitor+design+and+validation&doi=10.1021%2Fjm901408p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901408p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901408p%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-S.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520cyclic%2520acylguanidines%2520as%2520highly%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520amyloid%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitors%253A%2520part%2520I%253B%2520inhibitor%2520design%2520and%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D951%26epage%3D965%26doi%3D10.1021%2Fjm901408p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+Identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor&doi=10.1016%2Fj.bmcl.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0li_CTNzlQj-Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520Identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449%26doi%3D10.1016%2Fj.bmcl.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wyss, D. F.; Cumming, J. N.; Strickland, C. O.; Stamford, A. W.</span><span> </span><span class="NLM_article-title">BACE Inhibitors</span>. In  <span class="citation_source-book">Fragment-Based Drug Discovery: Lessons and Outlook</span>; <span class="NLM_contrib-group">Erlanson, D. A.; Jahnke, W.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">67</span>, pp  <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2F9783527683604.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=329-353&author=D.+F.+Wyss&author=J.+N.+Cumming&author=C.+O.+Strickland&author=A.+W.+Stamfordauthor=D.+A.+Erlanson&author=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Lessons+and+Outlook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1002%2F9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DBACE%2520Inhibitors%26btitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Lessons%2520and%2520Outlook%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26pub%3DWiley%26date%3D2016%26volume%3D67%26spage%3D329%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span> </span><span class="NLM_article-title">Inhibitors of BACE for treating Alzheimer’s disease: a fragment-based drug discovery story</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2013.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cbpa.2013.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23683349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=320-328&author=A.+Stamfordauthor=C.+Strickland&title=Inhibitors+of+BACE+for+treating+Alzheimer%E2%80%99s+disease%3A+a+fragment-based+drug+discovery+story&doi=10.1016%2Fj.cbpa.2013.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story</span></div><div class="casAuthors">Stamford, Andrew; Strickland, Corey</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-328</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Several fragment-based methods have been applied to the discovery of new lead sources for inhibitors of BACE1, an important therapeutic target for Alzheimer's disease.  Among the most common fragment hits were various amidine-contg. mols. in which the amidine engaged in discrete H-bond donor-acceptor interaction with the BACE1 catalytic dyad.  Structure and medicinal chem. knowledge-based optimization with emphasis on ligand efficiency resulted in identification of a key pharmacophore comprising a non-planar cyclic amidine scaffold directly attached to a Ph group projecting into S1.  This key pharmacophore is a common feature of known clin. candidates and has dominated the recent patent literature.  A structural comparison of the non-planar cyclic amidine motif with other BACE1 pharmacophores highlights its uniqueness and distinct advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLbpbjuHoU7Vg90H21EOLACvtfcHk0li6OhoFP1OcVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslaku7w%253D&md5=f39c9a0499fe096cf4c0719f4cb41e37</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2013.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520BACE%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520fragment-based%2520drug%2520discovery%2520story%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D17%26spage%3D320%26epage%3D328%26doi%3D10.1016%2Fj.cbpa.2013.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0li6OhoFP1OcVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span><span class="refDoi"> DOI: 10.1021/jm901414e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm901414e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0lgG0F1J2ugZPQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158%26doi%3D10.1021%2Fjm901414e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span><span class="refDoi"> DOI: 10.1021/jm9006752</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm9006752"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323%26doi%3D10.1021%2Fjm9006752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span><span class="refDoi"> DOI: 10.1021/jm800914n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+%CE%B2-secretase&doi=10.1021%2Fjm800914n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262%26doi%3D10.1021%2Fjm800914n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhdeo, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span> </span><span class="NLM_article-title">Acylguanidines as small-molecule β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6158</span><span class="NLM_x">–</span> <span class="NLM_lpage">6161</span><span class="refDoi"> DOI: 10.1021/jm0607451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6158-6161&author=D.+C.+Coleauthor=E.+S.+Manasauthor=J.+R.+Stockauthor=J.+S.+Condonauthor=L.+D.+Jenningsauthor=A.+Aulabaughauthor=R.+Chopraauthor=R.+Cowlingauthor=J.+W.+Ellingboeauthor=K.+Y.+Fanauthor=B.+L.+Harrisonauthor=Y.+Huauthor=S.+Jacobsenauthor=G.+Jinauthor=L.+Linauthor=F.+E.+Loveringauthor=M.+S.+Malamasauthor=M.+L.+Stahlauthor=J.+Strandauthor=M.+N.+Sukhdeoauthor=K.+Svensonauthor=M.+J.+Turnerauthor=E.+Wagnerauthor=J.+Wuauthor=P.+Zhouauthor=J.+Bard&title=Acylguanidines+as+small-molecule+%CE%B2-secretase+inhibitors&doi=10.1021%2Fjm0607451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20e&amp;dbid=16384&amp;doi=10.1021%2Fjm0607451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607451%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DCondon%26aufirst%3DJ.%2BS.%26aulast%3DJennings%26aufirst%3DL.%2BD.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DFan%26aufirst%3DK.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DSukhdeo%26aufirst%3DM.%2BN.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DM.%2BJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DBard%26aufirst%3DJ.%26atitle%3DAcylguanidines%2520as%2520small-molecule%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6158%26epage%3D6161%26doi%3D10.1021%2Fjm0607451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Baxter, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinzeel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A. B.</span><span> </span><span class="NLM_article-title">2-Amino-3,4 dihydroquinazolines as inhibitors of BACE-1 (β-Site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4264</span><span class="refDoi"> DOI: 10.1021/jm0705408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0705408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4161-4264&author=E.+W.+Baxterauthor=K.+A.+Conwayauthor=L.+Kennisauthor=F.+Bischoffauthor=M.+H.+Merckenauthor=H.+L.+De+Winterauthor=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=C.+Luoauthor=M.+K.+Scottauthor=Y.+Huangauthor=M.+Braekenauthor=S.+M.+A.+Pietersauthor=D.+J.+C.+Berthelotauthor=S.+Masureauthor=W.+D.+Bruinzeelauthor=A.+D.+Jordanauthor=M.+H.+Parkerauthor=R.+E.+Boydauthor=J.+Quauthor=R.+S.+Alexanderauthor=D.+E.+Brennemanauthor=A.+B.+Reitz&title=2-Amino-3%2C4+dihydroquinazolines+as+inhibitors+of+BACE-1+%28%CE%B2-Site+APP+cleaving+enzyme%29%3A+Use+of+structure+based+design+to+convert+a+micromolar+hit+into+a+nanomolar+lead&doi=10.1021%2Fjm0705408"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20f&amp;dbid=16384&amp;doi=10.1021%2Fjm0705408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705408%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BW.%26aulast%3DConway%26aufirst%3DK.%2BA.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DMercken%26aufirst%3DM.%2BH.%26aulast%3DDe%2BWinter%26aufirst%3DH.%2BL.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DM.%2BK.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBraeken%26aufirst%3DM.%26aulast%3DPieters%26aufirst%3DS.%2BM.%2BA.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DMasure%26aufirst%3DS.%26aulast%3DBruinzeel%26aufirst%3DW.%2BD.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DParker%26aufirst%3DM.%2BH.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DBrenneman%26aufirst%3DD.%2BE.%26aulast%3DReitz%26aufirst%3DA.%2BB.%26atitle%3D2-Amino-3%252C4%2520dihydroquinazolines%2520as%2520inhibitors%2520of%2520BACE-1%2520%2528%25CE%25B2-Site%2520APP%2520cleaving%2520enzyme%2529%253A%2520Use%2520of%2520structure%2520based%2520design%2520to%2520convert%2520a%2520micromolar%2520hit%2520into%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4161%26epage%3D4264%26doi%3D10.1021%2Fjm0705408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1021/jm0611962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1116-1123&author=C.+W.+Murrayauthor=O.+Callaghanauthor=G.+Chessariauthor=A.+Cleasbyauthor=M.+Congreveauthor=M.+Fredericksonauthor=M.+J.+Hartshornauthor=R.+McMenaminauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+%CE%B2-secretase&doi=10.1021%2Fjm0611962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20gR"><div class="casContent"><span class="casTitleNuber">20g</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to β-Secretase</span></div><div class="casAuthors">Murray, Christopher W.; Callaghan, Owen; Chessari, Gianni; Cleasby, Anne; Congreve, Miles; Frederickson, Martyn; Hartshorn, Michael J.; McMenamin, Rachel; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1116-1123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes an application of fragment screening to the aspartyl protease enzyme, β-secretase (BACE-1), using high throughput x-ray crystallog.  Three distinct chemotypes were identified by X-ray crystallog. as binding to the catalytic aspartates either via an aminoheterocycle (such as 2-aminoquinoline), a piperidine, or an aliph. hydroxyl group.  The fragment hits were weak inhibitors of BACE-1 in the millimolar range but were of interest because most of them displayed relatively good ligand efficiencies.  The aminoheterocycles exhibited a novel recognition motif that has not been seen before with aspartic proteases.  Virtual screening around this motif identified an aminopyridine with increased potency and attractive growth points for further elaboration using structure-based drug design.  The companion paper illustrates how sub-micromolar inhibitors were developed starting from this fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZHjESbj93LVg90H21EOLACvtfcHk0lhTccIuPyvp4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D&md5=1ff92bcf5bcb8f265709e3571e25ae8e</span></div><a href="/servlet/linkout?suffix=cit20g&amp;dbid=16384&amp;doi=10.1021%2Fjm0611962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611962%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1116%26epage%3D1123%26doi%3D10.1021%2Fjm0611962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1021/jm061197u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+%CE%B2-secretase&doi=10.1021%2Fjm061197u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20hR"><div class="casContent"><span class="casTitleNuber">20h</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase</span></div><div class="casAuthors">Congreve, Miles; Aharony, David; Albert, Jeffrey; Callaghan, Owen; Campbell, James; Carr, Robin A. E.; Chessari, Gianni; Cowan, Suzanna; Edwards, Philip D.; Frederickson, Martyn; McMenamin, Rachel; Murray, Christopher W.; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1124-1132</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme β-secretase (BACE-1).  Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chem. starting points.  Structure-based design approaches have led to identification of low micromolar lead compds. that retain these interactions and addnl. occupy adjacent hydrophobic pockets of the active site.  These leads form two subseries, for which compds. 4 (IC50 = 25 μM) and 6c (IC50 = 24 μM) are representative.  In the latter series, further optimization has led to 8a (IC50 = 690 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsyK6i2PI7CLVg90H21EOLACvtfcHk0lhTccIuPyvp4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7s%253D&md5=a96f52c59266cacdb25189535fce1e47</span></div><a href="/servlet/linkout?suffix=cit20h&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132%26doi%3D10.1021%2Fjm061197u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Beer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span> </span><span class="NLM_article-title">Discovery of a novel warhead against β-secretase through fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5903</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span><span class="refDoi"> DOI: 10.1021/jm070825k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&author=S.+Geschwindnerauthor=L.-L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+A.+Folmer&title=Discovery+of+a+novel+warhead+against+%CE%B2-secretase+through+fragment-based+lead+generation&doi=10.1021%2Fjm070825k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20iR"><div class="casContent"><span class="casTitleNuber">20i</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation</span></div><div class="casAuthors">Geschwindner, Stefan; Olsson, Lise-Lotte; Albert, Jeffrey S.; Deinum, Johanna; Edwards, Philip D.; de Beer, Tonny; Folmer, Rutger H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5903-5911</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation was applied to find novel small-mol. inhibitors of β-secretase (BACE-1), a key target for the treatment of Alzheimer's disease.  Fragment hits coming from a 1D NMR screen were characterized by BIAcore, and the most promising compds. were soaked into protein crystals to help the rational design of more potent hit analogs.  Problems arising due to the inability to grow BACE-1 crystals at the biol. relevant pH at which the screen was run were overcome by using endothiapepsin as a surrogate aspartyl protease.  Among others, the authors identified 6-substituted isocytosines as a novel warhead against BACE-1, and the accompanying paper in this journal describes how these were optimized to a lead series of nanomolar inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmfboHMnD47LVg90H21EOLACvtfcHk0lheaFkzJv1oQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrrJ&md5=01266da7a1bf718ca06fe5bd9c925b7c</span></div><a href="/servlet/linkout?suffix=cit20i&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520%25CE%25B2-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5903%26epage%3D5911%26doi%3D10.1021%2Fjm070825k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span><span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.-L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20jR"><div class="casContent"><span class="casTitleNuber">20j</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0lheaFkzJv1oQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit20j&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to <i>In Vivo</i> efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span><span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+In+Vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20kR"><div class="casContent"><span class="casTitleNuber">20k</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lhT6LzbpEBt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit20k&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520In%2520Vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmstroem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsblom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterky, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faelting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">Core refinement toward permeable β secretase (BACE-1) inhibitors with low hERG activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4181</span><span class="NLM_x">–</span> <span class="NLM_lpage">4205</span><span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstroemauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+Faeltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2+secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20l&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstroem%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2%2520secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Tamura, Y.; Suzuki, S.; Tada, Y.; Yonezawa, S.; Fujikoshi, C.; Matsumoto, S.; Kooriyama, Y.; Ueno, T.</span><span> </span><span class="NLM_article-title">Preparation of aminodihydrothiazine derivatives as BACE1 inhibitors</span>. PCT Int. Appl. WO 2008133274,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Tamura&author=S.+Suzuki&author=Y.+Tada&author=S.+Yonezawa&author=C.+Fujikoshi&author=S.+Matsumoto&author=Y.+Kooriyama&author=T.+Ueno&title=Preparation+of+aminodihydrothiazine+derivatives+as+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520aminodihydrothiazine%2520derivatives%2520as%2520BACE1%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Suzuki, Y.; Motoki, T.; Kaneko, T.; Takaishi, M.; Ishida, T.; Takeda, K.; Kita, Y.; Yamamoto, N.; Khan, A.; Dimopoulos, P.</span><span> </span><span class="NLM_article-title">Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</span>. PCT Int. Appl. WO 2009091016,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span><span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lhT6LzbpEBt2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0ljp595pyWW8TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploeger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueters, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">41245</span><span class="NLM_x">–</span> <span class="NLM_lpage">41257</span><span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23048024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=S.+Karlstr%C3%B6mauthor=S.+Gustavssonauthor=L.-L.+Olssonauthor=A.-C.+Rades%C3%A4terauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.-M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+F%C3%A4lting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Jeppsson, Fredrik; Eketjaell, Susanna; Janson, Juliette; Karlstroem, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesaeter, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">41245-41257</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid β peptide (Aβ) species.  Because cerebral deposition of Aβ species might be crit. for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease.  Here, the authors report the discovery and comprehensive preclin. characterization of AZD3839, a potent and selective inhibitor of human BACE1.  AZD3839 was identified using fragment-based screening and structure-based design.  In a concn.-dependent manner, AZD3839 inhibited BACE1 activity in a biochem. fluorescence resonance energy transfer (FRET) assay, Aβ and sAPPβ release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons.  Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, resp.  AZD3839 exhibited dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate.  Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects.  These results suggest that AZD3839 effectively reduces the levels of Aβ in brain, CSF, and plasma in several preclin. species.  It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias.  Based on the overall pharmacol. profile and its drug like properties, AZD3839 has been progressed into Phase 1 clin. trials in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi56XzYm8WhLVg90H21EOLACvtfcHk0ljp595pyWW8TQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE&md5=dd328c2e0b3de730de30f1e249f2403e</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevorkyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komjathy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martényi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Mart%C3%A9nyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lg9RznHIQZQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMart%25C3%25A9nyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lueoend, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frieauff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-%CE%B2+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0lg9RznHIQZQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-%25CE%25B2%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljwn4QYOFhRXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Aβ reduction without cardiovascular liabilities</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22fR"><div class="casContent"><span class="casTitleNuber">22f</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0ljwn4QYOFhRXw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit22f&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit22g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22gR"><div class="casContent"><span class="casTitleNuber">22g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0ljt5pyXpSo6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit22g&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Öhberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span><span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0ljt5pyXpSo6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) Inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+Inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0ljt5pyXpSo6gQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520Inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0lgRaZWAUcVgvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Rochin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurbain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Niel, G.</span><span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">10658</span><span class="NLM_x">–</span> <span class="NLM_lpage">10663</span><span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0lgRaZWAUcVgvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Esterházy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stützer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechsteiner, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieske, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marselli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr-Conte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffel, M.</span><span> </span><span class="NLM_article-title">BACE2 is a β cell-enriched protease that regulates pancreatic β cell function and mass</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=BACE2+is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lgRaZWAUcVgvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBACE2%2520is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Utility of unbound plasma drug levels and P glycoprotein transport data in prediction of central nervous system exposure</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1080/00498250903015402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1080%2F00498250903015402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=687-693&author=H.+Heauthor=K.+A.+Lyonsauthor=X.+Shenauthor=Z.+Yaoauthor=K.+Bleasbyauthor=G.+Chanauthor=M.+Hafeyauthor=X.+Liauthor=S.+Xuauthor=G.+M.+Salituroauthor=L.+H.+Cohenauthor=W.+Tang&title=Utility+of+unbound+plasma+drug+levels+and+P+glycoprotein+transport+data+in+prediction+of+central+nervous+system+exposure&doi=10.1080%2F00498250903015402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250903015402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250903015402%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DCohen%26aufirst%3DL.%2BH.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DUtility%2520of%2520unbound%2520plasma%2520drug%2520levels%2520and%2520P%2520glycoprotein%2520transport%2520data%2520in%2520prediction%2520of%2520central%2520nervous%2520system%2520exposure%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D687%26epage%3D693%26doi%3D10.1080%2F00498250903015402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1124/jpet.112.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+fluid+amyloid-%CE%B2+%28A%CE%B2%29+as+an+effect+biomarker+for+brain+A%CE%B2+lowering+verified+by+quantitative+preclinical+analyses&doi=10.1124%2Fjpet.112.192625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0ljkok0chDPsmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520effect%2520biomarker%2520for%2520brain%2520A%25CE%25B2%2520lowering%2520verified%2520by%2520quantitative%2520preclinical%2520analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375%26doi%3D10.1124%2Fjpet.112.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S. A. G.</span><span> </span><span class="NLM_article-title">Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1007/s11095-013-1189-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1007%2Fs11095-013-1189-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=670-683&author=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=K.+Tunbladauthor=F.+Jeppssonauthor=S.+Von+Bergauthor=C.+Nivaauthor=A.-C.+Rades%C3%A4terauthor=J.+F%C3%A4ltingauthor=S.+A.+G.+Visser&title=Population+PKPD+modeling+of+BACE1+inhibitor-induced+reduction+in+A%CE%B2+levels+in+vivo+and+correlation+to+in+vitro+potency+in+primary+cortical+neurons+from+mouse+and+guinea+pig&doi=10.1007%2Fs11095-013-1189-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1007%2Fs11095-013-1189-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-013-1189-y%26sid%3Dliteratum%253Aachs%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DTunblad%26aufirst%3DK.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DVon%2BBerg%26aufirst%3DS.%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DS.%2BA.%2BG.%26atitle%3DPopulation%2520PKPD%2520modeling%2520of%2520BACE1%2520inhibitor-induced%2520reduction%2520in%2520A%25CE%25B2%2520levels%2520in%2520vivo%2520and%2520correlation%2520to%2520in%2520vitro%2520potency%2520in%2520primary%2520cortical%2520neurons%2520from%2520mouse%2520and%2520guinea%2520pig%26jtitle%3DPharm.%2520Res.%26date%3D2014%26volume%3D31%26spage%3D670%26epage%3D683%26doi%3D10.1007%2Fs11095-013-1189-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tai, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, H. P.</span><span> </span><span class="NLM_article-title">The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat</span> <span class="citation_source-journal">J. Pharmacokinet. Pharmacodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1007/s10928-012-9246-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1007%2Fs10928-012-9246-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22481485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=227-237&author=L.+M.+Taiauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Flohrauthor=R.+Jakob-Roetneauthor=A.+Carusoauthor=H.+P.+Grimm&title=The+dynamics+of+A%CE%B2+distribution+after+%CE%B3-secretase+inhibitor+treatment%2C+as+determined+by+experimental+and+modelling+approaches+in+a+wild+type+rat&doi=10.1007%2Fs10928-012-9246-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28cR"><div class="casContent"><span class="casTitleNuber">28c</span><div class="casTitle"><span class="NLM_cas:atitle">The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat</span></div><div class="casAuthors">Tai, Leon M.; Jacobsen, Helmut; Ozmen, Laurence; Flohr, Alexander; Jakob-Roetne, Roland; Caruso, Antonello; Grimm, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Pharmacodynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">JPPOAH</span>;
        ISSN:<span class="NLM_cas:issn">1567-567X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibition of the enzyme(s) that produce the Amyloid beta (Aβ) peptide, namely BACE and γ-secretase, is considered an attractive target for Alzheimer's disease therapy.  However, the optimal pharmacokinetic-pharmacodynamic modeling method to describe the changes in Aβ levels after drug treatment is unclear.  In this study, turnover models were employed to describe Aβ levels following treatment with the γ-secretase inhibitor RO5036450, in the wild type rat.  Initially, Aβ level changes in the brain, cerebral spinal fluid (CSF) and plasma were modeled as sep. biol. compartments, which allowed the estn. of a compd. IC 50 and Aβ turnover.  While the data were well described, the model did not take into consideration that the CSF pool of Aβ most likely originates from the brain via the CSF drainage pathway.  Therefore, a sep. model was carried out, with the assumption that CSF Aβ levels originated from the brain.  The optimal model that described the data involved two brain Aβ 40 sub-compartments, one with a rapid turnover, from which CSF Aβ 40 is derived, and a second quasi-static pool of ∼20%.  Importantly, the estd. in vivo brain IC 50 was in a good range of the in vitro IC 50 (ratio, 1.4).  In conclusion, the PK/PD models presented here are well suited for describing the temporal changes in Aβ levels that occur after treatment with an Aβ lowering drug, and identifying physiol. parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM6gomsyyrKbVg90H21EOLACvtfcHk0liAI1-h9HA13A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOmtrY%253D&md5=ab4fdf450464626408ae92585d14f778</span></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1007%2Fs10928-012-9246-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-012-9246-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DL.%2BM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DH.%2BP.%26atitle%3DThe%2520dynamics%2520of%2520A%25CE%25B2%2520distribution%2520after%2520%25CE%25B3-secretase%2520inhibitor%2520treatment%252C%2520as%2520determined%2520by%2520experimental%2520and%2520modelling%2520approaches%2520in%2520a%2520wild%2520type%2520rat%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2012%26volume%3D39%26spage%3D227%26epage%3D237%26doi%3D10.1007%2Fs10928-012-9246-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Van Maanen, E.; Van Steeg, T.; Michener, M. S.; Savage, M. J.; Kennedy, M. E.; Kleijn, H. J.; Stone, J.; Danhof, M.</span><span> </span><span class="NLM_article-title">Systems pharmacology analysis of the amyloid cascade enables the identification of an Aβ<sub>42</sub> oligomer pool</span>.  <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1124/jpet.115.230565</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1124%2Fjpet.115.230565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=26826190" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=E.+Van+Maanen&author=T.+Van+Steeg&author=M.+S.+Michener&author=M.+J.+Savage&author=M.+E.+Kennedy&author=H.+J.+Kleijn&author=J.+Stone&author=M.+Danhof&title=Systems+pharmacology+analysis+of+the+amyloid+cascade+enables+the+identification+of+an+A%CE%B242+oligomer+pool&doi=10.1124%2Fjpet.115.230565"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230565%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMaanen%26aufirst%3DE.%26atitle%3DSystems%2520pharmacology%2520analysis%2520of%2520the%2520amyloid%2520cascade%2520enables%2520the%2520identification%2520of%2520an%2520A%25CE%25B242%2520oligomer%2520pool%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26doi%3D10.1124%2Fjpet.115.230565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4a','cit4b','cit4c','cit4d'],'ref5':['cit5a','cit5b','cit5c','cit5d','cit5e','cit5f','cit5g'],'ref6':['cit6a','cit6b'],'ref7':['cit7a','cit7b','cit7c'],'ref8':['cit8a','cit8b'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14a','cit14b','cit14c','cit14d','cit14e'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b','cit20c','cit20d','cit20e','cit20f','cit20g','cit20h','cit20i','cit20j','cit20k','cit20l','cit20m','cit20n'],'ref21':['cit21'],'ref22':['cit22a','cit22b','cit22c','cit22d','cit22e','cit22f','cit22g'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b','cit28c','cit28d']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 28 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">David L. McKinzie, Leonard L. Winneroski, Steven J. Green, Erik J. Hembre, Jon A. Erickson, Brian A. Willis, Scott A. Monk, Christopher D. Aluise, Thomas K. Baker, Jose E. Lopez, Jörg Hendle, James P. Beck, Richard A. Brier, Leonard N. Boggs, Anthony R. Borders, Patrick J. Cocke, Pablo Garcia-Losada, Stephen L. Lowe, Brian M. Mathes, Patrick C. May, Warren J. Porter, Stephanie L. Stout, David E. Timm, Brian M. Watson, Zhixiang Yang, <span class="NLM_string-name hlFld-ContribAuthor">Dustin J. Mergott</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Development of LY3202626, a Low-Dose, CNS-Penetrant BACE Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8076-8100. <a href="https://doi.org/10.1021/acs.jmedchem.1c00489" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00489</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00489&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00489%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BDevelopment%252Bof%252BLY3202626%25252C%252Ba%252BLow-Dose%25252C%252BCNS-Penetrant%252BBACE%252BInhibitor%26aulast%3DMcKinzie%26aufirst%3DDavid%2BL.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D17032021%26date%3D03062021%26volume%3D64%26issue%3D12%26spage%3D8076%26epage%3D8100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Bryan Li, Richard W. Barnhart, Amelie Dion, Steven Guinness, Alan Happe, Cheryl M. Hayward, Jeffrey Kohrt, Teresa Makowski, Mark Maloney, Jade D. Nelson, Asaad Nematalla, J. Christopher McWilliams, Zhihui Peng, Jeffrey Raggon, John Sagal, Gerald A. Weisenburger, Denghui Bao, Miguel Gonzalez, Jiangping Lu, Mark D. McLaws, Jian Tao, <span class="NLM_string-name hlFld-ContribAuthor">Baolin Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Process Development of a Second Generation β-Amyloid-Cleaving Enzyme Inhibitor—Improving the Robustness of a Halogen-Metal Exchange Using Continuous Stirred-Tank Reactors. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2021,</strong> <em>25 </em>
                                    (6)
                                     , 1440-1453. <a href="https://doi.org/10.1021/acs.oprd.1c00126" title="DOI URL">https://doi.org/10.1021/acs.oprd.1c00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.1c00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.1c00126%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DProcess%252BDevelopment%252Bof%252Ba%252BSecond%252BGeneration%252B%2525CE%2525B2-Amyloid-Cleaving%252BEnzyme%252BInhibitor%2525E2%252580%252594Improving%252Bthe%252BRobustness%252Bof%252Ba%252BHalogen-Metal%252BExchange%252BUsing%252BContinuous%252BStirred-Tank%252BReactors%26aulast%3DLi%26aufirst%3DBryan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D24052021%26volume%3D25%26issue%3D6%26spage%3D1440%26epage%3D1453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Alexei Buevich, John P. Caldwell, Lynn Hyde, Xianhai Huang, Xiaoxiang Liu, Brian McKittrick, Robert D. Mazzola, Dmitri Pissarnitski, Anandan Palani, Lili Zhang, Eric Parker, Li Xiao, Diane Rindgen, <span class="NLM_string-name hlFld-ContribAuthor">Zhaoning Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Leads for γ-Secretase Modulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (15)
                                     , 8216-8230. <a href="https://doi.org/10.1021/acs.jmedchem.0c00446" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00446</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00446&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00446%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DGeneration%252Bof%252BLeads%252Bfor%252B%2525CE%2525B3-Secretase%252BModulation%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D16032020%26date%3D04082020%26date%3D27072020%26volume%3D63%26issue%3D15%26spage%3D8216%26epage%3D8230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Hangchen Hu, Zhaoqiang Chen, Xiang Xu, <span class="NLM_string-name hlFld-ContribAuthor">Yechun Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Survey of the Binding Modes of BACE1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 880-889. <a href="https://doi.org/10.1021/acschemneuro.8b00420" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00420</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00420&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00420%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DStructure-Based%252BSurvey%252Bof%252Bthe%252BBinding%252BModes%252Bof%252BBACE1%252BInhibitors%26aulast%3DHu%26aufirst%3DHangchen%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D18082018%26date%3D12122018%26date%3D27122018%26date%3D12122018%26volume%3D10%26issue%3D2%26spage%3D880%26epage%3D889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Mihirbaran Mandal, Kaushik Mitra, Diane Grotz, Xinjie Lin, Jairam Palamanda, Pramila Kumari, Alexei Buevich, John P. Caldwell, Xia Chen, Kathleen Cox, Leonard Favreau, Lynn Hyde, Matthew E. Kennedy, Reshma Kuvelkar, Xiaoxiang Liu, Robert D. Mazzola, Eric Parker, Diane Rindgen, Edward Sherer, Hongwu Wang, Zhaoning Zhu, Andrew W. Stamford, <span class="NLM_string-name hlFld-ContribAuthor">Jared N. Cumming</span>. </span><span class="cited-content_cbyCitation_article-title">Overcoming Time-Dependent Inhibition (TDI) of Cytochrome P450 3A4 (CYP3A4) Resulting from Bioactivation of a Fluoropyrimidine Moiety. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (23)
                                     , 10700-10708. <a href="https://doi.org/10.1021/acs.jmedchem.8b01326" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01326</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01326%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOvercoming%252BTime-Dependent%252BInhibition%252B%252528TDI%252529%252Bof%252BCytochrome%252BP450%252B3A4%252B%252528CYP3A4%252529%252BResulting%252Bfrom%252BBioactivation%252Bof%252Ba%252BFluoropyrimidine%252BMoiety%26aulast%3DMandal%26aufirst%3DMihirbaran%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D22082018%26date%3D15112018%26date%3D02112018%26volume%3D61%26issue%3D23%26spage%3D10700%26epage%3D10708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Federica  Prati</span>, <span class="hlFld-ContribAuthor ">Giovanni  Bottegoni</span>, <span class="hlFld-ContribAuthor ">Maria Laura  Bolognesi</span>, and <span class="hlFld-ContribAuthor ">Andrea  Cavalli</span>  . </span><span class="cited-content_cbyCitation_article-title">BACE-1 Inhibitors: From Recent Single-Target Molecules to Multitarget Compounds for Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 619-637. <a href="https://doi.org/10.1021/acs.jmedchem.7b00393" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00393</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00393&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00393%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBACE-1%252BInhibitors%25253A%252BFrom%252BRecent%252BSingle-Target%252BMolecules%252Bto%252BMultitarget%252BCompounds%252Bfor%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DPrati%26aufirst%3DFederica%26date%3D2018%26date%3D2017%26date%3D2017%26date%3D13032017%26date%3D08082017%26date%3D08022018%26date%3D27072017%26volume%3D61%26issue%3D3%26spage%3D619%26epage%3D637" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jack D.  Scott</span>, <span class="hlFld-ContribAuthor ">Sarah W.  Li</span>, <span class="hlFld-ContribAuthor ">Andrew P. J.  Brunskill</span>, <span class="hlFld-ContribAuthor ">Xia  Chen</span>, <span class="hlFld-ContribAuthor ">Kathleen  Cox</span>, <span class="hlFld-ContribAuthor ">Jared N.  Cumming</span>, <span class="hlFld-ContribAuthor ">Mark  Forman</span>, <span class="hlFld-ContribAuthor ">Eric J.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Robert A.  Hodgson</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Qin  Jiang</span>, <span class="hlFld-ContribAuthor ">Ulrich  Iserloh</span>, <span class="hlFld-ContribAuthor ">Irina  Kazakevich</span>, <span class="hlFld-ContribAuthor ">Reshma  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">Hong  Mei</span>, <span class="hlFld-ContribAuthor ">John  Meredith</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Misiaszek</span>, <span class="hlFld-ContribAuthor ">Peter  Orth</span>, <span class="hlFld-ContribAuthor ">Lana M.  Rossiter</span>, <span class="hlFld-ContribAuthor ">Meagan  Slater</span>, <span class="hlFld-ContribAuthor ">Julie  Stone</span>, <span class="hlFld-ContribAuthor ">Corey O.  Strickland</span>, <span class="hlFld-ContribAuthor ">Johannes H.  Voigt</span>, <span class="hlFld-ContribAuthor ">Ganfeng  Wang</span>, <span class="hlFld-ContribAuthor ">Hongwu  Wang</span>, <span class="hlFld-ContribAuthor ">Yusheng  Wu</span>, <span class="hlFld-ContribAuthor ">William J.  Greenlee</span>, <span class="hlFld-ContribAuthor ">Eric M.  Parker</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, and <span class="hlFld-ContribAuthor ">Andrew W.  Stamford</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of the 3-Imino-1,2,4-thiadiazinane 1,1-Dioxide Derivative Verubecestat (MK-8931)–A β-Site Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (23)
                                     , 10435-10450. <a href="https://doi.org/10.1021/acs.jmedchem.6b00307" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00307</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00307&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00307%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bthe%252B3-Imino-1%25252C2%25252C4-thiadiazinane%252B1%25252C1-Dioxide%252BDerivative%252BVerubecestat%252B%252528MK-8931%252529%2525E2%252580%252593A%252B%2525CE%2525B2-Site%252BAmyloid%252BPrecursor%252BProtein%252BCleaving%252BEnzyme%252B1%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DScott%26aufirst%3DJack%2BD.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26022016%26date%3D18112016%26date%3D08122016%26volume%3D59%26issue%3D23%26spage%3D10435%26epage%3D10450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, <span class="hlFld-ContribAuthor ">Ken-ichi  Kusakabe</span>, <span class="hlFld-ContribAuthor ">Chien-Chi  Hsiao</span>, <span class="hlFld-ContribAuthor ">Harrie J. M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Small-molecule BACE1 inhibitors: a patent literature review (2011 to 2020). </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2021,</strong> <em>31 </em>
                                    (1)
                                     , 25-52. <a href="https://doi.org/10.1080/13543776.2021.1832463" title="DOI URL">https://doi.org/10.1080/13543776.2021.1832463</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2021.1832463&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2021.1832463%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DSmall-molecule%252BBACE1%252Binhibitors%25253A%252Ba%252Bpatent%252Bliterature%252Breview%252B%2525282011%252Bto%252B2020%252529%26aulast%3DRombouts%26aufirst%3DFrederik%26date%3D2021%26date%3D2020%26volume%3D31%26issue%3D1%26spage%3D25%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sonia  Losada-Barreiro</span>, <span class="hlFld-ContribAuthor ">Matej  Sova</span>, <span class="hlFld-ContribAuthor ">Janez  Mravljak</span>, <span class="hlFld-ContribAuthor ">Luciano  Saso</span>, <span class="hlFld-ContribAuthor ">Carlos  Bravo-Díaz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, In Vitro Antioxidant Properties and Distribution of a New Cyanothiophene-Based Phenolic Compound in Olive Oil-In-Water Emulsions. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2020,</strong> <em>9 </em>
                                    (7)
                                     , 623. <a href="https://doi.org/10.3390/antiox9070623" title="DOI URL">https://doi.org/10.3390/antiox9070623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox9070623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox9070623%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DSynthesis%25252C%252BIn%252BVitro%252BAntioxidant%252BProperties%252Band%252BDistribution%252Bof%252Ba%252BNew%252BCyanothiophene-Based%252BPhenolic%252BCompound%252Bin%252BOlive%252BOil-In-Water%252BEmulsions%26aulast%3DLosada-Barreiro%26aufirst%3DSonia%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D7%26spage%3D623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carolyn  Tallon</span>, <span class="hlFld-ContribAuthor ">Katherine L.  Marshall</span>, <span class="hlFld-ContribAuthor ">Matthew E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">Lynn A.  Hyde</span>, <span class="hlFld-ContribAuthor ">Mohamed. H.  Farah</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological BACE Inhibition Improves Axonal Regeneration in Nerve Injury and Disease Models. </span><span class="cited-content_cbyCitation_journal-name">Neurotherapeutics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (3)
                                     , 973-988. <a href="https://doi.org/10.1007/s13311-020-00852-3" title="DOI URL">https://doi.org/10.1007/s13311-020-00852-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13311-020-00852-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13311-020-00852-3%26sid%3Dliteratum%253Aachs%26jtitle%3DNeurotherapeutics%26atitle%3DPharmacological%252BBACE%252BInhibition%252BImproves%252BAxonal%252BRegeneration%252Bin%252BNerve%252BInjury%252Band%252BDisease%252BModels%26aulast%3DTallon%26aufirst%3DCarolyn%26date%3D2020%26date%3D2020%26volume%3D17%26issue%3D3%26spage%3D973%26epage%3D988" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muslum  Yildiz</span>. </span><span class="cited-content_cbyCitation_article-title">Docking studies suggest the important role of interactions among the catalytic dyad and inhibitors for designing Bace1 specific inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2020,</strong> <em>1208 </em>, 127893. <a href="https://doi.org/10.1016/j.molstruc.2020.127893" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.127893</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.127893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.127893%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DDocking%252Bstudies%252Bsuggest%252Bthe%252Bimportant%252Brole%252Bof%252Binteractions%252Bamong%252Bthe%252Bcatalytic%252Bdyad%252Band%252Binhibitors%252Bfor%252Bdesigning%252BBace1%252Bspecific%252Binhibitors%26aulast%3DYildiz%26aufirst%3DMuslum%26date%3D2020%26volume%3D1208%26spage%3D127893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiayang  Xie</span>, <span class="hlFld-ContribAuthor ">Ruirui  Liang</span>, <span class="hlFld-ContribAuthor ">Yajiang  Wang</span>, <span class="hlFld-ContribAuthor ">Junyi  Huang</span>, <span class="hlFld-ContribAuthor ">Xin  Cao</span>, <span class="hlFld-ContribAuthor ">Bing  Niu</span>. </span><span class="cited-content_cbyCitation_article-title">Progress in Target Drug Molecules for Alzheimer's Disease. </span><span class="cited-content_cbyCitation_journal-name">Current Topics in Medicinal Chemistry</span><span> <strong>2020,</strong> <em>20 </em>
                                    (1)
                                     , 4-36. <a href="https://doi.org/10.2174/1568026619666191203113745" title="DOI URL">https://doi.org/10.2174/1568026619666191203113745</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Topics%2520in%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bin%252BTarget%252BDrug%252BMolecules%252Bfor%252BAlzheimer%252527s%252BDisease%26aulast%3DXie%26aufirst%3DJiayang%26date%3D2020%26volume%3D20%26issue%3D1%26spage%3D4%26epage%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ulf  Neumann</span>, <span class="hlFld-ContribAuthor ">Rainer  Machauer</span>, <span class="hlFld-ContribAuthor ">Derya R.  Shimshek</span>. </span><span class="cited-content_cbyCitation_article-title">The β‐secretase (BACE) inhibitor NB‐360 in preclinical models: From amyloid‐β reduction to downstream disease‐relevant effects. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Pharmacology</span><span> <strong>2019,</strong> <em>176 </em>
                                    (18)
                                     , 3435-3446. <a href="https://doi.org/10.1111/bph.14582" title="DOI URL">https://doi.org/10.1111/bph.14582</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/bph.14582&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fbph.14582%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Pharmacology%26atitle%3DThe%252B%2525CE%2525B2%2525E2%252580%252590secretase%252B%252528BACE%252529%252Binhibitor%252BNB%2525E2%252580%252590360%252Bin%252Bpreclinical%252Bmodels%25253A%252BFrom%252Bamyloid%2525E2%252580%252590%2525CE%2525B2%252Breduction%252Bto%252Bdownstream%252Bdisease%2525E2%252580%252590relevant%252Beffects%26aulast%3DNeumann%26aufirst%3DUlf%26date%3D2019%26date%3D2019%26volume%3D176%26issue%3D18%26spage%3D3435%26epage%3D3446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masihuz  Zaman</span>, <span class="hlFld-ContribAuthor ">Asra Nasir  Khan</span>, <span class="hlFld-ContribAuthor ">Wahiduzzaman</span>, <span class="hlFld-ContribAuthor ">Syed Mohammad  Zakariya</span>, <span class="hlFld-ContribAuthor ">Rizwan Hasan  Khan</span>. </span><span class="cited-content_cbyCitation_article-title">Protein misfolding, aggregation and mechanism of amyloid cytotoxicity: An overview and therapeutic strategies to inhibit aggregation. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2019,</strong> <em>134 </em>, 1022-1037. <a href="https://doi.org/10.1016/j.ijbiomac.2019.05.109" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2019.05.109</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2019.05.109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2019.05.109%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DProtein%252Bmisfolding%25252C%252Baggregation%252Band%252Bmechanism%252Bof%252Bamyloid%252Bcytotoxicity%25253A%252BAn%252Boverview%252Band%252Btherapeutic%252Bstrategies%252Bto%252Binhibit%252Baggregation%26aulast%3DZaman%26aufirst%3DMasihuz%26date%3D2019%26volume%3D134%26spage%3D1022%26epage%3D1037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nima  Razzaghi-Asl</span>, <span class="hlFld-ContribAuthor ">Adibe  Karimi</span>, <span class="hlFld-ContribAuthor ">Ahmad  Ebadi</span>. </span><span class="cited-content_cbyCitation_article-title">The potential of natural product vs neurodegenerative disorders: In silico study of artoflavanocoumarin as BACE-1 inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2018,</strong> <em>77 </em>, 307-317. <a href="https://doi.org/10.1016/j.compbiolchem.2018.10.015" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2018.10.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2018.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2018.10.015%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DThe%252Bpotential%252Bof%252Bnatural%252Bproduct%252Bvs%252Bneurodegenerative%252Bdisorders%25253A%252BIn%252Bsilico%252Bstudy%252Bof%252Bartoflavanocoumarin%252Bas%252BBACE-1%252Binhibitor%26aulast%3DRazzaghi-Asl%26aufirst%3DNima%26date%3D2018%26volume%3D77%26spage%3D307%26epage%3D317" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohdan A.  Chalyk</span>, <span class="hlFld-ContribAuthor ">Kateryna V.  Hrebeniuk</span>, <span class="hlFld-ContribAuthor ">Konstantin S.  Gavrilenko</span>, <span class="hlFld-ContribAuthor ">Oleh V.  Shablykin</span>, <span class="hlFld-ContribAuthor ">Oksana O.  Yanshyna</span>, <span class="hlFld-ContribAuthor ">Daniil  Bash</span>, <span class="hlFld-ContribAuthor ">Pavel K.  Mykhailiuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr S.  Liashuk</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Bi- and Polyfunctional Isoxazoles from Amino Acid Derived Halogenoximes and Active Methylene Nitriles. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (22)
                                     , 2753-2761. <a href="https://doi.org/10.1002/ejoc.201800311" title="DOI URL">https://doi.org/10.1002/ejoc.201800311</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800311&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800311%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BBi-%252Band%252BPolyfunctional%252BIsoxazoles%252Bfrom%252BAmino%252BAcid%252BDerived%252BHalogenoximes%252Band%252BActive%252BMethylene%252BNitriles%26aulast%3DChalyk%26aufirst%3DBohdan%2BA.%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D22%26spage%3D2753%26epage%3D2761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Volodymyr L.  Mykhalchuk</span>, <span class="hlFld-ContribAuthor ">Vladimir S.  Yarmolchuk</span>, <span class="hlFld-ContribAuthor ">Roman O.  Doroschuk</span>, <span class="hlFld-ContribAuthor ">Andrey A.  Tolmachev</span>, <span class="hlFld-ContribAuthor ">Oleksandr O.  Grygorenko</span>. </span><span class="cited-content_cbyCitation_article-title">[3+2] Cycloaddition of an Azomethyne Ylide and Vinyl Sulfonyl Fluorides ― an Approach to Pyrrolidine-3-sulfonyl Fluorides. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>2018 </em>
                                    (22)
                                     , 2870-2876. <a href="https://doi.org/10.1002/ejoc.201800521" title="DOI URL">https://doi.org/10.1002/ejoc.201800521</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201800521&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201800521%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3D%25255B3%25252B2%25255D%252BCycloaddition%252Bof%252Ban%252BAzomethyne%252BYlide%252Band%252BVinyl%252BSulfonyl%252BFluorides%252B%2525E2%252580%252595%252Ban%252BApproach%252Bto%252BPyrrolidine-3-sulfonyl%252BFluorides%26aulast%3DMykhalchuk%26aufirst%3DVolodymyr%2BL.%26date%3D2018%26date%3D2018%26volume%3D2018%26issue%3D22%26spage%3D2870%26epage%3D2876" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Judite R. M.  Coimbra</span>, <span class="hlFld-ContribAuthor ">Daniela F. F.  Marques</span>, <span class="hlFld-ContribAuthor ">Salete J.  Baptista</span>, <span class="hlFld-ContribAuthor ">Cláudia M. F.  Pereira</span>, <span class="hlFld-ContribAuthor ">Paula I.  Moreira</span>, <span class="hlFld-ContribAuthor ">Teresa C. P.  Dinis</span>, <span class="hlFld-ContribAuthor ">Armanda E.  Santos</span>, <span class="hlFld-ContribAuthor ">Jorge A. R.  Salvador</span>. </span><span class="cited-content_cbyCitation_article-title">Highlights in BACE1 Inhibitors for Alzheimer's Disease Treatment. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2018,</strong> <em>6 </em><a href="https://doi.org/10.3389/fchem.2018.00178" title="DOI URL">https://doi.org/10.3389/fchem.2018.00178</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2018.00178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2018.00178%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DHighlights%252Bin%252BBACE1%252BInhibitors%252Bfor%252BAlzheimer%252527s%252BDisease%252BTreatment%26aulast%3DCoimbra%26aufirst%3DJudite%2BR.%2BM.%26date%3D2018%26date%3D2018%26volume%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riccardo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Elena  Lenci</span>, <span class="hlFld-ContribAuthor ">Gloria  Menchi</span>, <span class="hlFld-ContribAuthor ">Alberto  Pupi</span>, <span class="hlFld-ContribAuthor ">Andrea  Trabocchi</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2017,</strong> <em>25 </em>
                                    (19)
                                     , 5077-5083. <a href="https://doi.org/10.1016/j.bmc.2017.03.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2017.03.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2017.03.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2017.03.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bbicyclic%252Bacetals%252Bas%252BBeta%252BSecretase%252B%252528BACE1%252529%252Binhibitors%26aulast%3DInnocenti%26aufirst%3DRiccardo%26date%3D2017%26volume%3D25%26issue%3D19%26spage%3D5077%26epage%3D5083" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rodrigo  Aguayo-Ortiz</span>, <span class="hlFld-ContribAuthor ">Laura  Dominguez</span>. </span><span class="cited-content_cbyCitation_article-title">Generation of Amyloid-β Peptides by γ-Secretase. </span><span class="cited-content_cbyCitation_journal-name">Israel Journal of Chemistry</span><span> <strong>2017,</strong> <em>57 </em>
                                    (7-8)
                                     , 574-585. <a href="https://doi.org/10.1002/ijch.201600073" title="DOI URL">https://doi.org/10.1002/ijch.201600073</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ijch.201600073&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fijch.201600073%26sid%3Dliteratum%253Aachs%26jtitle%3DIsrael%2520Journal%2520of%2520Chemistry%26atitle%3DGeneration%252Bof%252BAmyloid-%2525CE%2525B2%252BPeptides%252Bby%252B%2525CE%2525B3-Secretase%26aulast%3DAguayo-Ortiz%26aufirst%3DRodrigo%26date%3D2017%26date%3D2016%26volume%3D57%26issue%3D7-8%26spage%3D574%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter J.  Lindsay-Scott</span>, <span class="hlFld-ContribAuthor ">Peter T.  Gallagher</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of heterocycles from arylacetonitriles: Powerful tools for medicinal chemists. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron Letters</span><span> <strong>2017,</strong> <em>58 </em>
                                    (27)
                                     , 2629-2635. <a href="https://doi.org/10.1016/j.tetlet.2017.05.089" title="DOI URL">https://doi.org/10.1016/j.tetlet.2017.05.089</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tetlet.2017.05.089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tetlet.2017.05.089%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%2520Letters%26atitle%3DSynthesis%252Bof%252Bheterocycles%252Bfrom%252Barylacetonitriles%25253A%252BPowerful%252Btools%252Bfor%252Bmedicinal%252Bchemists%26aulast%3DLindsay-Scott%26aufirst%3DPeter%2BJ.%26date%3D2017%26volume%3D58%26issue%3D27%26spage%3D2629%26epage%3D2635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Duc Toan  Truong</span>, <span class="hlFld-ContribAuthor ">Minh Tung  Nguyen</span>, <span class="hlFld-ContribAuthor ">Van V.  Vu</span>, <span class="hlFld-ContribAuthor ">Son Tung  Ngo</span>. </span><span class="cited-content_cbyCitation_article-title">Fast pulling of ligand approach for the design of β-secretase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemical Physics Letters</span><span> <strong>2017,</strong> <em>671 </em>, 142-146. <a href="https://doi.org/10.1016/j.cplett.2017.01.032" title="DOI URL">https://doi.org/10.1016/j.cplett.2017.01.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cplett.2017.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cplett.2017.01.032%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Physics%2520Letters%26atitle%3DFast%252Bpulling%252Bof%252Bligand%252Bapproach%252Bfor%252Bthe%252Bdesign%252Bof%252B%2525CE%2525B2-secretase%252B1%252Binhibitors%26aulast%3DTruong%26aufirst%3DDuc%2BToan%26date%3D2017%26volume%3D671%26spage%3D142%26epage%3D146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.W.  Stamford</span>, <span class="hlFld-ContribAuthor ">J.N.  Cumming</span>, <span class="hlFld-ContribAuthor ">J.D.  Scott</span>, <span class="hlFld-ContribAuthor ">C.O.  Strickland</span>. </span><span class="cited-content_cbyCitation_article-title">Verubecestat. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 204-251. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12453-9" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12453-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12453-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12453-9%26sid%3Dliteratum%253Aachs%26atitle%3DVerubecestat%26aulast%3DStamford%26aufirst%3DA.W.%26date%3D2017%26spage%3D204%26epage%3D251%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hall</span>, <span class="hlFld-ContribAuthor ">H.J.M.  Gijsen</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting β-Secretase (BACE) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 326-383. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13809-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13809-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13809-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13809-0%26sid%3Dliteratum%253Aachs%26atitle%3DTargeting%252B%2525CE%2525B2-Secretase%252B%252528BACE%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHall%26aufirst%3DA.%26date%3D2017%26spage%3D326%26epage%3D383%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roberto G. S.  Berlinck</span>, <span class="hlFld-ContribAuthor ">Ariane F.  Bertonha</span>, <span class="hlFld-ContribAuthor ">Mirelle  Takaki</span>, <span class="hlFld-ContribAuthor ">Julie P. G.  Rodriguez</span>. </span><span class="cited-content_cbyCitation_article-title">The chemistry and biology of guanidine natural products. </span><span class="cited-content_cbyCitation_journal-name">Natural Product Reports</span><span> <strong>2017,</strong> <em>34 </em>
                                    (11)
                                     , 1264-1301. <a href="https://doi.org/10.1039/C7NP00037E" title="DOI URL">https://doi.org/10.1039/C7NP00037E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7NP00037E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7NP00037E%26sid%3Dliteratum%253Aachs%26jtitle%3DNatural%2520Product%2520Reports%26atitle%3DThe%252Bchemistry%252Band%252Bbiology%252Bof%252Bguanidine%252Bnatural%252Bproducts%26aulast%3DBerlinck%26aufirst%3DRoberto%2BG.%2BS.%26date%3D2017%26date%3D2017%26volume%3D34%26issue%3D11%26spage%3D1264%26epage%3D1301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Myuri  Ruthirakuhan</span>, <span class="hlFld-ContribAuthor ">Nathan  Herrmann</span>, <span class="hlFld-ContribAuthor ">Ivonne  Suridjan</span>, <span class="hlFld-ContribAuthor ">Eleenor H  Abraham</span>, <span class="hlFld-ContribAuthor ">Ilan  Farber</span>, <span class="hlFld-ContribAuthor ">Krista L.  Lanctôt</span>. </span><span class="cited-content_cbyCitation_article-title">Beyond immunotherapy: new approaches for disease modifying treatments for early Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Pharmacotherapy</span><span> <strong>2016,</strong> <em>17 </em>
                                    (18)
                                     , 2417-2429. <a href="https://doi.org/10.1080/14656566.2016.1258060" title="DOI URL">https://doi.org/10.1080/14656566.2016.1258060</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14656566.2016.1258060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14656566.2016.1258060%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Pharmacotherapy%26atitle%3DBeyond%252Bimmunotherapy%25253A%252Bnew%252Bapproaches%252Bfor%252Bdisease%252Bmodifying%252Btreatments%252Bfor%252Bearly%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DRuthirakuhan%26aufirst%3DMyuri%26date%3D2016%26date%3D2016%26volume%3D17%26issue%3D18%26spage%3D2417%26epage%3D2429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Riqiang  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs. </span><span class="cited-content_cbyCitation_journal-name">Translational Neurodegeneration</span><span> <strong>2016,</strong> <em>5 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s40035-016-0061-5" title="DOI URL">https://doi.org/10.1186/s40035-016-0061-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s40035-016-0061-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs40035-016-0061-5%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Neurodegeneration%26atitle%3DStepping%252Bcloser%252Bto%252Btreating%252BAlzheimer%2525E2%252580%252599s%252Bdisease%252Bpatients%252Bwith%252BBACE1%252Binhibitor%252Bdrugs%26aulast%3DYan%26aufirst%3DRiqiang%26date%3D2016%26date%3D2016%26volume%3D5%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. E.  Kennedy</span>, <span class="hlFld-ContribAuthor ">A. W.  Stamford</span>, <span class="hlFld-ContribAuthor ">X.  Chen</span>, <span class="hlFld-ContribAuthor ">K.  Cox</span>, <span class="hlFld-ContribAuthor ">J. N.  Cumming</span>, <span class="hlFld-ContribAuthor ">M. F.  Dockendorf</span>, <span class="hlFld-ContribAuthor ">M.  Egan</span>, <span class="hlFld-ContribAuthor ">L.  Ereshefsky</span>, <span class="hlFld-ContribAuthor ">R. A.  Hodgson</span>, <span class="hlFld-ContribAuthor ">L. A.  Hyde</span>, <span class="hlFld-ContribAuthor ">S.  Jhee</span>, <span class="hlFld-ContribAuthor ">H. J.  Kleijn</span>, <span class="hlFld-ContribAuthor ">R.  Kuvelkar</span>, <span class="hlFld-ContribAuthor ">W.  Li</span>, <span class="hlFld-ContribAuthor ">B. A.  Mattson</span>, <span class="hlFld-ContribAuthor ">H.  Mei</span>, <span class="hlFld-ContribAuthor ">J.  Palcza</span>, <span class="hlFld-ContribAuthor ">J. D.  Scott</span>, <span class="hlFld-ContribAuthor ">M.  Tanen</span>, <span class="hlFld-ContribAuthor ">M. D.  Troyer</span>, <span class="hlFld-ContribAuthor ">J. L.  Tseng</span>, <span class="hlFld-ContribAuthor ">J. A.  Stone</span>, <span class="hlFld-ContribAuthor ">E. M.  Parker</span>, <span class="hlFld-ContribAuthor ">M. S.  Forman</span>. </span><span class="cited-content_cbyCitation_article-title">The BACE1 inhibitor verubecestat (MK-8931) reduces CNS  -amyloid in animal models and in Alzheimers disease patients. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2016,</strong> <em>8 </em>
                                    (363)
                                     , 363ra150-363ra150. <a href="https://doi.org/10.1126/scitranslmed.aad9704" title="DOI URL">https://doi.org/10.1126/scitranslmed.aad9704</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aad9704&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aad9704%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DThe%252BBACE1%252Binhibitor%252Bverubecestat%252B%252528MK-8931%252529%252Breduces%252BCNS%252B%2525C2%2525A0-amyloid%252Bin%252Banimal%252Bmodels%252Band%252Bin%252BAlzheimers%252Bdisease%252Bpatients%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26date%3D2016%26date%3D2016%26volume%3D8%26issue%3D363%26spage%3D363ra150%26epage%3D363ra150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Discovery of bicyclic iminopyrimidinones <b>6</b>, <b>7</b>, and <b>8</b> from fragment <b>1</b> by rational design and SAR development through iminohydantoins <b>2</b> and <b>3</b> and iminopyrimidinone <b>4</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Structures of representative published BACE inhibitors that lower central Aβ in monkeys and/or dogs.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of P1 Thiophene Analogues <b>10</b>–<b>17</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 10% Pd/C, H<sub>2</sub>, methanol, rt, 92%; (b) NBS, DMF, rt, 60%; (c) Zn(CN)<sub>2</sub>, Zn, PdCl<sub>2</sub>(dppf), DMA, 80 °C, then Et<sub>3</sub>N, (Boc)<sub>2</sub>O, CH<sub>2</sub>Cl<sub>2</sub>, rt, 71%; (d) TBAF, THF, 0 °C to rt, 80%; (e) heteroaryl halide, tris(dibenzylideneacetone)dipalladium(0), Na-O<i>t</i>Bu, (2-biphenylyl)di-<i>tert</i>-butylphosphine (JohnPhos), toluene, 70 °C, 5–60%; (f) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (g) NCS, DMF, 50 °C, 80%.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of 2,4-Difluorophenyl Analogue <b>9</b><sup>a</sup> and Related Analogues <b>18</b>–<b>22</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) glyoxylic acid (50% (w/w) in water), K<sub>2</sub>CO<sub>3</sub>, MeOH, 70 °C, 89%; (b) 7% conc H<sub>2</sub>SO<sub>4</sub> in formic acid, reflux, 94%; (c) cat. TFA in THF, 0 °C to rt, concentration then dilution with MeOH, rt, 57%; (d) DPPA, Et<sub>3</sub>N, toluene, 66 °C then acetic acid, TMS–ethanol, reflux, 48%; (e) 4 N HCl in dioxane, rt; (f) <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate, EDCI, DIEA, DMF, 30 °C, 63%; (g) HPLC, AD column; (h) H<sub>2</sub>, 20% Pd(OH)<sub>2</sub>/C, MeOH, rt, 91%; (i) 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine, Pd(OAc)<sub>2</sub>, Na-O<i>t</i>Bu, toluene, 2′-(di-<i>tert</i>-butylphosphino)-<i>N</i>,<i>N</i>-dimethyl-[1,1′-biphenyl]-2-amine, 100 °C; (j) TFA, DCM, 58% from <b>41</b>.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of 2,6-Difluorophenyl Analogue <b>23</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, AcOH, dioxane, 80 °C, 34%; (b) LiOH·H<sub>2</sub>O, THF, 40 °C; (c) acetic anhydride, 90 °C, 99%; (d) cat. TFA in THF, 0 °C to rt, concentration then dilution with premixed MeOH/Et<sub>3</sub>N, −60 °C to rt, 56%; (e) 20% Pd(OH)<sub>2</sub> on carbon, H<sub>2</sub>, MeOH, rt; (f) CbzCl, Et<sub>3</sub>N, THF, dioxane, rt, 64% from <b>45</b>; (g) DPPA, Et<sub>3</sub>N, toluene, 75 °C, then TMS–ethanol, 110 °C, 67%; (h) 4 N HCl in dioxane, rt; (i) <i>t</i>-butyl <i>N</i>-[(methylamino)thioxomethyl]carbamate, EDCI, DIEA, DMF, rt, 57%; (j) HPLC, AD column; (k) 20% Pd(OH)<sub>2</sub> on carbon, H<sub>2</sub>, MeOH, rt, 98%; (l) 2-chloro-5-fluoro-4-methoxy-6-methylpyrimidine, tris(dibenzylideneacetone)dipalladium(0), Na-O<i>t</i>Bu, (2-biphenylyl)di-<i>tert</i>-butylphosphine (JohnPhos), toluene, 65 °C, 46%; (m) TFA, DCM, 63%.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of Pyrrolidine Intermediate En Route to 2,3,6-Trifluorophenyl Analogue <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NaCN, EtOH, H<sub>2</sub>O, reflux, 79%; (b) glyoxalic acid monohydrate, K<sub>2</sub>CO<sub>3</sub>, MeOH, 0 °C to rt; (c) 10% conc H<sub>2</sub>SO<sub>4</sub> in formic acid, 100 °C; (d) 5% conc H<sub>2</sub>SO<sub>4</sub> in MeOH, reflux, 41%; (e) <i>N</i>-benzyl-1-methoxy-<i>N</i>-((trimethylsilyl)methyl)methanamine, cat. TFA, THF, 0 °C to rt, 100%; (f) 15% conc H<sub>2</sub>SO<sub>4</sub> in water, reflux; (g) Ac<sub>2</sub>O, 90 °C, concentration then dilution with premixed MeOH/Et<sub>3</sub>N, −78 °C to rt; (h) Pd(OH)<sub>2</sub>, MeOH, rt; (i) CbzCl, Et<sub>3</sub>N, THF, 0 °C to rt, 79%.</p></p></figure><figure data-id="fig3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Superimposed X-ray conformation of iminopyrimidinone <b>6</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0">5hd0</a>), <b>7</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g">4h3g</a>), and <b>8</b> (magenta, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>) in the active site of BACE1 with red surface showing the location of catalytic aspartic acids. (b) Structures of <b>6</b>, <b>7</b>, and <b>8</b> with their respective BACE1 <i>K</i><sub>i</sub>, CYP3A4 IC<sub>50</sub> (pre), CatD/BACE1 selectivity, and calculated properties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a) Superimposition of X-ray crystal structures of <b>11</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>) and <b>8</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>) complexed with BACE1. Red surface represents the catalytic dyad Asp<sup>32</sup> and Asp<sup>228</sup>. (b) Overlay of X-ray crystal structures of <b>11</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>), <b>15</b> (blue, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx">5hdx</a>), <b>16</b> (purple, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz">5hdz</a>) and <b>17</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5">5he5</a>). The red ball represents the bridging water molecule between the Trp<sup>76</sup> and the nitrogen of the pyrimidine of <b>15</b>, <b>16</b>, and <b>17</b>. Pyrimidine moieties of <b>15</b>, <b>16</b>, and <b>17</b> have shifted almost 1.9 Å toward S2′ binding site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) X-ray crystal structure of <b>9</b> complexed with BACE1. The hydroxyl moiety of Tyr<sup>71</sup> of the flap is 2.9 Å away from the 2-fluorine of 2,4-difluorophenyl group of compound <b>9</b>. (b) Superimposition of X-ray crystal structures of <b>9</b> (yellow, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he7">5he7</a>) and a racemic sample of <b>23</b> (green, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4">5he4</a>) complexed with BACE1. The 6-fluorine of the bound enantiomer of <b>23</b> is 3.1 Å away from the backbone carbonyl of Gly<sup>230</sup> and is 3.4 Å away from the carbonyl of the side chain carboxylic acid of Asp<sup>32</sup>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Measured total concentration of <b>9</b> in plasma (<i>C</i><sub>P</sub>), CSF (<i>C</i><sub>CSF</sub>), and brain (<i>C</i><sub>B</sub>) of rats at doses ranging from 0.3 mg/kg to 300 mg/kg. (b) Effect of acute oral administration of compound <b>9</b> on the reduction of plasma, CSF, and cortical Aβ<sub>40</sub> levels in rats.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Acute PK/PD profile of compound <b>9</b> in cisterna magna ported rhesus monkeys. Plasma and CSF samples were collected at 2, 4, 6, 8, 12, 24, and 48 h after oral administration of <b>9</b> (10, 30, or 100 mg/kg) and analyzed for both compound concentrations and Aβ<sub>40</sub> levels. (a) Plasma and CSF concentrations of <b>9</b> over time. (b) Pharmacokinetic parameters of <b>9</b>. (c) Plasma Aβ<sub>40</sub> levels. (d) CSF Aβ<sub>40</sub> levels. (e) CSF Aβ<sub>42</sub> levels. (f) CSF sAPPβ levels.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/medium/jm-2015-01995e_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Acute effect of compound <b>9</b> (10 mg/kg) on CSF and cortical Aβ<sub>40</sub> levels in cynomolgus monkeys (*<i>p</i> = 0.0014, **<i>p</i> < 0.0007).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2016/jmcmar.2016.59.issue-7/acs.jmedchem.5b01995/20160414/images/large/jm-2015-01995e_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.5b01995&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43883" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43883" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 28 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span>Alzheimer’s Disease Facts and Figures; <span class="NLM_publisher-name">Alzheimer’s Association</span>: <span class="NLM_publisher-loc">Chicago</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">; </span><a href="http://www.alz.org/facts/downloads/facts_figures_2015.pdf" class="extLink">http://www.alz.org/facts/downloads/facts_figures_2015.pdf</a> (accessed February 13, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Alzheimer%E2%80%99s+Disease+Facts+and+Figures%3B+Alzheimer%E2%80%99s+Association%3A+Chicago%2C+2015%3B+http%3A%2F%2Fwww.alz.org%2Ffacts%2Fdownloads%2Ffacts_figures_2015.pdf+%28accessed+February+13%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Disease%2520Facts%2520and%2520Figures%26pub%3DAlzheimer%25E2%2580%2599s%2520Association%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span>World Alzheimer Report; <span class="NLM_publisher-name">Alzheimer’s Disease International</span>: <span class="NLM_publisher-loc">London</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span><span class="NLM_x">, </span><a href="http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf" class="extLink">http://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf</a> (accessed February 13, 2016).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=World+Alzheimer+Report%3B+Alzheimer%E2%80%99s+Disease+International%3A+London%2C+2015%2C+http%3A%2F%2Fwww.alz.co.uk%2Fresearch%2FWorldAlzheimerReport2015.pdf+%28accessed+February+13%2C+2016%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DWorld%2520Alzheimer%2520Report%26pub%3DAlzheimer%25E2%2580%2599s%2520Disease%2520International%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Tariot, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Federoff, H. J.</span><span> </span><span class="NLM_article-title">Current treatment for Alzheimer disease and future prospects</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">S105</span><span class="NLM_x">–</span> <span class="NLM_lpage">S113</span><span class="refDoi"> DOI: 10.1097/00002093-200307004-00005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F00002093-200307004-00005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2003&pages=S105-S113&author=P.+N.+Tariotauthor=H.+J.+Federoff&title=Current+treatment+for+Alzheimer+disease+and+future+prospects&doi=10.1097%2F00002093-200307004-00005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1097%2F00002093-200307004-00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00002093-200307004-00005%26sid%3Dliteratum%253Aachs%26aulast%3DTariot%26aufirst%3DP.%2BN.%26aulast%3DFederoff%26aufirst%3DH.%2BJ.%26atitle%3DCurrent%2520treatment%2520for%2520Alzheimer%2520disease%2520and%2520future%2520prospects%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2003%26volume%3D17%26spage%3DS105%26epage%3DS113%26doi%3D10.1097%2F00002093-200307004-00005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Nordberg, A.</span><span> </span><span class="NLM_article-title">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer disease</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">S12</span><span class="NLM_x">–</span> <span class="NLM_lpage">S18</span><span class="refDoi"> DOI: 10.1097/01.wad.0000213804.59187.2d</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F01.wad.0000213804.59187.2d" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16772751" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=S12-S18&author=A.+Nordberg&title=Mechanisms+behind+the+neuroprotective+actions+of+cholinesterase+inhibitors+in+Alzheimer+disease&doi=10.1097%2F01.wad.0000213804.59187.2d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3bR"><div class="casContent"><span class="casTitleNuber">3b</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanisms behind the neuroprotective actions of cholinesterase inhibitors in Alzheimer's disease</span></div><div class="casAuthors">Nordberg, Agneta</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2, Suppl. 1</span>),
    <span class="NLM_cas:pages">S12-S18</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Inhibitors of the enzyme acetylcholinesterase (AChE) are presently used as long-term symptomatic treatments for patients with Alzheimer's disease (AD), as they enhance central levels of synaptic acetylcholine.  The accumulation of evidence implicating AChE in the pathogenesis of AD raises the question of whether, in addn. to their palliative actions, inhibitors of this enzyme are able to act as disease-modifying agents.  In addn. to their catalytic effects, there is a suggestion that AChE inhibitors may influence expression of AChE isoforms and increase expression of nicotinic receptors, both of which correlate with cognitive improvements in AD patients.  The neuroprotective effect of nicotine, presumably mediated via nicotinic receptors, against β-amyloid (Aβ) toxicity and its effect on amyloid precursor protein (APP) and Aβ prodn. has previously been established.  It has also been shown that AChE inhibitors influence APP processing and attenuate Aβ-induced toxicity via mechanisms including interruption of the prodn. of Aβ, alteration of the levels of Aβ 1-50 and 1-52, and formation of the sol. form of APP.  Some of these effects seem to occur independently of nicotinic receptors, however.  If such exptl. in vitro observations can be extrapolated into clin. neuroprotective properties, AChE inhibitors could pos. modulate the disease course of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_vn_esJ9_SLVg90H21EOLACvtfcHk0lhEG9e01C22xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XlsFeju7k%253D&md5=367c676ee4a4c2f1e6eb1985f5f7a556</span></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000213804.59187.2d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000213804.59187.2d%26sid%3Dliteratum%253Aachs%26aulast%3DNordberg%26aufirst%3DA.%26atitle%3DMechanisms%2520behind%2520the%2520neuroprotective%2520actions%2520of%2520cholinesterase%2520inhibitors%2520in%2520Alzheimer%2520disease%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3DS12%26epage%3DS18%26doi%3D10.1097%2F01.wad.0000213804.59187.2d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Bullock, R.</span><span> </span><span class="NLM_article-title">Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date</span> <span class="citation_source-journal">Alzheimer Dis. Assoc. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">29</span><span class="refDoi"> DOI: 10.1097/01.wad.0000201847.29836.a5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1097%2F01.wad.0000201847.29836.a5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16493232" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=23-29&author=R.+Bullock&title=Efficacy+and+safety+of+memantine+in+moderate-to-severe+Alzheimer+disease%3A+the+evidence+to+date&doi=10.1097%2F01.wad.0000201847.29836.a5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy and safety of memantine in moderate-to-severe Alzheimer's disease: the evidence to date</span></div><div class="casAuthors">Bullock, Roger</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer Disease and Associated Disorders</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-29</span>CODEN:
                <span class="NLM_cas:coden">ADADE2</span>;
        ISSN:<span class="NLM_cas:issn">0893-0341</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">A review.  Memantine, a moderate-affinity, uncompetitive N-methyl-D-aspartate receptor antagonist, is currently the only agent approved for moderately severe to severe Alzheimer disease (AD) in Europe and for moderate-to-severe Alzheimer disease in the United States.  In clin. trials, memantine has consistently demonstrated a reduced rate of deterioration on global, cognitive, functional, and behavioral measures, across a range of outcome measures compared with usual care.  Notably, improvements vs. placebo were seen in individual activities of daily living and behavior, particularly agitation.  Efficacy was demonstrated in patients with newly diagnosed Alzheimer disease, patients previously or currently receiving acetylcholinesterase inhibitors, and both institutionalized and community-dwelling Alzheimer disease patients.  Memantine has a tolerability profile similar to placebo.  This review presents the results of key clin. trials, and includes clin. relevant analyses, such as nos.-needed-to-treat and effect sizes.  Increased dependency and institutionalization are significant cost drivers in Alzheimer disease.  Memantine is able to reduce dependency, caregiver time required, and mean monthly caregiver and societal costs.  Recent studies of the relationship between Alzheimer disease progression, caregiver burden, and health-care costs emphasize the need for treatments such as memantine that can slow the rate of decline in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoek-h3moVHKrVg90H21EOLACvtfcHk0lhEG9e01C22xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xhslemu7Y%253D&md5=4c1ef99e957070d2f300d2e6b5c48de8</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.1097%2F01.wad.0000201847.29836.a5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.wad.0000201847.29836.a5%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DR.%26atitle%3DEfficacy%2520and%2520safety%2520of%2520memantine%2520in%2520moderate-to-severe%2520Alzheimer%2520disease%253A%2520the%2520evidence%2520to%2520date%26jtitle%3DAlzheimer%2520Dis.%2520Assoc.%2520Disord.%26date%3D2006%26volume%3D20%26spage%3D23%26epage%3D29%26doi%3D10.1097%2F01.wad.0000201847.29836.a5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lambert, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amouyel, P.</span><span> </span><span class="NLM_article-title">Genetics of Alzheimer’s disease: new evidences for an old hypothesis?</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">295</span><span class="NLM_x">–</span> <span class="NLM_lpage">301</span><span class="refDoi"> DOI: 10.1016/j.gde.2011.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.gde.2011.02.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=295-301&author=J.-C.+Lambertauthor=P.+Amouyel&title=Genetics+of+Alzheimer%E2%80%99s+disease%3A+new+evidences+for+an+old+hypothesis%3F&doi=10.1016%2Fj.gde.2011.02.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4a&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2011.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2011.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DLambert%26aufirst%3DJ.-C.%26aulast%3DAmouyel%26aufirst%3DP.%26atitle%3DGenetics%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520new%2520evidences%2520for%2520an%2520old%2520hypothesis%253F%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2011%26volume%3D21%26spage%3D295%26epage%3D301%26doi%3D10.1016%2Fj.gde.2011.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Walter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaether, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steiner, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">The cell biology of Alzheimer’s disease: uncovering the secrets of secretases</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">585</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span><span class="refDoi"> DOI: 10.1016/S0959-4388(00)00253-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2FS0959-4388%2800%2900253-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2001&pages=585-590&author=J.+Walterauthor=C.+Kaetherauthor=H.+Steinerauthor=C.+Haass&title=The+cell+biology+of+Alzheimer%E2%80%99s+disease%3A+uncovering+the+secrets+of+secretases&doi=10.1016%2FS0959-4388%2800%2900253-1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4b&amp;dbid=16384&amp;doi=10.1016%2FS0959-4388%2800%2900253-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-4388%252800%252900253-1%26sid%3Dliteratum%253Aachs%26aulast%3DWalter%26aufirst%3DJ.%26aulast%3DKaether%26aufirst%3DC.%26aulast%3DSteiner%26aufirst%3DH.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DThe%2520cell%2520biology%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520uncovering%2520the%2520secrets%2520of%2520secretases%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D2001%26volume%3D11%26spage%3D585%26epage%3D590%26doi%3D10.1016%2FS0959-4388%2800%2900253-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Stege, G. J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosman, G. J. C. G. M.</span><span> </span><span class="NLM_article-title">The biochemistry of Alzheimer’s disease</span> <span class="citation_source-journal">Drugs Aging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">437</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span><span class="refDoi"> DOI: 10.2165/00002512-199914060-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.2165%2F00002512-199914060-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10408742" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADyaK1MXktFShu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1999&pages=437-446&author=G.+J.+J.+Stegeauthor=G.+J.+C.+G.+M.+Bosman&title=The+biochemistry+of+Alzheimer%E2%80%99s+disease&doi=10.2165%2F00002512-199914060-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4cR"><div class="casContent"><span class="casTitleNuber">4c</span><div class="casTitle"><span class="NLM_cas:atitle">The biochemistry of Alzheimer's disease</span></div><div class="casAuthors">Stege, Gerard J. J.; Bosman, Giel J. C. G. M.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs & Aging</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">437-446</span>CODEN:
                <span class="NLM_cas:coden">DRAGE6</span>;
        ISSN:<span class="NLM_cas:issn">1170-229X</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review, with 106 refs.  In the course of the biochem. efforts devoted to elucidation of the cause(s) and mechanism(s) of neurodegeneration in Alzheimer's disease (AD), much attention has been given to the processes by which amyloid is generated from amyloid precursor protein, notwithstanding the finding that mutations in 2 other proteins, presenilin 1 and 2, are assocd. with early-onset, familial AD in the majority of patients.  In addn., the reason why the apolipoprotein E ε4 allele is over-represented in patients with the sporadic form of AD is unknown.  Furthermore, the degree of dementia is clearly assocd. more with the degree of neurofibrillary pathol. than with the amyloid plaque burden.  In general, amyloid formation may very well be at the end of a pathophysiol. cascade, set in motion by many different triggers.  This cascade could involve excessive apoptosis, followed by necrosis and inflammation.  In this process, microglia as well as astrocytes are involved.  Disturbance of 1 or more crit. signal transduction processes, esp. at the level of the plasma membrane, may be an important trigger.  The pathogenesis of AD is complicated, but further identification of the processes of neurodegeneration will also lead to identification of the factors that make specific neurons vulnerable and, hopefully, point the way to a means to prevent neuronal degeneration at an early stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoXf6nWiFmPrVg90H21EOLACvtfcHk0lj1cdum_Hn1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXktFShu74%253D&md5=bc21e459622864bedc5977c50e4480dc</span></div><a href="/servlet/linkout?suffix=cit4c&amp;dbid=16384&amp;doi=10.2165%2F00002512-199914060-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002512-199914060-00004%26sid%3Dliteratum%253Aachs%26aulast%3DStege%26aufirst%3DG.%2BJ.%2BJ.%26aulast%3DBosman%26aufirst%3DG.%2BJ.%2BC.%2BG.%2BM.%26atitle%3DThe%2520biochemistry%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DDrugs%2520Aging%26date%3D1999%26volume%3D14%26spage%3D437%26epage%3D446%26doi%3D10.2165%2F00002512-199914060-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit4d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Mucke, L.</span><span> </span><span class="NLM_article-title">Neuroscience: Alzheimer’s disease</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">461</span><span class="NLM_x">, </span> <span class="NLM_fpage">895</span><span class="NLM_x">–</span> <span class="NLM_lpage">897</span><span class="refDoi"> DOI: 10.1038/461895a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2F461895a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=19829367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KntLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=461&publication_year=2009&pages=895-897&author=L.+Mucke&title=Neuroscience%3A+Alzheimer%E2%80%99s+disease&doi=10.1038%2F461895a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4dR"><div class="casContent"><span class="casTitleNuber">4d</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroscience: Alzheimer's disease</span></div><div class="casAuthors">Mucke, Lennart</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">461</span>
        (<span class="NLM_cas:issue">7266</span>),
    <span class="NLM_cas:pages">895-897</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The neurodegenerative disorder Alzheimer's disease is becoming more prevalent in aging populations worldwide.  The identification of effective treatments will require a better understanding of the physiol. mechanisms involved, and innovative approaches to drug development and evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphIaMIviIdeLVg90H21EOLACvtfcHk0lj1cdum_Hn1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KntLrK&md5=602e450d267d313e11ef2ef9d0152cd2</span></div><a href="/servlet/linkout?suffix=cit4d&amp;dbid=16384&amp;doi=10.1038%2F461895a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F461895a%26sid%3Dliteratum%253Aachs%26aulast%3DMucke%26aufirst%3DL.%26atitle%3DNeuroscience%253A%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNature%26date%3D2009%26volume%3D461%26spage%3D895%26epage%3D897%26doi%3D10.1038%2F461895a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis for Alzheimer’s disease: an appraisal for the development of therapeutics</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">698</span><span class="NLM_x">–</span> <span class="NLM_lpage">712</span><span class="refDoi"> DOI: 10.1038/nrd3505</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnrd3505" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=21852788" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=698-712&author=E.+Karranauthor=M.+Merckenauthor=B.+De+Strooper&title=The+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+disease%3A+an+appraisal+for+the+development+of+therapeutics&doi=10.1038%2Fnrd3505"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics</span></div><div class="casAuthors">Karran, Eric; Mercken, Marc; De Strooper, Bart</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">698-712</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The amyloid cascade hypothesis, which posits that the deposition of the amyloid-β peptide in the brain is a central event in Alzheimer's disease pathol., has dominated research for the past twenty years.  Several therapeutics that were purported to reduce amyloid-β prodn. or aggregation have failed in Phase III clin. testing, and many others are in various stages of development.  Therefore, it is timely to review the science underpinning the amyloid cascade hypothesis, consider what type of clin. trials will constitute a valid test of this hypothesis and explore whether amyloid-β-directed therapeutics will provide the medicines that are urgently needed by society for treating this devastating disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_-zjcfHaQ87Vg90H21EOLACvtfcHk0lj1cdum_Hn1UA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVelsL3L&md5=cf2824a56a4c3df6e265d8788970729d</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.1038%2Fnrd3505&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd3505%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DMercken%26aufirst%3DM.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520an%2520appraisal%2520for%2520the%2520development%2520of%2520therapeutics%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2011%26volume%3D10%26spage%3D698%26epage%3D712%26doi%3D10.1038%2Fnrd3505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jonsson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atwal, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Snaedal, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jonsson, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sulem, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gudbjartsson, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maloney, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoyte, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustafson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhangale, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huttenlocher, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bjornsdottir, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andreassen, O. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joensson, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palotie, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Behrens, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnusson, O. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thorsteinsdottir, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stefansson, K.</span><span> </span><span class="NLM_article-title">A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">488</span><span class="NLM_x">, </span> <span class="NLM_fpage">96</span><span class="NLM_x">–</span> <span class="NLM_lpage">99</span><span class="refDoi"> DOI: 10.1038/nature11283</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnature11283" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22801501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=488&publication_year=2012&pages=96-99&author=T.+Jonssonauthor=J.+K.+Atwalauthor=S.+Steinbergauthor=J.+Snaedalauthor=P.+V.+Jonssonauthor=S.+Bjornssonauthor=H.+Stefanssonauthor=P.+Sulemauthor=D.+Gudbjartssonauthor=J.+Maloneyauthor=K.+Hoyteauthor=A.+Gustafsonauthor=Y.+Liuauthor=Y.+Luauthor=T.+Bhangaleauthor=R.+R.+Grahamauthor=J.+Huttenlocherauthor=G.+Bjornsdottirauthor=O.+A.+Andreassenauthor=E.+G.+Joenssonauthor=A.+Palotieauthor=T.+W.+Behrensauthor=O.+T.+Magnussonauthor=A.+Kongauthor=U.+Thorsteinsdottirauthor=R.+J.+Wattsauthor=K.+Stefansson&title=A+mutation+in+APP+protects+against+Alzheimer%E2%80%99s+disease+and+age-related+cognitive+decline&doi=10.1038%2Fnature11283"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5bR"><div class="casContent"><span class="casTitleNuber">5b</span><div class="casTitle"><span class="NLM_cas:atitle">A mutation in APP protects against Alzheimer's disease and age-related cognitive decline</span></div><div class="casAuthors">Jonsson, Thorlakur; Atwal, Jasvinder K.; Steinberg, Stacy; Snaedal, Jon; Jonsson, Palmi V.; Bjornsson, Sigurbjorn; Stefansson, Hreinn; Sulem, Patrick; Gudbjartsson, Daniel; Maloney, Janice; Hoyte, Kwame; Gustafson, Amy; Liu, Yichin; Lu, Yanmei; Bhangale, Tushar; Graham, Robert R.; Huttenlocher, Johanna; Bjornsdottir, Gyda; Andreassen, Ole A.; Joensson, Erik G.; Palotie, Aarno; Behrens, Timothy W.; Magnusson, Olafur T.; Kong, Augustine; Thorsteinsdottir, Unnur; Watts, Ryan J.; Stefansson, Kari</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">488</span>
        (<span class="NLM_cas:issue">7409</span>),
    <span class="NLM_cas:pages">96-99</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The prevalence of dementia in the Western world in people over the age of 60 has been estd. to be greater than 5%, about two-thirds of which are due to Alzheimer's disease.  The age-specific prevalence of Alzheimer's disease nearly doubles every 5 years after age 65, leading to a prevalence of greater than 25% in those over the age of 90 (ref. 3).  Here, to search for low-frequency variants in the amyloid-β precursor protein (APP) gene with a significant effect on the risk of Alzheimer's disease, we studied coding variants in APP in a set of whole-genome sequence data from 1795 Icelanders.  We found a coding mutation (A673T) in the APP gene that protects against Alzheimer's disease and cognitive decline in the elderly without Alzheimer's disease.  This substitution is adjacent to the aspartyl protease β-site in APP, and results in an approx. 40% redn. in the formation of amyloidogenic peptides in vitro.  The strong protective effect of the A673T substitution against Alzheimer's disease provides proof of principle for the hypothesis that reducing the β-cleavage of APP may protect against the disease.  Furthermore, as the A673T allele also protects against cognitive decline in the elderly without Alzheimer's disease, the two may be mediated through the same or similar mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4AFwQCLRQOLVg90H21EOLACvtfcHk0ljdUuXG7Keapw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWmt73M&md5=4db9cb2e3842d5a9d4af4ce102249b70</span></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=10.1038%2Fnature11283&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature11283%26sid%3Dliteratum%253Aachs%26aulast%3DJonsson%26aufirst%3DT.%26aulast%3DAtwal%26aufirst%3DJ.%2BK.%26aulast%3DSteinberg%26aufirst%3DS.%26aulast%3DSnaedal%26aufirst%3DJ.%26aulast%3DJonsson%26aufirst%3DP.%2BV.%26aulast%3DBjornsson%26aufirst%3DS.%26aulast%3DStefansson%26aufirst%3DH.%26aulast%3DSulem%26aufirst%3DP.%26aulast%3DGudbjartsson%26aufirst%3DD.%26aulast%3DMaloney%26aufirst%3DJ.%26aulast%3DHoyte%26aufirst%3DK.%26aulast%3DGustafson%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DBhangale%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DR.%2BR.%26aulast%3DHuttenlocher%26aufirst%3DJ.%26aulast%3DBjornsdottir%26aufirst%3DG.%26aulast%3DAndreassen%26aufirst%3DO.%2BA.%26aulast%3DJoensson%26aufirst%3DE.%2BG.%26aulast%3DPalotie%26aufirst%3DA.%26aulast%3DBehrens%26aufirst%3DT.%2BW.%26aulast%3DMagnusson%26aufirst%3DO.%2BT.%26aulast%3DKong%26aufirst%3DA.%26aulast%3DThorsteinsdottir%26aufirst%3DU.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DStefansson%26aufirst%3DK.%26atitle%3DA%2520mutation%2520in%2520APP%2520protects%2520against%2520Alzheimer%25E2%2580%2599s%2520disease%2520and%2520age-related%2520cognitive%2520decline%26jtitle%3DNature%26date%3D2012%26volume%3D488%26spage%3D96%26epage%3D99%26doi%3D10.1038%2Fnature11283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hardy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selkoe, D. J.</span><span> </span><span class="NLM_article-title">The Amyloid hypothesis of Alzheimer’s disease: Progress and problems on the road to therapeutics</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">297</span><span class="NLM_x">, </span> <span class="NLM_fpage">353</span><span class="NLM_x">–</span> <span class="NLM_lpage">356</span><span class="refDoi"> DOI: 10.1126/science.1072994</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1126%2Fscience.1072994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=12130773" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=297&publication_year=2002&pages=353-356&author=J.+Hardyauthor=D.+J.+Selkoe&title=The+Amyloid+hypothesis+of+Alzheimer%E2%80%99s+disease%3A+Progress+and+problems+on+the+road+to+therapeutics&doi=10.1126%2Fscience.1072994"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics</span></div><div class="casAuthors">Hardy, John; Selkoe, Dennis J.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">297</span>
        (<span class="NLM_cas:issue">5580</span>),
    <span class="NLM_cas:pages">353-356</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  It has been more than 10 yr since it was first proposed that the neurodegeneration in Alzheimer's disease (AD) may be caused by deposition of amyloid β-peptide (Aβ) in plaques in brain tissue.  According to the amyloid hypothesis, accumulation of Aβ in the brain is the primary influence driving AD pathogenesis.  The rest of the disease process, including formation of neurofibrillary tangles contg. tau protein, is proposed to result from an imbalance between Aβ prodn. and Aβ clearance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9G5omTHR6cbVg90H21EOLACvtfcHk0ljdUuXG7Keapw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xls1Cju7s%253D&md5=f7b8db1bc6f13e85f887b73f3042e86e</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1126%2Fscience.1072994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1072994%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26aulast%3DSelkoe%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520Amyloid%2520hypothesis%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Progress%2520and%2520problems%2520on%2520the%2520road%2520to%2520therapeutics%26jtitle%3DScience%26date%3D2002%26volume%3D297%26spage%3D353%26epage%3D356%26doi%3D10.1126%2Fscience.1072994" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Korczyn, A. D.</span><span> </span><span class="NLM_article-title">The amyloid cascade hypothesis</span> <span class="citation_source-journal">Alzheimer's Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">176</span><span class="NLM_x">–</span> <span class="NLM_lpage">178</span><span class="refDoi"> DOI: 10.1016/j.jalz.2007.11.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.jalz.2007.11.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=18631966" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnslKgsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2008&pages=176-178&author=A.+D.+Korczyn&title=The+amyloid+cascade+hypothesis&doi=10.1016%2Fj.jalz.2007.11.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5dR"><div class="casContent"><span class="casTitleNuber">5d</span><div class="casTitle"><span class="NLM_cas:atitle">The amyloid cascade hypothesis</span></div><div class="casAuthors">Korczyn, Amos D.</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's & Dementia</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">176-178</span>CODEN:
                <span class="NLM_cas:coden">ADLEBN</span>;
        ISSN:<span class="NLM_cas:issn">1552-5260</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  The amyloid deposits in the brains of patients with Alzheimer's disease have attracted attention and are now considered not only an essential requirement for pathol. diagnosis but also an important clue to the pathogenesis of the disease.  This article looks critically at the basis of the "amyloid cascade hypothesis" to conclude that there are many issues that need to be resolved since they are inconsistent with the hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrra1GCUOJiJLVg90H21EOLACvtfcHk0lh0EoQZ6PR5CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnslKgsbw%253D&md5=0f450f43d608598b2e0ccb59075ec981</span></div><a href="/servlet/linkout?suffix=cit5d&amp;dbid=16384&amp;doi=10.1016%2Fj.jalz.2007.11.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jalz.2007.11.008%26sid%3Dliteratum%253Aachs%26aulast%3DKorczyn%26aufirst%3DA.%2BD.%26atitle%3DThe%2520amyloid%2520cascade%2520hypothesis%26jtitle%3DAlzheimer%2527s%2520Dementia%26date%3D2008%26volume%3D4%26spage%3D176%26epage%3D178%26doi%3D10.1016%2Fj.jalz.2007.11.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">Has the amyloid cascade hypothesis for Alzheimer’s been proved?</span> <span class="citation_source-journal">Curr. Alzheimer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">73</span><span class="refDoi"> DOI: 10.2174/156720506775697098</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.2174%2F156720506775697098" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16472206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28XisVant7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2006&pages=71-73&author=J.+Hardy&title=Has+the+amyloid+cascade+hypothesis+for+Alzheimer%E2%80%99s+been+proved%3F&doi=10.2174%2F156720506775697098"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5eR"><div class="casContent"><span class="casTitleNuber">5e</span><div class="casTitle"><span class="NLM_cas:atitle">Has the amyloid cascade hypothesis for Alzheimer's disease been proved?</span></div><div class="casAuthors">Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Current Alzheimer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-73</span>CODEN:
                <span class="NLM_cas:coden">CARUBY</span>;
        ISSN:<span class="NLM_cas:issn">1567-2050</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review with refs.  After much initial debate for and against the role of amyloid in Alzheimer's disease (AD), mutations on the amyloid precursor protein (APP) and processing pathways that increase levels of the amyloid β peptide of 42 residues (Aβ42) have established that faulty function or processing of these proteins are responsible for AD pathogenesis.  Given the neurotoxicity of aggregates of Ab42, the central role of this peptide in AD pathogenesis is self evident.  In this article, I summarize the major pieces of evidence adduced to support the amyloid cascade hypothesis and point out their limitations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqE6iEcNF7UI7Vg90H21EOLACvtfcHk0lh0EoQZ6PR5CQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisVant7o%253D&md5=08292f72462f6b494734c7380c7ca744</span></div><a href="/servlet/linkout?suffix=cit5e&amp;dbid=16384&amp;doi=10.2174%2F156720506775697098&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156720506775697098%26sid%3Dliteratum%253Aachs%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DHas%2520the%2520amyloid%2520cascade%2520hypothesis%2520for%2520Alzheimer%25E2%2580%2599s%2520been%2520proved%253F%26jtitle%3DCurr.%2520Alzheimer%2520Res.%26date%3D2006%26volume%3D3%26spage%3D71%26epage%3D73%26doi%3D10.2174%2F156720506775697098" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Selkoe, D.</span><span> </span><span class="NLM_article-title">Alzheimer’s disease: genes, proteins, and therapy</span> <span class="citation_source-journal">Physiol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">741</span><span class="NLM_x">–</span> <span class="NLM_lpage">766</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2001&pages=741-766&author=D.+Selkoe&title=Alzheimer%E2%80%99s+disease%3A+genes%2C+proteins%2C+and+therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSelkoe%26aufirst%3DD.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520genes%252C%2520proteins%252C%2520and%2520therapy%26jtitle%3DPhysiol.%2520Rev.%26date%3D2001%26volume%3D81%26spage%3D741%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Archer, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edison, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frost, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeatman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossor, M. N.</span><span> </span><span class="NLM_article-title">Amyloid load and cerebral atrophy in Alzheimer’s disease: a 11C-BIP positron emission tomography study</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">147</span><span class="refDoi"> DOI: 10.1002/ana.20889</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2Fana.20889" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=16802294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A280%3ADC%252BD28vms1entg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2006&pages=145-147&author=H.+A.+Archerauthor=P.+Edisonauthor=D.+J.+Brooksauthor=J.+Barnesauthor=C.+Frostauthor=T.+Yeatmanauthor=N.+C.+Foxauthor=M.+N.+Rossor&title=Amyloid+load+and+cerebral+atrophy+in+Alzheimer%E2%80%99s+disease%3A+a+11C-BIP+positron+emission+tomography+study&doi=10.1002%2Fana.20889"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5gR"><div class="casContent"><span class="casTitleNuber">5g</span><div class="casTitle"><span class="NLM_cas:atitle">Amyloid load and cerebral atrophy in Alzheimer's disease: an 11C-PIB positron emission tomography study</span></div><div class="casAuthors">Archer Hilary A; Edison Paul; Brooks David J; Barnes Jo; Frost Chris; Yeatman Tom; Fox Nick C; Rossor Martin N</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">145-7</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">To determine the relationship between cerebral amyloid plaque load and rates of cerebral atrophy in Alzheimer's disease. (11)C-PIB((11)C-6-OH benzothiazole)PET (positron emission tomography) findings were correlated with volumetric magnetic resonance imaging (MRI) measurements in nine subjects with mild to moderate AD.  Analysis revealed a positive correlation between rates of whole brain atrophy and whole brain (p = 0.019) and regional (11)C-PIB uptake.  This provides support for the central role of amyloid deposition in the pathogenesis of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTrBNwOByLjIAqdek-gHSrIfW6udTcc2eYgMORq5fOLoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vms1entg%253D%253D&md5=9979e03c8fa101fe3e5ed7777b696f7c</span></div><a href="/servlet/linkout?suffix=cit5g&amp;dbid=16384&amp;doi=10.1002%2Fana.20889&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20889%26sid%3Dliteratum%253Aachs%26aulast%3DArcher%26aufirst%3DH.%2BA.%26aulast%3DEdison%26aufirst%3DP.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DFrost%26aufirst%3DC.%26aulast%3DYeatman%26aufirst%3DT.%26aulast%3DFox%26aufirst%3DN.%2BC.%26aulast%3DRossor%26aufirst%3DM.%2BN.%26atitle%3DAmyloid%2520load%2520and%2520cerebral%2520atrophy%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%252011C-BIP%2520positron%2520emission%2520tomography%2520study%26jtitle%3DAnn.%2520Neurol.%26date%3D2006%26volume%3D60%26spage%3D145%26epage%3D147%26doi%3D10.1002%2Fana.20889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Doody, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farlow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwatsubo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vellas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kieburtz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aisen, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethuraman, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohs, R.</span><span> </span><span class="NLM_article-title">A Phase 3 trial of semagacestat for treatment of Alzheimer’s disease</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">369</span><span class="NLM_x">, </span> <span class="NLM_fpage">341</span><span class="NLM_x">–</span> <span class="NLM_lpage">350</span><span class="refDoi"> DOI: 10.1056/NEJMoa1210951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1056%2FNEJMoa1210951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23883379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=369&publication_year=2013&pages=341-350&author=R.+S.+Doodyauthor=R.+Ramanauthor=M.+Farlowauthor=T.+Iwatsuboauthor=B.+Vellasauthor=S.+Joffeauthor=K.+Kieburtzauthor=F.+Heauthor=X.+Sunauthor=R.+G.+Thomasauthor=P.+S.+Aisenauthor=E.+Siemersauthor=G.+Sethuramanauthor=R.+Mohs&title=A+Phase+3+trial+of+semagacestat+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1056%2FNEJMoa1210951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 3 trial of semagacestat for treatment of Alzheimer's disease</span></div><div class="casAuthors">Doody, Rachelle S.; Raman, Rema; Farlow, Martin; Iwatsubo, Takeshi; Vellas, Bruno; Joffe, Steven; Kieburtz, Karl; He, Feng; Sun, Xiaoying; Thomas, Ronald G.; Aisen, Paul S.; Siemers, Eric; Sethuraman, Gopalan; Mohs, Richard</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">369</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">341-350</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease is characterized by the presence of cortical amyloid-beta (Aβ) protein plaques, which result from the sequential action of β-secretase and γ-secretase on amyloid precursor protein.  Semagacestat is a small-mol. γ-secretase inhibitor that was developed as a potential treatment for Alzheimer's disease.  Methods: We conducted a double-blind, placebo-controlled trial in which 1537 patients with probable Alzheimer's disease underwent randomization to receive 100 mg of semagacestat, 140 mg of semagacestat, or placebo daily.  Changes in cognition from baseline to week 76 were assessed with the use of the cognitive subscale of the Alzheimer's Disease Assessment Scale for cognition (ADAS-cog), on which scores range from 0 to 70 and higher scores indicate greater cognitive impairment, and changes in functioning were assessed with the Alzheimer's Disease Cooperative Study-Activities of Daily Living (ADCS-ADL) scale, on which scores range from 0 to 78 and higher scores indicate better functioning.  A mixed-model repeated-measures anal. was used.  Results: The trial was terminated before completion on the basis of a recommendation by the data and safety monitoring board.  At termination, there were 189 patients in the group receiving placebo, 153 patients in the group receiving 100 mg of semagacestat, and 121 patients in the group receiving 140 mg of semagacestat.  The ADAS-cog scores worsened in all three groups (mean change, 6.4 points in the placebo group, 7.5 points in the group receiving 100 mg of the study drug, and 7.8 points in the group receiving 140 mg; P = 0.15 and P = 0.07, resp., for the comparison with placebo).  The ADCS-ADL scores also worsened in all groups (mean change at week 76, -9.0 points in the placebo group, -10.5 points in the 100-mg group, and -12.6 points in the 140-mg group; P = 0.14 and P<0.001, resp., for the comparison with placebo).  Patients treated with semagacestat lost more wt. and had more skin cancers and infections, treatment discontinuations due to adverse events, and serious adverse events (P<0.001 for all comparisons with placebo).  Lab. abnormalities included reduced levels of lymphocytes, T cells, Igs, albumin, total protein, and uric acid and elevated levels of eosinophils, monocytes, and cholesterol; the urine pH was also elevated.  Conclusions: As compared with placebo, semagacestat did not improve cognitive status, and patients receiving the higher dose had significant worsening of functional ability.  Semagacestat was assocd. with more adverse events, including skin cancers and infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrMQCX6dUTyl7Vg90H21EOLACvtfcHk0ljtNbat0XSmYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtF2nur7L&md5=366f2545b2156100af31993c809feac1</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa1210951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa1210951%26sid%3Dliteratum%253Aachs%26aulast%3DDoody%26aufirst%3DR.%2BS.%26aulast%3DRaman%26aufirst%3DR.%26aulast%3DFarlow%26aufirst%3DM.%26aulast%3DIwatsubo%26aufirst%3DT.%26aulast%3DVellas%26aufirst%3DB.%26aulast%3DJoffe%26aufirst%3DS.%26aulast%3DKieburtz%26aufirst%3DK.%26aulast%3DHe%26aufirst%3DF.%26aulast%3DSun%26aufirst%3DX.%26aulast%3DThomas%26aufirst%3DR.%2BG.%26aulast%3DAisen%26aufirst%3DP.%2BS.%26aulast%3DSiemers%26aufirst%3DE.%26aulast%3DSethuraman%26aufirst%3DG.%26aulast%3DMohs%26aufirst%3DR.%26atitle%3DA%2520Phase%25203%2520trial%2520of%2520semagacestat%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2013%26volume%3D369%26spage%3D341%26epage%3D350%26doi%3D10.1056%2FNEJMoa1210951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">DeStrooper, B.</span><span> </span><span class="NLM_article-title">Lessons from a failed γ-secretase Alzheimer trial</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">159</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">–</span> <span class="NLM_lpage">726</span><span class="refDoi"> DOI: 10.1016/j.cell.2014.10.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cell.2014.10.016" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=159&publication_year=2014&pages=721-726&author=B.+DeStrooper&title=Lessons+from+a+failed+%CE%B3-secretase+Alzheimer+trial&doi=10.1016%2Fj.cell.2014.10.016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1016%2Fj.cell.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cell.2014.10.016%26sid%3Dliteratum%253Aachs%26aulast%3DDeStrooper%26aufirst%3DB.%26atitle%3DLessons%2520from%2520a%2520failed%2520%25CE%25B3-secretase%2520Alzheimer%2520trial%26jtitle%3DCell%26date%3D2014%26volume%3D159%26spage%3D721%26epage%3D726%26doi%3D10.1016%2Fj.cell.2014.10.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Reardon, S.</span><span> </span><span class="NLM_article-title">Alzheimer antibody drugs show questionable potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">–</span> <span class="NLM_lpage">592</span><span class="refDoi"> DOI: 10.1038/nrd4709</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnrd4709" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&pages=591-592&author=S.+Reardon&title=Alzheimer+antibody+drugs+show+questionable+potential&doi=10.1038%2Fnrd4709"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7a&amp;dbid=16384&amp;doi=10.1038%2Fnrd4709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4709%26sid%3Dliteratum%253Aachs%26aulast%3DReardon%26aufirst%3DS.%26atitle%3DAlzheimer%2520antibody%2520drugs%2520show%2520questionable%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2015%26volume%3D14%26spage%3D591%26epage%3D592%26doi%3D10.1038%2Fnrd4709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Karran, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hardy, J.</span><span> </span><span class="NLM_article-title">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x">, </span> <span class="NLM_fpage">185</span><span class="NLM_x">–</span> <span class="NLM_lpage">205</span><span class="refDoi"> DOI: 10.1002/ana.24188</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2Fana.24188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24853080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=2014&pages=185-205&author=E.+Karranauthor=J.+Hardy&title=A+critique+of+the+drug+discovery+and+phase+3+clinical+programs+targeting+the+amyloid+hypothesis+for+Alzheimer+disease&doi=10.1002%2Fana.24188"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7bR"><div class="casContent"><span class="casTitleNuber">7b</span><div class="casTitle"><span class="NLM_cas:atitle">A critique of the drug discovery and phase 3 clinical programs targeting the amyloid hypothesis for Alzheimer disease</span></div><div class="casAuthors">Karran, Eric; Hardy, John</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">185-205</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Review of a critique of the drug discovery and phase 3 clin. programs targeting the amyloid hypothesis for Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjQE-UU2jSXbVg90H21EOLACvtfcHk0ljtNbat0XSmYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWlu77K&md5=64287890331df95f3e2594ef711cdc27</span></div><a href="/servlet/linkout?suffix=cit7b&amp;dbid=16384&amp;doi=10.1002%2Fana.24188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.24188%26sid%3Dliteratum%253Aachs%26aulast%3DKarran%26aufirst%3DE.%26aulast%3DHardy%26aufirst%3DJ.%26atitle%3DA%2520critique%2520of%2520the%2520drug%2520discovery%2520and%2520phase%25203%2520clinical%2520programs%2520targeting%2520the%2520amyloid%2520hypothesis%2520for%2520Alzheimer%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2014%26volume%3D76%26spage%3D185%26epage%3D205%26doi%3D10.1002%2Fana.24188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit7c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Prins, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheltens, P.</span><span> </span><span class="NLM_article-title">Treating Alzheimer’s disease with monoclonal antibodies: current status and outlook for the future</span> <span class="citation_source-journal">Alzheimer's Res. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">56</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span><span class="refDoi"> DOI: 10.1186/alzrt220</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1186%2Falzrt220" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtlWqur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=56-61&author=N.+D.+Prinsauthor=P.+Scheltens&title=Treating+Alzheimer%E2%80%99s+disease+with+monoclonal+antibodies%3A+current+status+and+outlook+for+the+future&doi=10.1186%2Falzrt220"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7cR"><div class="casContent"><span class="casTitleNuber">7c</span><div class="casTitle"><span class="NLM_cas:atitle">Treating Alzheimer's disease with monoclonal antibodies: current status and outlook for the future</span></div><div class="casAuthors">Prins, Niels D.; Scheltens, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Alzheimer's Research & Therapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">56/1-56/6, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">ARTLCD</span>;
        ISSN:<span class="NLM_cas:issn">1758-9193</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">In the past decade, Alzheimer's disease drug discovery has been directed at 'disease modifying drugs' that are able to counteract the progression of Alzheimer's disease by intervening in specific parts of its neuropathol. process.  Passive immunization with monoclonal antibodies (mAbs) may be able to clear toxic amyloid-β species either directly or through microglia or complement activation, thereby halting the amyloid cascade and preventing neurodegeneration and cognitive and functional decline.  Thus far, results from two large phase 3 trial programs with bapineuzumab and solaneuzumab, resp., have brought rather disappointing results.  Possible explanations could be that these compds. were either targeting the wrong amyloid-β species, or were given too late in the disease process.  Several new mAbs targeting various amyloid-β epitopes are now being tested in ongoing phase 2 and 3 clin. trials.  The present review discusses the various mAbs aimed at amyloid-β, summarizes trial results and provides an outlook for the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTG2QS0c-0zbVg90H21EOLACvtfcHk0lj5gbnoCOtGug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtlWqur4%253D&md5=dae320be2b99baeab5d5f01d6f05b62a</span></div><a href="/servlet/linkout?suffix=cit7c&amp;dbid=16384&amp;doi=10.1186%2Falzrt220&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Falzrt220%26sid%3Dliteratum%253Aachs%26aulast%3DPrins%26aufirst%3DN.%2BD.%26aulast%3DScheltens%26aufirst%3DP.%26atitle%3DTreating%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520monoclonal%2520antibodies%253A%2520current%2520status%2520and%2520outlook%2520for%2520the%2520future%26jtitle%3DAlzheimer%2527s%2520Res.%2520Ther.%26date%3D2013%26volume%3D5%26spage%3D56%26epage%3D61%26doi%3D10.1186%2Falzrt220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denis, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kha, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gong, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richards, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span> </span><span class="NLM_article-title">Mice deficient in BACE1, the Alzheimer’s beta secretase, have normal phenotype and abolished beta-amyloid generation</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">231</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span><span class="refDoi"> DOI: 10.1038/85059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2F85059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=11224535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2001&pages=231-232&author=Y.+Luoauthor=B.+Bolonauthor=S.+Kahnauthor=B.+D.+Bennettauthor=S.+Babu-Khanauthor=P.+Denisauthor=W.+Fanauthor=H.+Khaauthor=J.+Zhangauthor=Y.+Gongauthor=L.+Martinauthor=J.+C.+Louisauthor=Q.+Yanauthor=W.+G.+Richardsauthor=M.+Citronauthor=R.+Vassar&title=Mice+deficient+in+BACE1%2C+the+Alzheimer%E2%80%99s+beta+secretase%2C+have+normal+phenotype+and+abolished+beta-amyloid+generation&doi=10.1038%2F85059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8aR"><div class="casContent"><span class="casTitleNuber">8a</span><div class="casTitle"><span class="NLM_cas:atitle">Mice deficient in BACE1, the Alzheimer's β-secretase, have normal phenotype and abolished β-amyloid generation</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Kahn, Steve; Bennett, Brian D.; Babu-Khan, Safura; Denis, Paul; Fan, Wei; Kha, Hue; Zhang, Jianhua; Gong, Yunhua; Martin, Laura; Louis, Jean-Claude; Yan, Qiao; Richards, William G.; Citron, Martin; Vassar, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">231-232</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">Mice deficient in beta-site APP-cleaving enzyme 1 (BACE1) lack Aβ- and β-secretase-cleaved APP C-terminal fragments (CTFs) in the brain.  Moreover, BACE1-/- mice are normal in appearance and behavior and are healthy and fertile.  These results provide validation of BACE1 as the major β-secretase in vivo and indicated that BACE2 is not significant in β-secretase cleavage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqx9Z5X-KkqkbVg90H21EOLACvtfcHk0lj5gbnoCOtGug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXhsF2rtbY%253D&md5=f733e8c48464c6521ce302be48c76b12</span></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1038%2F85059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F85059%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DKahn%26aufirst%3DS.%26aulast%3DBennett%26aufirst%3DB.%2BD.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DDenis%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DW.%26aulast%3DKha%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLouis%26aufirst%3DJ.%2BC.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DRichards%26aufirst%3DW.%2BG.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DVassar%26aufirst%3DR.%26atitle%3DMice%2520deficient%2520in%2520BACE1%252C%2520the%2520Alzheimer%25E2%2580%2599s%2520beta%2520secretase%252C%2520have%2520normal%2520phenotype%2520and%2520abolished%2520beta-amyloid%2520generation%26jtitle%3DNat.%2520Neurosci.%26date%3D2001%26volume%3D4%26spage%3D231%26epage%3D232%26doi%3D10.1038%2F85059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolon, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damore, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzpatrick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span> </span><span class="NLM_article-title">BACE1 (beta secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time</span> <span class="citation_source-journal">Neurobiol. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">88</span><span class="refDoi"> DOI: 10.1016/S0969-9961(03)00104-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2FS0969-9961%2803%2900104-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=13678669" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnt1amt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2003&pages=81-88&author=Y.+Luoauthor=B.+Bolonauthor=M.+A.+Damoreauthor=D.+Fitzpatrickauthor=H.+Liuauthor=J.+Zhangauthor=Q.+Yanauthor=R.+Vassarauthor=M.+Citron&title=BACE1+%28beta+secretase%29+knockout+mice+do+not+acquire+compensatory+gene+expression+changes+or+develop+neural+lesions+over+time&doi=10.1016%2FS0969-9961%2803%2900104-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) knockout mice do not acquire compensatory gene expression changes or develop neural lesions over time</span></div><div class="casAuthors">Luo, Yi; Bolon, Brad; Damore, Michael A.; Fitzpatrick, Dan; Liu, Hantao; Zhang, Jianhua; Yan, Qiao; Vassar, Robert; Citron, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Disease</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-88</span>CODEN:
                <span class="NLM_cas:coden">NUDIEM</span>;
        ISSN:<span class="NLM_cas:issn">0969-9961</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">The formation of Alzheimer's Aβ peptide is initiated when the amyloid precursor protein (APP) is cleaved by the enzyme β-secretase (BACE1); inhibition of this cleavage has been proposed as a means of treating Alzheimer's disease. (AD) We have previously shown that young BACE1 knockout mice (BACE1 KO) do not generate Aβ but in other respects appear normal.  Here we have extended this anal. to include both gene expression profiling and phenotypic assessment of older BACE1 KO animals to evaluate the impact of chronic Aβ deficiency.  We did not detect global compensatory changes in neural gene expression in young BACE1 KO mice.  In particular, expression of the β-secretase homolog BACE2 was not upregulated.  Furthermore, we found no structural alterations in any organ, including all central and peripheral neural tissues, of BACE1 KO mice up to 14 mo of age.  Aged BACE1 KO mice engineered to overexpress human APP (BACE1 KO/APPtg) did not develop amyloid plaques.  These data provide evidence that neither β-secretase nor Aβ plays a vital role in mouse physiol. and that chronic β-secretase inhibition could be a useful approach in treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGov3-UtSwdlHrVg90H21EOLACvtfcHk0lj5gbnoCOtGug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnt1amt7g%253D&md5=69eac3e7707d9abc8e85fd082053b91e</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1016%2FS0969-9961%2803%2900104-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-9961%252803%252900104-9%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DBolon%26aufirst%3DB.%26aulast%3DDamore%26aufirst%3DM.%2BA.%26aulast%3DFitzpatrick%26aufirst%3DD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DQ.%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DCitron%26aufirst%3DM.%26atitle%3DBACE1%2520%2528beta%2520secretase%2529%2520knockout%2520mice%2520do%2520not%2520acquire%2520compensatory%2520gene%2520expression%2520changes%2520or%2520develop%2520neural%2520lesions%2520over%2520time%26jtitle%3DNeurobiol.%2520Dis.%26date%3D2003%26volume%3D14%26spage%3D81%26epage%3D88%26doi%3D10.1016%2FS0969-9961%2803%2900104-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">McConlogue, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buttini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brigham, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freedman, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Games, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson-Wood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Motter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinha, S.</span><span> </span><span class="NLM_article-title">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x">, </span> <span class="NLM_fpage">26326</span><span class="NLM_x">–</span> <span class="NLM_lpage">26334</span><span class="refDoi"> DOI: 10.1074/jbc.M611687200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1074%2Fjbc.M611687200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=17616527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2007&pages=26326-26334&author=L.+McConlogueauthor=M.+Buttiniauthor=J.+P.+Andersonauthor=E.+F.+Brighamauthor=K.+S.+Chenauthor=S.+B.+Freedmanauthor=D.+Gamesauthor=K.+Johnson-Woodauthor=M.+Leeauthor=M.+Zellerauthor=W.+Liuauthor=R.+Motterauthor=S.+Sinha&title=Partial+reduction+of+BACE1+has+dramatic+effects+on+Alzheimer+plaque+and+synaptic+pathology+in+APP+transgenic+mice&doi=10.1074%2Fjbc.M611687200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Partial reduction of BACE1 has dramatic effects on Alzheimer plaque and synaptic pathology in APP transgenic mice</span></div><div class="casAuthors">McConlogue, Lisa; Buttini, Manuel; Anderson, John P.; Brigham, Elizabeth F.; Chen, Karen S.; Freedman, Stephen B.; Games, Dora; Johnson-Wood, Kelly; Lee, Michael; Zeller, Michelle; Liu, Weiqun; Motter, Ruth; Sinha, Sukanto</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">282</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">26326-26334</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The aspartyl protease β-site amyloid precursor protein cleaving enzyme 1 (BACE1) initiates processing of amyloid precursor protein (APP) into amyloid β (Aβ) peptide, the major component of Alzheimer disease (AD) plaques.  To det. the role that BACE1 plays in the development of Aβ-driven AD-like pathol., we have crossed PDAPP mice, a transgenic mouse model of AD overexpressing human mutated APP, onto mice with either a homozygous or heterozygous BACE1 gene knockout.  Anal. of PDAPP/BACE(-/-) mice demonstrated that BACE1 is absolutely required for both Aβ generation and the development of age-assocd. plaque pathol.  Furthermore, synaptic deficits, a neurodegenerative pathol. characteristic of AD, were also reversed in the bigenic mice.  To det. the extent of BACE1 redn. required to significantly inhibit pathol., PDAPP mice having a heterozygous BACE1 gene knock-out were evaluated for Aβ generation and for the development of pathol.  Although the 50% redn. in BACE1 enzyme levels caused only a 12% decrease in Aβ levels in young mice, it nonetheless resulted in a dramatic redn. in Aβ plaques, neuritic burden, and synaptic deficits in older mice.  Quant. analyses indicate that brain Aβ levels in young APP transgenic mice are not the sole determinant for the changes in plaque pathol. mediated by reduced BACE1.  These observations demonstrate that partial redns. of BACE1 enzyme activity and concomitant Aβ levels lead to dramatic inhibition of Aβ-driven AD-like pathol., making BACE1 an excellent target for therapeutic intervention in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolXkPkhLFworVg90H21EOLACvtfcHk0ljfZrPPGhzq0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpslGjt74%253D&md5=5cd1df8e7c16473d8116de3226c78cd4</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M611687200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M611687200%26sid%3Dliteratum%253Aachs%26aulast%3DMcConlogue%26aufirst%3DL.%26aulast%3DButtini%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DJ.%2BP.%26aulast%3DBrigham%26aufirst%3DE.%2BF.%26aulast%3DChen%26aufirst%3DK.%2BS.%26aulast%3DFreedman%26aufirst%3DS.%2BB.%26aulast%3DGames%26aufirst%3DD.%26aulast%3DJohnson-Wood%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DZeller%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DMotter%26aufirst%3DR.%26aulast%3DSinha%26aufirst%3DS.%26atitle%3DPartial%2520reduction%2520of%2520BACE1%2520has%2520dramatic%2520effects%2520on%2520Alzheimer%2520plaque%2520and%2520synaptic%2520pathology%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2007%26volume%3D282%26spage%3D26326%26epage%3D26334%26doi%3D10.1074%2Fjbc.M611687200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Vassar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhn, P.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, Ch.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajendran, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lichtenthaler, S. F. J.</span><span> </span><span class="NLM_article-title">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4</span><span class="NLM_x">–</span> <span class="NLM_lpage">28</span><span class="refDoi"> DOI: 10.1111/jnc.12715</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1111%2Fjnc.12715" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24646365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2014&pages=4-28&author=R.+Vassarauthor=P.-H.+Kuhnauthor=Ch.+Haassauthor=M.+E.+Kennedyauthor=L.+Rajendranauthor=P.+C.+Wongauthor=S.+F.+J.+Lichtenthaler&title=Function%2C+therapeutic+potential+and+cell+biology+of+BACE+proteases%3A+current+status+and+future+prospects&doi=10.1111%2Fjnc.12715"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Function, therapeutic potential and cell biology of BACE proteases: current status and future prospects</span></div><div class="casAuthors">Vassar, Robert; Kuhn, Peer-Hendrik; Haass, Christian; Kennedy, Matthew E.; Rajendran, Lawrence; Wong, Philip C.; Lichtenthaler, Stefan F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">130</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-28</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  The β-site APP cleaving enzymes 1 and 2 (BACE1 and BACE2) were initially identified as transmembrane aspartyl proteases cleaving the amyloid precursor protein (APP).  BACE1 is a major drug target for Alzheimer's disease because BACE1-mediated cleavage of APP is the first step in the generation of the pathogenic amyloid-β peptides.  BACE1, which is highly expressed in the nervous system, is also required for myelination by cleaving neuregulin 1.  Several recent proteomic and in vivo studies using BACE1- and BACE2-deficient mice demonstrate a much wider range of physiol. substrates and functions for both proteases within and outside of the nervous system.  For BACE1 this includes axon guidance, neurogenesis, muscle spindle formation, and neuronal network functions, whereas BACE2 was shown to be involved in pigmentation and pancreatic β-cell function.  This review highlights the recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer's disease.  The protease BACE1 is a major drug target in Alzheimer disease.  Together with its homolog BACE2, both proteases have an increasing no. of functions within and outside of the nervous system.  This review highlights recent progress in understanding cell biol., substrates, and functions of BACE proteases and discusses the therapeutic options and potential mechanism-based liabilities, in particular for BACE inhibitors in Alzheimer disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxkCRjc9dYMLVg90H21EOLACvtfcHk0ljfZrPPGhzq0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVSqtL7M&md5=79e394bb720ad6639f8efc86138fcd60</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1111%2Fjnc.12715&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.12715%26sid%3Dliteratum%253Aachs%26aulast%3DVassar%26aufirst%3DR.%26aulast%3DKuhn%26aufirst%3DP.-H.%26aulast%3DHaass%26aufirst%3DCh.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DRajendran%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DP.%2BC.%26aulast%3DLichtenthaler%26aufirst%3DS.%2BF.%2BJ.%26atitle%3DFunction%252C%2520therapeutic%2520potential%2520and%2520cell%2520biology%2520of%2520BACE%2520proteases%253A%2520current%2520status%2520and%2520future%2520prospects%26jtitle%3DJ.%2520Neurochem.%26date%3D2014%26volume%3D130%26spage%3D4%26epage%3D28%26doi%3D10.1111%2Fjnc.12715" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Novak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaufmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeStrooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span> </span><span class="NLM_article-title">Control of peripheral nerve myelination by the β-secretase BACE1</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">314</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">666</span><span class="refDoi"> DOI: 10.1126/science.1132341</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1126%2Fscience.1132341" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=2006&pages=664-666&author=M.+Willemauthor=A.+N.+Garrattauthor=B.+Novakauthor=M.+Citronauthor=S.+Kaufmannauthor=A.+Rittgerauthor=B.+DeStrooperauthor=P.+Saftigauthor=C.+Birchmeierauthor=C.+Haass&title=Control+of+peripheral+nerve+myelination+by+the+%CE%B2-secretase+BACE1&doi=10.1126%2Fscience.1132341"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1126%2Fscience.1132341&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1132341%26sid%3Dliteratum%253Aachs%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DNovak%26aufirst%3DB.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DKaufmann%26aufirst%3DS.%26aulast%3DRittger%26aufirst%3DA.%26aulast%3DDeStrooper%26aufirst%3DB.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DBirchmeier%26aufirst%3DC.%26aulast%3DHaass%26aufirst%3DC.%26atitle%3DControl%2520of%2520peripheral%2520nerve%2520myelination%2520by%2520the%2520%25CE%25B2-secretase%2520BACE1%26jtitle%3DScience%26date%3D2006%26volume%3D314%26spage%3D664%26epage%3D666%26doi%3D10.1126%2Fscience.1132341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">He, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macklin, W. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trapp, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, R.</span><span> </span><span class="NLM_article-title">Bace1 modulates myelination in the central and peripheral nervous system</span> <span class="citation_source-journal">Nat. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">1520</span><span class="NLM_x">–</span> <span class="NLM_lpage">1525</span><span class="refDoi"> DOI: 10.1038/nn1797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Fnn1797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=17099708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Cns7nP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=1520-1525&author=X.+Huauthor=C.+W.+Hicksauthor=W.+Heauthor=P.+Wongauthor=W.+B.+Macklinauthor=B.+D.+Trappauthor=R.+Yan&title=Bace1+modulates+myelination+in+the+central+and+peripheral+nervous+system&doi=10.1038%2Fnn1797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 modulates myelination in the central and peripheral nervous system</span></div><div class="casAuthors">Hu, Xiangyou; Hicks, Caitlin W.; He, Wanxia; Wong, Philip; Macklin, Wendy B.; Trapp, Bruce D.; Yan, Riqiang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Neuroscience</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1520-1525</span>CODEN:
                <span class="NLM_cas:coden">NANEFN</span>;
        ISSN:<span class="NLM_cas:issn">1097-6256</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Bace1 is an endopeptidase that cleaves the amyloid precursor protein at the β-secretase site.  Apart from this cleavage, the functional importance of Bace1 in other physiol. events is unknown.  We show here that Bace1 regulates the process of myelination and myelin sheath thickness in the central and peripheral nerves.  In Bace1-null mice, the process of myelination was delayed and myelin thickness was markedly reduced, indicating that genetic deletion of Bace1 causes hypomyelination.  Bace1-null mice also showed altered neurol. behaviors such as elevated pain sensitivity and reduced grip strength.  Further mechanistic studies showed an altered neuregulin-Akt signaling pathway in Bace1-null mice.  Full-length neuregulin-1 was increased and its cleavage product was decreased in the CNS of Bace1-null mice.  Furthermore, phosphorylated Akt was also reduced.  Based upon these and previous studies, we postulate that neuronally enriched Bace1 cleaves neuregulin-1 and that processed neuregulin-1 regulates myelination by means of phosphorylation of Akt in myelin-forming cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCWcMnd4xVWrVg90H21EOLACvtfcHk0lgUpRExAcsHzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Cns7nP&md5=a8df10ae9c3e3243e564a017288a57c6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1038%2Fnn1797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnn1797%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DX.%26aulast%3DHicks%26aufirst%3DC.%2BW.%26aulast%3DHe%26aufirst%3DW.%26aulast%3DWong%26aufirst%3DP.%26aulast%3DMacklin%26aufirst%3DW.%2BB.%26aulast%3DTrapp%26aufirst%3DB.%2BD.%26aulast%3DYan%26aufirst%3DR.%26atitle%3DBace1%2520modulates%2520myelination%2520in%2520the%2520central%2520and%2520peripheral%2520nervous%2520system%26jtitle%3DNat.%2520Neurosci.%26date%3D2006%26volume%3D9%26spage%3D1520%26epage%3D1525%26doi%3D10.1038%2Fnn1797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Cheret, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willem, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fricker, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wende, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wulf-Goldenberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahirovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nave, K.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saftig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haass, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garratt, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birchmeier, C.</span><span> </span><span class="NLM_article-title">Bace1 and neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">2015</span><span class="NLM_x">–</span> <span class="NLM_lpage">2028</span><span class="refDoi"> DOI: 10.1038/emboj.2013.146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1038%2Femboj.2013.146" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23792428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVersr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2013&pages=2015-2028&author=C.+Cheretauthor=M.+Willemauthor=F.+R.+Frickerauthor=H.+Wendeauthor=A.+Wulf-Goldenbergauthor=S.+Tahirovicauthor=K.-A.+Naveauthor=P.+Saftigauthor=C.+Haassauthor=A.+N.+Garrattauthor=D.+L.+Bennettauthor=C.+Birchmeier&title=Bace1+and+neuregulin-1+cooperate+to+control+formation+and+maintenance+of+muscle+spindles&doi=10.1038%2Femboj.2013.146"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Bace1 and neuregulin-1 cooperate to control formation and maintenance of muscle spindles</span></div><div class="casAuthors">Cheret, Cyril; Willem, Michael; Fricker, Florence R.; Wende, Hagen; Wulf-Goldenberg, Annika; Tahirovic, Sabina; Nave, Klaus-Armin; Saftig, Paul; Haass, Christian; Garratt, Alistair N.; Bennett, David L.; Birchmeier, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2015-2028</span>CODEN:
                <span class="NLM_cas:coden">EMJODG</span>;
        ISSN:<span class="NLM_cas:issn">0261-4189</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Secretase 1 (Bace1) was identified through its crit. role in prodn. of amyloid-β peptides (Aβ), the major component of amyloid plaques in Alzheimer's disease.  Bace1 is considered a promising target for the treatment of this pathol., but also processes addnl. substrates, among them neuregulin-1 (Nrg1).  The authors' biochem. anal. indicated that Bace1 processed the Ig-contg. β1 Nrg1 (IgNrg1β1) isoform.  The authors found that a graded redn. in IgNrg1 signal strength in vivo resulted in increasingly severe deficits in the formation and maturation of muscle spindles, a proprioceptive organ crit. for muscle coordination.  Further, it was shown that Bace1 was required for formation and maturation of the muscle spindle.  Finally, pharmacol. inhibition and conditional mutagenesis in adult animals demonstrated that Bace1 and Nrg1 were essential to sustain muscle spindles and to maintain motor coordination.  The results assigned to Bace1 a role in the control of coordinated movement through its regulation of muscle spindle physiol., and implicated IgNrg1-dependent processing as a mol. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp74BUA5mCeAbVg90H21EOLACvtfcHk0lgUpRExAcsHzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVersr8%253D&md5=7cf5ecb44dd55bca5096792720638560</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Femboj.2013.146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Femboj.2013.146%26sid%3Dliteratum%253Aachs%26aulast%3DCheret%26aufirst%3DC.%26aulast%3DWillem%26aufirst%3DM.%26aulast%3DFricker%26aufirst%3DF.%2BR.%26aulast%3DWende%26aufirst%3DH.%26aulast%3DWulf-Goldenberg%26aufirst%3DA.%26aulast%3DTahirovic%26aufirst%3DS.%26aulast%3DNave%26aufirst%3DK.-A.%26aulast%3DSaftig%26aufirst%3DP.%26aulast%3DHaass%26aufirst%3DC.%26aulast%3DGarratt%26aufirst%3DA.%2BN.%26aulast%3DBennett%26aufirst%3DD.%2BL.%26aulast%3DBirchmeier%26aufirst%3DC.%26atitle%3DBace1%2520and%2520neuregulin-1%2520cooperate%2520to%2520control%2520formation%2520and%2520maintenance%2520of%2520muscle%2520spindles%26jtitle%3DEMBO%2520J.%26date%3D2013%26volume%3D32%26spage%3D2015%26epage%3D2028%26doi%3D10.1038%2Femboj.2013.146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ghosh, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osswald, H. L.</span><span> </span><span class="NLM_article-title">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer’s disease</span> <span class="citation_source-journal">Chem. Soc. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">6765</span><span class="NLM_x">–</span> <span class="NLM_lpage">6813</span><span class="refDoi"> DOI: 10.1039/C3CS60460H</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1039%2FC3CS60460H" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=24691405" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2014&pages=6765-6813&author=A.+K.+Ghoshauthor=H.+L.+Osswald&title=BACE1+%28%CE%B2-secretase%29+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1039%2FC3CS60460H"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">BACE1 (β-secretase) inhibitors for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Ghosh, Arun K.; Osswald, Heather L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Society Reviews</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6765-6813</span>CODEN:
                <span class="NLM_cas:coden">CSRVBR</span>;
        ISSN:<span class="NLM_cas:issn">0306-0012</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">BACE1 (β-secretase, memapsin 2, Asp2) has emerged as a promising target for the treatment of Alzheimer's disease.  BACE1 is an aspartic protease which functions in the first step of the pathway leading to the prodn. and deposition of amyloid-β peptide (Aβ).  Its gene deletion showed only mild phenotypes.  BACE1 inhibition has direct implications in the Alzheimer's disease pathol. without largely affecting viability.  However, inhibiting BACE1 selectively in vivo has presented many challenges to medicinal chemists.  Since its identification in 2000, inhibitors covering many different structural classes have been designed and developed.  These inhibitors can be largely classified as either peptidomimetic or non-peptidic inhibitors.  Progress in these fields resulted in inhibitors that contain many targeted drug-like characteristics.  In this review, we describe structure-based design strategies and evolution of a wide range of BACE1 inhibitors including compds. that have been shown to reduce brain Aβ, rescue the cognitive decline in transgenic AD mice and inhibitor drug candidates that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGri59_pgGAbxLVg90H21EOLACvtfcHk0lhrDN8F40eEYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsV2mt7nJ&md5=dab445bf7efb6fdc0c80e032d3bb0071</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1039%2FC3CS60460H&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC3CS60460H%26sid%3Dliteratum%253Aachs%26aulast%3DGhosh%26aufirst%3DA.%2BK.%26aulast%3DOsswald%26aufirst%3DH.%2BL.%26atitle%3DBACE1%2520%2528%25CE%25B2-secretase%2529%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DChem.%2520Soc.%2520Rev.%26date%3D2014%26volume%3D43%26spage%3D6765%26epage%3D6813%26doi%3D10.1039%2FC3CS60460H" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Potent pyrrolidine and piperidine-based BACE-1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">414</span><span class="NLM_x">–</span> <span class="NLM_lpage">417</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2007.10.116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=414-417&author=U.+Iserlohauthor=Y.+Wuauthor=J.+N.+Cummingauthor=J.+Panauthor=L.+Y.+Wangauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=X.+Chenauthor=E.+M.+Parkerauthor=C.+Stricklandauthor=J.+Voigt&title=Potent+pyrrolidine+and+piperidine-based+BACE-1+inhibitors&doi=10.1016%2Fj.bmcl.2007.10.116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.116%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%2BY.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DPotent%2520pyrrolidine%2520and%2520piperidine-based%2520BACE-1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D414%26epage%3D417%26doi%3D10.1016%2Fj.bmcl.2007.10.116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span> </span><span class="NLM_article-title">Discovery of an orally efficacious 4-phenoxypyrrolidine-based BACE-1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">418</span><span class="NLM_x">–</span> <span class="NLM_lpage">422</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2007.10.053</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2007.10.053" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=418-422&author=U.+Iserlohauthor=J.+Panauthor=A.+W.+Stamfordauthor=M.+E.+Kennedyauthor=Q.+Zhangauthor=L.+Zhangauthor=E.+M.+Parkerauthor=N.+A.+McHughauthor=L.+Favreauauthor=C.+Stricklandauthor=J.+Voigt&title=Discovery+of+an+orally+efficacious+4-phenoxypyrrolidine-based+BACE-1+inhibitor&doi=10.1016%2Fj.bmcl.2007.10.053"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.10.053&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.10.053%26sid%3Dliteratum%253Aachs%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520efficacious%25204-phenoxypyrrolidine-based%2520BACE-1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D418%26epage%3D422%26doi%3D10.1016%2Fj.bmcl.2007.10.053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, T. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaspari, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobbs, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowrie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHugh, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozgur, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saionz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span> </span><span class="NLM_article-title">Rational design of novel potent piperazinone and imidazolidinone BACE1 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">3236</span><span class="NLM_x">–</span> <span class="NLM_lpage">3241</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2008.04.050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2008.04.050" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=3236-3241&author=J.+N.+Cummingauthor=T.+X.+Leauthor=S.+Babuauthor=C.+Carrollauthor=X.+Chenauthor=L.+Favreauauthor=P.+Gaspariauthor=T.+Guoauthor=D.+W.+Hobbsauthor=Y.+Huangauthor=U.+Iserlohauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=G.+Liauthor=J.+Lowrieauthor=N.+A.+McHughauthor=L.+Ozgurauthor=J.+Panauthor=E.+M.+Parkerauthor=K.+Saionzauthor=A.+W.+Stamfordauthor=C.+Stricklandauthor=D.+Tadesseauthor=J.+Voigtauthor=L.+Wangauthor=Y.+Wuauthor=L.+Zhangauthor=Q.+Zhang&title=Rational+design+of+novel+potent+piperazinone+and+imidazolidinone+BACE1+inhibitors&doi=10.1016%2Fj.bmcl.2008.04.050"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.04.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.04.050%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLe%26aufirst%3DT.%2BX.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DCarroll%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DGaspari%26aufirst%3DP.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DHobbs%26aufirst%3DD.%2BW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DLowrie%26aufirst%3DJ.%26aulast%3DMcHugh%26aufirst%3DN.%2BA.%26aulast%3DOzgur%26aufirst%3DL.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DSaionz%26aufirst%3DK.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26atitle%3DRational%2520design%2520of%2520novel%2520potent%2520piperazinone%2520and%2520imidazolidinone%2520BACE1%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D3236%26epage%3D3241%26doi%3D10.1016%2Fj.bmcl.2008.04.050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and preparation of a potent series of hydroxyethylamine containing β-secretase inhibitors that demonstrate robust reduction of central β-amyloid</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9009</span><span class="NLM_x">–</span> <span class="NLM_lpage">9024</span><span class="refDoi"> DOI: 10.1021/jm300119p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300119p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9009-9024&author=M.+M.+Weissauthor=T.+Williamsonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=T.+A.+Dineenauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=C.+Rattanauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+preparation+of+a+potent+series+of+hydroxyethylamine+containing+%CE%B2-secretase+inhibitors+that+demonstrate+robust+reduction+of+central+%CE%B2-amyloid&doi=10.1021%2Fjm300119p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14d&amp;dbid=16384&amp;doi=10.1021%2Fjm300119p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300119p%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520preparation%2520of%2520a%2520potent%2520series%2520of%2520hydroxyethylamine%2520containing%2520%25CE%25B2-secretase%2520inhibitors%2520that%2520demonstrate%2520robust%2520reduction%2520of%2520central%2520%25CE%25B2-amyloid%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9009%26epage%3D9024%26doi%3D10.1021%2Fjm300119p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Dineen, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu-Khan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Croghan, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esmay, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graceffa, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Imbeah-Ampiah, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaller, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreiman, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monenschein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pennington, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">San Miguel, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhong, W.</span><span> </span><span class="NLM_article-title">Design and synthesis of potent, orally efficacious hydroxyethylamine derived β-Site amyloid precursor protein cleaving enzyme (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9025</span><span class="NLM_x">–</span> <span class="NLM_lpage">9044</span><span class="refDoi"> DOI: 10.1021/jm300118s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300118s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9025-9044&author=T.+A.+Dineenauthor=M.+M.+Weissauthor=T.+Williamsonauthor=P.+Actonauthor=S.+Babu-Khanauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=Y.+Chengauthor=M.+Citronauthor=M.+D.+Croghanauthor=R.+T.+Dunnauthor=J.+Esmayauthor=R.+F.+Graceffaauthor=S.+S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=D.+B.+Horneauthor=H.+Huangauthor=R.+Imbeah-Ampiahauthor=T.+Juddauthor=M.+R.+Kallerauthor=C.+R.+Kreimanauthor=D.+S.+Laauthor=V.+Liauthor=P.+Lopezauthor=S.+Louieauthor=H.+Monenscheinauthor=T.+T.+Nguyenauthor=L.+D.+Penningtonauthor=T.+San+Miguelauthor=E.+A.+Sickmierauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=D.+A.+Whittingtonauthor=S.+Woodauthor=Q.+Xueauthor=B.+H.+Yangauthor=V.+F.+Patelauthor=W.+Zhong&title=Design+and+synthesis+of+potent%2C+orally+efficacious+hydroxyethylamine+derived+%CE%B2-Site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors&doi=10.1021%2Fjm300118s"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14eR"><div class="casContent"><span class="casTitleNuber">14e</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Potent, Orally Efficacious Hydroxyethylamine Derived β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors</span></div><div class="casAuthors">Dineen, Thomas A.; Weiss, Matthew M.; Williamson, Toni; Acton, Paul; Babu-Khan, Safura; Bartberger, Michael D.; Brown, James; Chen, Kui; Cheng, Yuan; Citron, Martin; Croghan, Michael D.; Dunn, Robert T.; Esmay, Joel; Graceffa, Russell F.; Harried, Scott S.; Hickman, Dean; Hitchcock, Stephen A.; Horne, Daniel B.; Huang, Hongbing; Imbeah-Ampiah, Ronke; Judd, Ted; Kaller, Matthew R.; Kreiman, Charles R.; La, Daniel S.; Li, Vivian; Lopez, Patricia; Louie, Steven; Monenschein, Holger; Nguyen, Thomas T.; Pennington, Lewis D.; San Miguel, Tisha; Sickmier, E. Allen; Vargas, Hugo M.; Wahl, Robert C.; Wen, Paul H.; Whittington, Douglas A.; Wood, Stephen; Xue, Qiufen; Yang, Bryant H.; Patel, Vinod F.; Zhong, Wenge</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9025-9044</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We have previously shown that hydroxyethylamines can be potent inhibitors of the BACE1 enzyme and that the generation of BACE1 inhibitors with CYP 3A4 inhibitory activities in this scaffold affords compds. (e.g., 1, I) with sufficient bioavailability and pharmacokinetic profiles to reduce central amyloid-β peptide (Aβ) levels in wild-type rats following oral dosing.  In this article, we describe further modifications of the Ph ring of the hydroxyethylamine series to afford potent, dual BACE1/CYP 3A4 inhibitors which demonstrate improved penetration into the CNS.  Several of these compds. caused robust redn. of Aβ levels in rat CSF and brain following oral dosing, and compd. II exhibited an improved cardiovascular safety profile relative to 1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqApKWBnTeHErVg90H21EOLACvtfcHk0lhmNNJw0W1MAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XkvFOnsbg%253D&md5=1c6ad4a5aa1583864bd778715e1453ea</span></div><a href="/servlet/linkout?suffix=cit14e&amp;dbid=16384&amp;doi=10.1021%2Fjm300118s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300118s%26sid%3Dliteratum%253Aachs%26aulast%3DDineen%26aufirst%3DT.%2BA.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DActon%26aufirst%3DP.%26aulast%3DBabu-Khan%26aufirst%3DS.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DCroghan%26aufirst%3DM.%2BD.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEsmay%26aufirst%3DJ.%26aulast%3DGraceffa%26aufirst%3DR.%2BF.%26aulast%3DHarried%26aufirst%3DS.%2BS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DHorne%26aufirst%3DD.%2BB.%26aulast%3DHuang%26aufirst%3DH.%26aulast%3DImbeah-Ampiah%26aufirst%3DR.%26aulast%3DJudd%26aufirst%3DT.%26aulast%3DKaller%26aufirst%3DM.%2BR.%26aulast%3DKreiman%26aufirst%3DC.%2BR.%26aulast%3DLa%26aufirst%3DD.%2BS.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%26aulast%3DMonenschein%26aufirst%3DH.%26aulast%3DNguyen%26aufirst%3DT.%2BT.%26aulast%3DPennington%26aufirst%3DL.%2BD.%26aulast%3DSan%2BMiguel%26aufirst%3DT.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DXue%26aufirst%3DQ.%26aulast%3DYang%26aufirst%3DB.%2BH.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DZhong%26aufirst%3DW.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520potent%252C%2520orally%2520efficacious%2520hydroxyethylamine%2520derived%2520%25CE%25B2-Site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9025%26epage%3D9044%26doi%3D10.1021%2Fjm300118s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Wang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nechuta, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span> </span><span class="NLM_article-title">Application of fragment-based NMR screening, X-ray crystallography, structure- based design, and focused chemical library design to identify novel μM leads for the development of nM BACE-1 (β-site APP cleaving enzyme 1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">942</span><span class="NLM_x">–</span> <span class="NLM_lpage">950</span><span class="refDoi"> DOI: 10.1021/jm901472u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901472u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=942-950&author=Y.-S.+Wangauthor=C.+Stricklandauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=B.+M.+Beyerauthor=M.+M.+Seniorauthor=E.+M.+Smithauthor=T.+L.+Nechutaauthor=V.+S.+Madisonauthor=M.+Czarnieckiauthor=B.+A.+McKittrickauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=J.+C.+Hunterauthor=W.+J.+Greenleeauthor=D.+F.+Wyss&title=Application+of+fragment-based+NMR+screening%2C+X-ray+crystallography%2C+structure-+based+design%2C+and+focused+chemical+library+design+to+identify+novel+%CE%BCM+leads+for+the+development+of+nM+BACE-1+%28%CE%B2-site+APP+cleaving+enzyme+1%29+inhibitors&doi=10.1021%2Fjm901472u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm901472u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901472u%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DY.-S.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DSenior%26aufirst%3DM.%2BM.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DNechuta%26aufirst%3DT.%2BL.%26aulast%3DMadison%26aufirst%3DV.%2BS.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DApplication%2520of%2520fragment-based%2520NMR%2520screening%252C%2520X-ray%2520crystallography%252C%2520structure-%2520based%2520design%252C%2520and%2520focused%2520chemical%2520library%2520design%2520to%2520identify%2520novel%2520%25CE%25BCM%2520leads%2520for%2520the%2520development%2520of%2520nM%2520BACE-1%2520%2528%25CE%25B2-site%2520APP%2520cleaving%2520enzyme%25201%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D942%26epage%3D950%26doi%3D10.1021%2Fjm901472u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, Z.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wyss, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Discovery of cyclic acylguanidines as highly potent and selective β-site amyloid cleaving enzyme (BACE) inhibitors: part I; inhibitor design and validation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span><span class="refDoi"> DOI: 10.1021/jm901408p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901408p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=951-965&author=Z.+Zhuauthor=Z.-Y.+Sunauthor=Y.+Yeauthor=J.+Voigtauthor=C.+Stricklandauthor=E.+M.+Smithauthor=J.+Cummingauthor=L.+Wangauthor=J.+Wongauthor=Y.-S.+Wangauthor=D.+F.+Wyssauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=E.+Parkerauthor=B.+A.+McKittrickauthor=A.+Stamfordauthor=M.+Czarnieckiauthor=W.+Greenleeauthor=J.+C.+Hunter&title=Discovery+of+cyclic+acylguanidines+as+highly+potent+and+selective+%CE%B2-site+amyloid+cleaving+enzyme+%28BACE%29+inhibitors%3A+part+I%3B+inhibitor+design+and+validation&doi=10.1021%2Fjm901408p"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901408p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901408p%26sid%3Dliteratum%253Aachs%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DSun%26aufirst%3DZ.-Y.%26aulast%3DYe%26aufirst%3DY.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DCumming%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.-S.%26aulast%3DWyss%26aufirst%3DD.%2BF.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DCzarniecki%26aufirst%3DM.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DDiscovery%2520of%2520cyclic%2520acylguanidines%2520as%2520highly%2520potent%2520and%2520selective%2520%25CE%25B2-site%2520amyloid%2520cleaving%2520enzyme%2520%2528BACE%2529%2520inhibitors%253A%2520part%2520I%253B%2520inhibitor%2520design%2520and%2520validation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D951%26epage%3D965%26doi%3D10.1021%2Fjm901408p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durkin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iserloh, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Czarniecki, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">2444</span><span class="NLM_x">–</span> <span class="NLM_lpage">2449</span><span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.bmcl.2012.02.013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22390835" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2444-2449&author=J.+N.+Cummingauthor=E.+M.+Smithauthor=L.+Wangauthor=J.+Misiaszekauthor=J.+Durkinauthor=J.+Panauthor=U.+Iserlohauthor=Y.+Wuauthor=Z.+Zhuauthor=C.+Stricklandauthor=J.+Voigtauthor=X.+Chenauthor=M.+E.+Kennedyauthor=R.+Kuvelkarauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=M.+F.+Czarnieckiauthor=W.+J.+Greenleeauthor=B.+A.+McKittrickauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Structure+based+design+of+iminohydantoin+BACE1+inhibitors%3A+Identification+of+an+orally+available%2C+centrally+active+BACE1+inhibitor&doi=10.1016%2Fj.bmcl.2012.02.013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Structure based design of iminohydantoin BACE1 inhibitors: Identification of an orally available, centrally active BACE1 inhibitor</span></div><div class="casAuthors">Cumming, Jared N.; Smith, Elizabeth M.; Wang, Lingyan; Misiaszek, Jeffrey; Durkin, James; Pan, Jianping; Iserloh, Ulrich; Wu, Yusheng; Zhu, Zhaoning; Strickland, Corey; Voigt, Johannes; Chen, Xia; Kennedy, Matthew E.; Kuvelkar, Reshma; Hyde, Lynn A.; Cox, Kathleen; Favreau, Leonard; Czarniecki, Michael F.; Greenlee, William J.; McKittrick, Brian A.; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2444-2449</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">From an initial lead 2-imino-1-methyl-4,4-diphenyl-5-imidazolidinone, a structure-based design approach led to identification of the novel, high-affinity iminohydantoin BACE1 inhibitor I that lowers CNS-derived Aβ following oral administration to rats.  SAR development in the S3 and F' subsites of BACE1 for this series, the synthetic approaches employed in this effort, and in vivo data for I are reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3tWBE09QKNLVg90H21EOLACvtfcHk0li9YUvudxQvXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1ektbY%253D&md5=783b6cb9a6d9608ff5e9dc4f5d634397</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.013%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DSmith%26aufirst%3DE.%2BM.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DDurkin%26aufirst%3DJ.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DIserloh%26aufirst%3DU.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCzarniecki%26aufirst%3DM.%2BF.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DStructure%2520based%2520design%2520of%2520iminohydantoin%2520BACE1%2520inhibitors%253A%2520Identification%2520of%2520an%2520orally%2520available%252C%2520centrally%2520active%2520BACE1%2520inhibitor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2444%26epage%3D2449%26doi%3D10.1016%2Fj.bmcl.2012.02.013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadesse, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misiaszek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span> </span><span class="NLM_article-title">Discovery of an orally available, brain penetrant BACE1 inhibitor that affords robust CNS Aβ reduction</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">897</span><span class="NLM_x">–</span> <span class="NLM_lpage">902</span><span class="refDoi"> DOI: 10.1021/ml3001165</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml3001165" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=897-902&author=A.+W.+Stamfordauthor=J.+D.+Scottauthor=S.+W.+Liauthor=S.+Babuauthor=D.+Tadesseauthor=R.+Hunterauthor=Y.+Wuauthor=J.+Misiaszekauthor=J.+N.+Cummingauthor=E.+J.+Gilbertauthor=C.+Huangauthor=B.+A.+McKittrickauthor=L.+Hongauthor=T.+Guoauthor=Z.+Zhuauthor=C.+Stricklandauthor=P.+Orthauthor=J.+H.+Voigtauthor=M.+E.+Kennedyauthor=X.+Chenauthor=R.+Kuvelkarauthor=R.+Hodgsonauthor=L.+A.+Hydeauthor=K.+Coxauthor=L.+Favreauauthor=E.+M.+Parkerauthor=W.+J.+Greenlee&title=Discovery+of+an+orally+available%2C+brain+penetrant+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction&doi=10.1021%2Fml3001165"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml3001165&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3001165%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DScott%26aufirst%3DJ.%2BD.%26aulast%3DLi%26aufirst%3DS.%2BW.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DTadesse%26aufirst%3DD.%26aulast%3DHunter%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DMisiaszek%26aufirst%3DJ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DGilbert%26aufirst%3DE.%2BJ.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DHong%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DVoigt%26aufirst%3DJ.%2BH.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520available%252C%2520brain%2520penetrant%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D897%26epage%3D902%26doi%3D10.1021%2Fml3001165" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wyss, D. F.; Cumming, J. N.; Strickland, C. O.; Stamford, A. W.</span><span> </span><span class="NLM_article-title">BACE Inhibitors</span>. In  <span class="citation_source-book">Fragment-Based Drug Discovery: Lessons and Outlook</span>; <span class="NLM_contrib-group">Erlanson, D. A.; Jahnke, W.</span>, Eds.; <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">67</span>, pp  <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">353</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1002%2F9783527683604.ch14" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=329-353&author=D.+F.+Wyss&author=J.+N.+Cumming&author=C.+O.+Strickland&author=A.+W.+Stamfordauthor=D.+A.+Erlanson&author=W.+Jahnke&title=Fragment-Based+Drug+Discovery%3A+Lessons+and+Outlook"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.1002%2F9783527683604.ch14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527683604.ch14%26sid%3Dliteratum%253Aachs%26aulast%3DWyss%26aufirst%3DD.%2BF.%26atitle%3DBACE%2520Inhibitors%26btitle%3DFragment-Based%2520Drug%2520Discovery%253A%2520Lessons%2520and%2520Outlook%26aulast%3DErlanson%26aufirst%3DD.%2BA.%26pub%3DWiley%26date%3D2016%26volume%3D67%26spage%3D329%26epage%3D353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span> </span><span class="NLM_article-title">Inhibitors of BACE for treating Alzheimer’s disease: a fragment-based drug discovery story</span> <span class="citation_source-journal">Curr. Opin. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">320</span><span class="NLM_x">–</span> <span class="NLM_lpage">328</span><span class="refDoi"> DOI: 10.1016/j.cbpa.2013.04.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cbpa.2013.04.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23683349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnslaku7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2013&pages=320-328&author=A.+Stamfordauthor=C.+Strickland&title=Inhibitors+of+BACE+for+treating+Alzheimer%E2%80%99s+disease%3A+a+fragment-based+drug+discovery+story&doi=10.1016%2Fj.cbpa.2013.04.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of BACE for treating Alzheimer's disease: a fragment-based drug discovery story</span></div><div class="casAuthors">Stamford, Andrew; Strickland, Corey</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">320-328</span>CODEN:
                <span class="NLM_cas:coden">COCBF4</span>;
        ISSN:<span class="NLM_cas:issn">1367-5931</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Several fragment-based methods have been applied to the discovery of new lead sources for inhibitors of BACE1, an important therapeutic target for Alzheimer's disease.  Among the most common fragment hits were various amidine-contg. mols. in which the amidine engaged in discrete H-bond donor-acceptor interaction with the BACE1 catalytic dyad.  Structure and medicinal chem. knowledge-based optimization with emphasis on ligand efficiency resulted in identification of a key pharmacophore comprising a non-planar cyclic amidine scaffold directly attached to a Ph group projecting into S1.  This key pharmacophore is a common feature of known clin. candidates and has dominated the recent patent literature.  A structural comparison of the non-planar cyclic amidine motif with other BACE1 pharmacophores highlights its uniqueness and distinct advantages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfLbpbjuHoU7Vg90H21EOLACvtfcHk0lhIGFB1oXzzSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnslaku7w%253D&md5=f39c9a0499fe096cf4c0719f4cb41e37</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1016%2Fj.cbpa.2013.04.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cbpa.2013.04.016%26sid%3Dliteratum%253Aachs%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DStrickland%26aufirst%3DC.%26atitle%3DInhibitors%2520of%2520BACE%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520fragment-based%2520drug%2520discovery%2520story%26jtitle%3DCurr.%2520Opin.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D17%26spage%3D320%26epage%3D328%26doi%3D10.1016%2Fj.cbpa.2013.04.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hunt, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watts, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, A. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawardana, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burkard, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geck Do, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutcher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rana, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallan, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLisle, R. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rizzi, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regal, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sammond, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groneberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purkey, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marlow, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, T. P.</span><span> </span><span class="NLM_article-title">Spirocyclic β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors: From hit to lowering of cerebrospinal fluid (CSF) amyloid β in a higher species</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3379</span><span class="NLM_x">–</span> <span class="NLM_lpage">3403</span><span class="refDoi"> DOI: 10.1021/jm4002154</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4002154" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3379-3403&author=K.+W.+Huntauthor=A.+W.+Cookauthor=R.+J.+Wattsauthor=C.+T.+Clarkauthor=G.+Vigersauthor=D.+Smithauthor=A.+T.+Metcalfauthor=I.+W.+Gunawardanaauthor=M.+Burkardauthor=A.+A.+Coxauthor=M.+K.+Geck+Doauthor=D.+Dutcherauthor=A.+A.+Thomasauthor=S.+Ranaauthor=N.+C.+Kallanauthor=R.+K.+DeLisleauthor=J.+P.+Rizziauthor=K.+Regalauthor=D.+Sammondauthor=R.+Gronebergauthor=M.+Siuauthor=H.+Purkeyauthor=J.+P.+Lyssikatosauthor=A.+Marlowauthor=X.+Liuauthor=T.+P.+Tang&title=Spirocyclic+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29+inhibitors%3A+From+hit+to+lowering+of+cerebrospinal+fluid+%28CSF%29+amyloid+%CE%B2+in+a+higher+species&doi=10.1021%2Fjm4002154"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20aR"><div class="casContent"><span class="casTitleNuber">20a</span><div class="casTitle"><span class="NLM_cas:atitle">Spirocyclic β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1) Inhibitors: From Hit to Lowering of Cerebrospinal Fluid (CSF) Amyloid β in a Higher Species</span></div><div class="casAuthors">Hunt, Kevin W.; Cook, Adam W.; Watts, Ryan J.; Clark, Christopher T.; Vigers, Guy; Smith, Darin; Metcalf, Andrew T.; Gunawardana, Indrani W.; Burkard, Michael; Cox, April A.; Geck Do, Mary K.; Dutcher, Darrin; Thomas, Allen A.; Rana, Sumeet; Kallan, Nicholas C.; DeLisle, Robert K.; Rizzi, James P.; Regal, Kelly; Sammond, Douglas; Groneberg, Robert; Siu, Michael; Purkey, Hans; Lyssikatos, Joseph P.; Marlow, Allison; Liu, Xingrong; Tang, Tony P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3379-3403</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A hallmark of Alzheimer's disease is the brain deposition of amyloid beta (Aβ), a peptide of 36-43 amino acids that is likely a primary driver of neurodegeneration.  Aβ is produced by the sequential cleavage of APP by BACE1 and γ-secretase; therefore, inhibition of BACE1 represents an attractive therapeutic target to slow or prevent Alzheimer's disease.  Herein are described BACE1 inhibitors with limited mol. flexibility and mol. wt. that decrease CSF Aβ in vivo, despite efflux.  Starting with spirocycle I, the authors explore structure-activity relationships of core changes, P3 moieties, and Asp binding functional groups in order to optimize BACE1 affinity, cathepsin D selectivity, and blood-brain barrier (BBB) penetration.  Using wild type guinea pig and rat, they demonstrate a PK/PD relationship between free drug concns. in the brain and CSF Aβ lowering.  Optimization of brain exposure led to the discovery of (R)-II which reduced CSF Aβ in rodents and in monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYTaFN1ZrY-bVg90H21EOLACvtfcHk0lhIGFB1oXzzSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXkslagsLg%253D&md5=b0f610967870013abee4a4bf4ce28b7f</span></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=10.1021%2Fjm4002154&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4002154%26sid%3Dliteratum%253Aachs%26aulast%3DHunt%26aufirst%3DK.%2BW.%26aulast%3DCook%26aufirst%3DA.%2BW.%26aulast%3DWatts%26aufirst%3DR.%2BJ.%26aulast%3DClark%26aufirst%3DC.%2BT.%26aulast%3DVigers%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DMetcalf%26aufirst%3DA.%2BT.%26aulast%3DGunawardana%26aufirst%3DI.%2BW.%26aulast%3DBurkard%26aufirst%3DM.%26aulast%3DCox%26aufirst%3DA.%2BA.%26aulast%3DGeck%2BDo%26aufirst%3DM.%2BK.%26aulast%3DDutcher%26aufirst%3DD.%26aulast%3DThomas%26aufirst%3DA.%2BA.%26aulast%3DRana%26aufirst%3DS.%26aulast%3DKallan%26aufirst%3DN.%2BC.%26aulast%3DDeLisle%26aufirst%3DR.%2BK.%26aulast%3DRizzi%26aufirst%3DJ.%2BP.%26aulast%3DRegal%26aufirst%3DK.%26aulast%3DSammond%26aufirst%3DD.%26aulast%3DGroneberg%26aufirst%3DR.%26aulast%3DSiu%26aufirst%3DM.%26aulast%3DPurkey%26aufirst%3DH.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMarlow%26aufirst%3DA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DTang%26aufirst%3DT.%2BP.%26atitle%3DSpirocyclic%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520From%2520hit%2520to%2520lowering%2520of%2520cerebrospinal%2520fluid%2520%2528CSF%2529%2520amyloid%2520%25CE%25B2%2520in%2520a%2520higher%2520species%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3379%26epage%3D3403%26doi%3D10.1021%2Fjm4002154" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magolda, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pangalos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Design and synthesis of 5,5′-disubstituted aminohydantoins as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1146</span><span class="NLM_x">–</span> <span class="NLM_lpage">1158</span><span class="refDoi"> DOI: 10.1021/jm901414e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901414e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1146-1158&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=R.+Chopraauthor=A.+Ollandauthor=J.+Bardauthor=S.+Jacobsenauthor=R.+L.+Magoldaauthor=M.+Pangalosauthor=A.+J.+Robichaud&title=Design+and+synthesis+of+5%2C5%E2%80%B2-disubstituted+aminohydantoins+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm901414e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20bR"><div class="casContent"><span class="casTitleNuber">20b</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of 5,5'-Disubstituted Aminohydantoins as Potent and Selective Human β-Secretase (BACE1) Inhibitors</span></div><div class="casAuthors">Malamas, Michael S.; Erdei, Jim; Gunawan, Iwan; Turner, Jim; Hu, Yun; Wagner, Erik; Fan, Kristi; Chopra, Rajiv; Olland, Andrea; Bard, Jonathan; Jacobsen, Steve; Magolda, Ronald L.; Pangalos, Menelas; Robichaud, Albert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1146-1158</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of small mol. aminohydantoins as potent and selective human β-secretase inhibitors is reported.  These analogs exhibit low nanomolar potency for BACE1, show comparable activity in a cell-based (ELISA) assay, and demonstrate > 100 × selectivity for the other structurally related aspartyl proteases BACE2, cathepsinD, renin, and pepsin.  On the basis of the cocrystal structure of the HTS-hit I in the BACE1 active site and by use of a structure-based drug design approach, we methodically explored the comparatively large binding pocket of the BACE1 enzyme and identified key interactions between the ligand and the protein that contributed to the affinity.  One of the more potent compds., (S)-II, displayed an IC50 value for BACE1 of 10 nM and exhibited comparable cellular activity (EC50 = 20 nM) in the ELISA assay.  Acute oral administration of (S)-II at 100 mg/kg resulted in a 69% redn. of plasma Aβ40 at 8 h in a Tg2576 mouse (p < 0.001).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovSHqfBBe70bVg90H21EOLACvtfcHk0li-Yih60YvF-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFaisrzN&md5=a27e4fbd64ed167ca7baae773c178fbc</span></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=10.1021%2Fjm901414e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901414e%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DMagolda%26aufirst%3DR.%2BL.%26aulast%3DPangalos%26aufirst%3DM.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%25205%252C5%25E2%2580%25B2-disubstituted%2520aminohydantoins%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1146%26epage%3D1158%26doi%3D10.1021%2Fjm901414e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erdei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunawan, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barnes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hui, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robichaud, A. J.</span><span> </span><span class="NLM_article-title">Aminoimidazoles as potent and selective human β-secretase (BACE1) inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">6314</span><span class="NLM_x">–</span> <span class="NLM_lpage">6323</span><span class="refDoi"> DOI: 10.1021/jm9006752</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9006752" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6314-6323&author=M.+S.+Malamasauthor=J.+Erdeiauthor=I.+Gunawanauthor=K.+Barnesauthor=M.+Johnsonauthor=Y.+Huiauthor=J.+Turnerauthor=Y.+Huauthor=E.+Wagnerauthor=K.+Fanauthor=A.+Ollandauthor=J.+Bardauthor=A.+J.+Robichaud&title=Aminoimidazoles+as+potent+and+selective+human+%CE%B2-secretase+%28BACE1%29+inhibitors&doi=10.1021%2Fjm9006752"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20c&amp;dbid=16384&amp;doi=10.1021%2Fjm9006752&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9006752%26sid%3Dliteratum%253Aachs%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DErdei%26aufirst%3DJ.%26aulast%3DGunawan%26aufirst%3DI.%26aulast%3DBarnes%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DM.%26aulast%3DHui%26aufirst%3DY.%26aulast%3DTurner%26aufirst%3DJ.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DFan%26aufirst%3DK.%26aulast%3DOlland%26aufirst%3DA.%26aulast%3DBard%26aufirst%3DJ.%26aulast%3DRobichaud%26aufirst%3DA.%2BJ.%26atitle%3DAminoimidazoles%2520as%2520potent%2520and%2520selective%2520human%2520%25CE%25B2-secretase%2520%2528BACE1%2529%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6314%26epage%3D6323%26doi%3D10.1021%2Fjm9006752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Barrow, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rittle, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ngo, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simon, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sankaranarayanan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colussi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tugusheva, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, M.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Espeseth, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolfe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietrak, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levorse, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Discovery and X-ray crystallographic analysis of a spiropiperidine iminohydantoin inhibitor of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">6259</span><span class="NLM_x">–</span> <span class="NLM_lpage">6262</span><span class="refDoi"> DOI: 10.1021/jm800914n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm800914n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6259-6262&author=J.+C.+Barrowauthor=S.+R.+Staufferauthor=K.+E.+Rittleauthor=P.+L.+Ngoauthor=Z.+Yangauthor=H.+G.+Selnickauthor=S.+L.+Grahamauthor=S.+Munshiauthor=G.+B.+McGaugheyauthor=M.+K.+Hollowayauthor=A.+J.+Simonauthor=E.+A.+Priceauthor=S.+Sankaranarayananauthor=D.+Colussiauthor=K.+Tugushevaauthor=M.-T.+Laiauthor=A.+S.+Espesethauthor=M.+Xuauthor=Q.+Huangauthor=A.+Wolfeauthor=B.+Pietrakauthor=P.+Zuckauthor=D.+A.+Levorseauthor=D.+Hazudaauthor=J.+P.+Vacca&title=Discovery+and+X-ray+crystallographic+analysis+of+a+spiropiperidine+iminohydantoin+inhibitor+of+%CE%B2-secretase&doi=10.1021%2Fjm800914n"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20d&amp;dbid=16384&amp;doi=10.1021%2Fjm800914n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800914n%26sid%3Dliteratum%253Aachs%26aulast%3DBarrow%26aufirst%3DJ.%2BC.%26aulast%3DStauffer%26aufirst%3DS.%2BR.%26aulast%3DRittle%26aufirst%3DK.%2BE.%26aulast%3DNgo%26aufirst%3DP.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DMunshi%26aufirst%3DS.%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DSimon%26aufirst%3DA.%2BJ.%26aulast%3DPrice%26aufirst%3DE.%2BA.%26aulast%3DSankaranarayanan%26aufirst%3DS.%26aulast%3DColussi%26aufirst%3DD.%26aulast%3DTugusheva%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DM.-T.%26aulast%3DEspeseth%26aufirst%3DA.%2BS.%26aulast%3DXu%26aufirst%3DM.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DWolfe%26aufirst%3DA.%26aulast%3DPietrak%26aufirst%3DB.%26aulast%3DZuck%26aufirst%3DP.%26aulast%3DLevorse%26aufirst%3DD.%2BA.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DDiscovery%2520and%2520X-ray%2520crystallographic%2520analysis%2520of%2520a%2520spiropiperidine%2520iminohydantoin%2520inhibitor%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D6259%26epage%3D6262%26doi%3D10.1021%2Fjm800914n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Cole, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manas, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condon, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, L. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aulabaugh, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chopra, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowling, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellingboe, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, K. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovering, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malamas, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahl, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strand, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sukhdeo, M. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bard, J.</span><span> </span><span class="NLM_article-title">Acylguanidines as small-molecule β-secretase inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6158</span><span class="NLM_x">–</span> <span class="NLM_lpage">6161</span><span class="refDoi"> DOI: 10.1021/jm0607451</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0607451" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6158-6161&author=D.+C.+Coleauthor=E.+S.+Manasauthor=J.+R.+Stockauthor=J.+S.+Condonauthor=L.+D.+Jenningsauthor=A.+Aulabaughauthor=R.+Chopraauthor=R.+Cowlingauthor=J.+W.+Ellingboeauthor=K.+Y.+Fanauthor=B.+L.+Harrisonauthor=Y.+Huauthor=S.+Jacobsenauthor=G.+Jinauthor=L.+Linauthor=F.+E.+Loveringauthor=M.+S.+Malamasauthor=M.+L.+Stahlauthor=J.+Strandauthor=M.+N.+Sukhdeoauthor=K.+Svensonauthor=M.+J.+Turnerauthor=E.+Wagnerauthor=J.+Wuauthor=P.+Zhouauthor=J.+Bard&title=Acylguanidines+as+small-molecule+%CE%B2-secretase+inhibitors&doi=10.1021%2Fjm0607451"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20e&amp;dbid=16384&amp;doi=10.1021%2Fjm0607451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0607451%26sid%3Dliteratum%253Aachs%26aulast%3DCole%26aufirst%3DD.%2BC.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DStock%26aufirst%3DJ.%2BR.%26aulast%3DCondon%26aufirst%3DJ.%2BS.%26aulast%3DJennings%26aufirst%3DL.%2BD.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DChopra%26aufirst%3DR.%26aulast%3DCowling%26aufirst%3DR.%26aulast%3DEllingboe%26aufirst%3DJ.%2BW.%26aulast%3DFan%26aufirst%3DK.%2BY.%26aulast%3DHarrison%26aufirst%3DB.%2BL.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DJacobsen%26aufirst%3DS.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLovering%26aufirst%3DF.%2BE.%26aulast%3DMalamas%26aufirst%3DM.%2BS.%26aulast%3DStahl%26aufirst%3DM.%2BL.%26aulast%3DStrand%26aufirst%3DJ.%26aulast%3DSukhdeo%26aufirst%3DM.%2BN.%26aulast%3DSvenson%26aufirst%3DK.%26aulast%3DTurner%26aufirst%3DM.%2BJ.%26aulast%3DWagner%26aufirst%3DE.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DBard%26aufirst%3DJ.%26atitle%3DAcylguanidines%2520as%2520small-molecule%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6158%26epage%3D6161%26doi%3D10.1021%2Fjm0607451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Baxter, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conway, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennis, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bischoff, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mercken, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Winter, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynolds, C. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tounge, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braeken, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pieters, S. M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berthelot, D. J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Masure, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruinzeel, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brenneman, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reitz, A. B.</span><span> </span><span class="NLM_article-title">2-Amino-3,4 dihydroquinazolines as inhibitors of BACE-1 (β-Site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar lead</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">4161</span><span class="NLM_x">–</span> <span class="NLM_lpage">4264</span><span class="refDoi"> DOI: 10.1021/jm0705408</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0705408" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=4161-4264&author=E.+W.+Baxterauthor=K.+A.+Conwayauthor=L.+Kennisauthor=F.+Bischoffauthor=M.+H.+Merckenauthor=H.+L.+De+Winterauthor=C.+H.+Reynoldsauthor=B.+A.+Toungeauthor=C.+Luoauthor=M.+K.+Scottauthor=Y.+Huangauthor=M.+Braekenauthor=S.+M.+A.+Pietersauthor=D.+J.+C.+Berthelotauthor=S.+Masureauthor=W.+D.+Bruinzeelauthor=A.+D.+Jordanauthor=M.+H.+Parkerauthor=R.+E.+Boydauthor=J.+Quauthor=R.+S.+Alexanderauthor=D.+E.+Brennemanauthor=A.+B.+Reitz&title=2-Amino-3%2C4+dihydroquinazolines+as+inhibitors+of+BACE-1+%28%CE%B2-Site+APP+cleaving+enzyme%29%3A+Use+of+structure+based+design+to+convert+a+micromolar+hit+into+a+nanomolar+lead&doi=10.1021%2Fjm0705408"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20f&amp;dbid=16384&amp;doi=10.1021%2Fjm0705408&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0705408%26sid%3Dliteratum%253Aachs%26aulast%3DBaxter%26aufirst%3DE.%2BW.%26aulast%3DConway%26aufirst%3DK.%2BA.%26aulast%3DKennis%26aufirst%3DL.%26aulast%3DBischoff%26aufirst%3DF.%26aulast%3DMercken%26aufirst%3DM.%2BH.%26aulast%3DDe%2BWinter%26aufirst%3DH.%2BL.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26aulast%3DTounge%26aufirst%3DB.%2BA.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DScott%26aufirst%3DM.%2BK.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DBraeken%26aufirst%3DM.%26aulast%3DPieters%26aufirst%3DS.%2BM.%2BA.%26aulast%3DBerthelot%26aufirst%3DD.%2BJ.%2BC.%26aulast%3DMasure%26aufirst%3DS.%26aulast%3DBruinzeel%26aufirst%3DW.%2BD.%26aulast%3DJordan%26aufirst%3DA.%2BD.%26aulast%3DParker%26aufirst%3DM.%2BH.%26aulast%3DBoyd%26aufirst%3DR.%2BE.%26aulast%3DQu%26aufirst%3DJ.%26aulast%3DAlexander%26aufirst%3DR.%2BS.%26aulast%3DBrenneman%26aufirst%3DD.%2BE.%26aulast%3DReitz%26aufirst%3DA.%2BB.%26atitle%3D2-Amino-3%252C4%2520dihydroquinazolines%2520as%2520inhibitors%2520of%2520BACE-1%2520%2528%25CE%25B2-Site%2520APP%2520cleaving%2520enzyme%2529%253A%2520Use%2520of%2520structure%2520based%2520design%2520to%2520convert%2520a%2520micromolar%2520hit%2520into%2520a%2520nanomolar%2520lead%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D4161%26epage%3D4264%26doi%3D10.1021%2Fjm0705408" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleasby, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartshorn, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1116</span><span class="NLM_x">–</span> <span class="NLM_lpage">1123</span><span class="refDoi"> DOI: 10.1021/jm0611962</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0611962" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1116-1123&author=C.+W.+Murrayauthor=O.+Callaghanauthor=G.+Chessariauthor=A.+Cleasbyauthor=M.+Congreveauthor=M.+Fredericksonauthor=M.+J.+Hartshornauthor=R.+McMenaminauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+%CE%B2-secretase&doi=10.1021%2Fjm0611962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20gR"><div class="casContent"><span class="casTitleNuber">20g</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to β-Secretase</span></div><div class="casAuthors">Murray, Christopher W.; Callaghan, Owen; Chessari, Gianni; Cleasby, Anne; Congreve, Miles; Frederickson, Martyn; Hartshorn, Michael J.; McMenamin, Rachel; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1116-1123</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This paper describes an application of fragment screening to the aspartyl protease enzyme, β-secretase (BACE-1), using high throughput x-ray crystallog.  Three distinct chemotypes were identified by X-ray crystallog. as binding to the catalytic aspartates either via an aminoheterocycle (such as 2-aminoquinoline), a piperidine, or an aliph. hydroxyl group.  The fragment hits were weak inhibitors of BACE-1 in the millimolar range but were of interest because most of them displayed relatively good ligand efficiencies.  The aminoheterocycles exhibited a novel recognition motif that has not been seen before with aspartic proteases.  Virtual screening around this motif identified an aminopyridine with increased potency and attractive growth points for further elaboration using structure-based drug design.  The companion paper illustrates how sub-micromolar inhibitors were developed starting from this fragment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxZHjESbj93LVg90H21EOLACvtfcHk0lgJC8PB-5ivEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7o%253D&md5=1ff92bcf5bcb8f265709e3571e25ae8e</span></div><a href="/servlet/linkout?suffix=cit20g&amp;dbid=16384&amp;doi=10.1021%2Fjm0611962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0611962%26sid%3Dliteratum%253Aachs%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCleasby%26aufirst%3DA.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DHartshorn%26aufirst%3DM.%2BJ.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1116%26epage%3D1123%26doi%3D10.1021%2Fjm0611962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMenamin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallis, N.</span><span> </span><span class="NLM_article-title">Application of fragment screening by X-ray crystallography to the discovery of aminopyridines as inhibitors of β-secretase</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1124</span><span class="NLM_x">–</span> <span class="NLM_lpage">1132</span><span class="refDoi"> DOI: 10.1021/jm061197u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061197u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20h&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhvFags7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1124-1132&author=M.+Congreveauthor=D.+Aharonyauthor=J.+Albertauthor=O.+Callaghanauthor=J.+Campbellauthor=R.+A.+E.+Carrauthor=G.+Chessariauthor=S.+Cowanauthor=P.+D.+Edwardsauthor=M.+Fredericksonauthor=R.+McMenaminauthor=C.+W.+Murrayauthor=S.+Patelauthor=N.+Wallis&title=Application+of+fragment+screening+by+X-ray+crystallography+to+the+discovery+of+aminopyridines+as+inhibitors+of+%CE%B2-secretase&doi=10.1021%2Fjm061197u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20hR"><div class="casContent"><span class="casTitleNuber">20h</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Fragment Screening by X-ray Crystallography to the Discovery of Aminopyridines as Inhibitors of β-Secretase</span></div><div class="casAuthors">Congreve, Miles; Aharony, David; Albert, Jeffrey; Callaghan, Owen; Campbell, James; Carr, Robin A. E.; Chessari, Gianni; Cowan, Suzanna; Edwards, Philip D.; Frederickson, Martyn; McMenamin, Rachel; Murray, Christopher W.; Patel, Sahil; Wallis, Nicola</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1124-1132</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead discovery has been successfully applied to the aspartyl protease enzyme β-secretase (BACE-1).  Fragment hits that contained an aminopyridine motif binding to the two catalytic aspartic acid residues in the active site of the enzyme were the chem. starting points.  Structure-based design approaches have led to identification of low micromolar lead compds. that retain these interactions and addnl. occupy adjacent hydrophobic pockets of the active site.  These leads form two subseries, for which compds. 4 (IC50 = 25 μM) and 6c (IC50 = 24 μM) are representative.  In the latter series, further optimization has led to 8a (IC50 = 690 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsyK6i2PI7CLVg90H21EOLACvtfcHk0liKccSUglihkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhvFags7s%253D&md5=a96f52c59266cacdb25189535fce1e47</span></div><a href="/servlet/linkout?suffix=cit20h&amp;dbid=16384&amp;doi=10.1021%2Fjm061197u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061197u%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAlbert%26aufirst%3DJ.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%26aulast%3DCarr%26aufirst%3DR.%2BA.%2BE.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCowan%26aufirst%3DS.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DMcMenamin%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DWallis%26aufirst%3DN.%26atitle%3DApplication%2520of%2520fragment%2520screening%2520by%2520X-ray%2520crystallography%2520to%2520the%2520discovery%2520of%2520aminopyridines%2520as%2520inhibitors%2520of%2520%25CE%25B2-secretase%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1124%26epage%3D1132%26doi%3D10.1021%2Fjm061197u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20i"><span><span class="NLM_label">(i) </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deinum, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Beer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span> </span><span class="NLM_article-title">Discovery of a novel warhead against β-secretase through fragment-based lead generation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5903</span><span class="NLM_x">–</span> <span class="NLM_lpage">5911</span><span class="refDoi"> DOI: 10.1021/jm070825k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070825k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20i&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5903-5911&author=S.+Geschwindnerauthor=L.-L.+Olssonauthor=J.+S.+Albertauthor=J.+Deinumauthor=P.+D.+Edwardsauthor=T.+de+Beerauthor=R.+H.+A.+Folmer&title=Discovery+of+a+novel+warhead+against+%CE%B2-secretase+through+fragment-based+lead+generation&doi=10.1021%2Fjm070825k"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20iR"><div class="casContent"><span class="casTitleNuber">20i</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Novel Warhead against β-Secretase through Fragment-Based Lead Generation</span></div><div class="casAuthors">Geschwindner, Stefan; Olsson, Lise-Lotte; Albert, Jeffrey S.; Deinum, Johanna; Edwards, Philip D.; de Beer, Tonny; Folmer, Rutger H. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5903-5911</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation was applied to find novel small-mol. inhibitors of β-secretase (BACE-1), a key target for the treatment of Alzheimer's disease.  Fragment hits coming from a 1D NMR screen were characterized by BIAcore, and the most promising compds. were soaked into protein crystals to help the rational design of more potent hit analogs.  Problems arising due to the inability to grow BACE-1 crystals at the biol. relevant pH at which the screen was run were overcome by using endothiapepsin as a surrogate aspartyl protease.  Among others, the authors identified 6-substituted isocytosines as a novel warhead against BACE-1, and the accompanying paper in this journal describes how these were optimized to a lead series of nanomolar inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmfboHMnD47LVg90H21EOLACvtfcHk0liKccSUglihkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrrJ&md5=01266da7a1bf718ca06fe5bd9c925b7c</span></div><a href="/servlet/linkout?suffix=cit20i&amp;dbid=16384&amp;doi=10.1021%2Fjm070825k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070825k%26sid%3Dliteratum%253Aachs%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DDeinum%26aufirst%3DJ.%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3Dde%2BBeer%26aufirst%3DT.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26atitle%3DDiscovery%2520of%2520a%2520novel%2520warhead%2520against%2520%25CE%25B2-secretase%2520through%2520fragment-based%2520lead%2520generation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5903%26epage%3D5911%26doi%3D10.1021%2Fjm070825k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Edwards, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albert, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sylvester, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aharony, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andisik, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callaghan, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chessari, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frederickson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Folmer, R. H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geschwindner, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koether, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krumrine, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauger, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spear, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tian, G.</span><span> </span><span class="NLM_article-title">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5925</span><span class="refDoi"> DOI: 10.1021/jm070829p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070829p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20j&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5912-5925&author=P.+D.+Edwardsauthor=J.+S.+Albertauthor=M.+Sylvesterauthor=D.+Aharonyauthor=D.+Andisikauthor=O.+Callaghanauthor=J.+B.+Campbellauthor=R.+A.+Carrauthor=G.+Chessariauthor=M.+Congreveauthor=M.+Fredericksonauthor=R.+H.+A.+Folmerauthor=S.+Geschwindnerauthor=G.+Koetherauthor=K.+Kolmodinauthor=J.+Krumrineauthor=R.+C.+Maugerauthor=C.+W.+Murrayauthor=L.-L.+Olssonauthor=S.+Patelauthor=N.+Spearauthor=G.+Tian&title=Application+of+fragment-based+lead+generation+to+the+discovery+of+novel%2C+cyclic+amidine+%CE%B2-secretase+inhibitors+with+nanomolar+potency%2C+cellular+activity%2C+and+high+ligand+efficiency&doi=10.1021%2Fjm070829p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20jR"><div class="casContent"><span class="casTitleNuber">20j</span><div class="casTitle"><span class="NLM_cas:atitle">Application of fragment-based lead generation to the discovery of novel, cyclic amidine β-secretase inhibitors with nanomolar potency, cellular activity, and high ligand efficiency</span></div><div class="casAuthors">Edwards, Philip D.; Albert, Jeffrey S.; Sylvester, Mark; Aharony, David; Andisik, Donald; Callaghan, Owen; Campbell, James B.; Carr, Robin A.; Chessari, Gianni; Congreve, Miles; Frederickson, Martyn; Folmer, Rutger H. A.; Geschwindner, Stefan; Koether, Gerard; Kolmodin, Karin; Krumrine, Jennifer; Mauger, Russell C.; Murray, Christopher W.; Olsson, Lise-Lotte; Patel, Sahil; Spear, Nate; Tian, Gaochao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">5912-5925</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fragment-based lead generation has led to the discovery of a novel series of cyclic amidine-based inhibitors of β-secretase (BACE-1).  Initial fragment hits with an isocytosine core having millimolar potency were identified via NMR affinity screening.  Structure-guided evolution of these fragments using x-ray crystallog. together with potency detn. using surface plasmon resonance and functional enzyme inhibition assays afforded micromolar inhibitors.  Similarity searching around the isocytosine core led to the identification of a related series of inhibitors, the dihydroisocytosines.  By leveraging the knowledge of the ligand-BACE-1 recognition features generated from the isocytosines, the dihydroisocytosines were efficiently optimized to submicromolar potency.  Compd. (I), with an IC50 of 80 nM, a ligand efficiency of 0.37, and cellular activity of 470 nM, emerged as the lead structure for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmm71A2gRltrVg90H21EOLACvtfcHk0liKccSUglihkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1KitrbP&md5=140f3ade2b7754f62eb73589c5de4d7b</span></div><a href="/servlet/linkout?suffix=cit20j&amp;dbid=16384&amp;doi=10.1021%2Fjm070829p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070829p%26sid%3Dliteratum%253Aachs%26aulast%3DEdwards%26aufirst%3DP.%2BD.%26aulast%3DAlbert%26aufirst%3DJ.%2BS.%26aulast%3DSylvester%26aufirst%3DM.%26aulast%3DAharony%26aufirst%3DD.%26aulast%3DAndisik%26aufirst%3DD.%26aulast%3DCallaghan%26aufirst%3DO.%26aulast%3DCampbell%26aufirst%3DJ.%2BB.%26aulast%3DCarr%26aufirst%3DR.%2BA.%26aulast%3DChessari%26aufirst%3DG.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DFrederickson%26aufirst%3DM.%26aulast%3DFolmer%26aufirst%3DR.%2BH.%2BA.%26aulast%3DGeschwindner%26aufirst%3DS.%26aulast%3DKoether%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKrumrine%26aufirst%3DJ.%26aulast%3DMauger%26aufirst%3DR.%2BC.%26aulast%3DMurray%26aufirst%3DC.%2BW.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DSpear%26aufirst%3DN.%26aulast%3DTian%26aufirst%3DG.%26atitle%3DApplication%2520of%2520fragment-based%2520lead%2520generation%2520to%2520the%2520discovery%2520of%2520novel%252C%2520cyclic%2520amidine%2520%25CE%25B2-secretase%2520inhibitors%2520with%2520nanomolar%2520potency%252C%2520cellular%2520activity%252C%2520and%2520high%2520ligand%2520efficiency%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5912%26epage%3D5925%26doi%3D10.1021%2Fjm070829p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louie, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Michelsen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nixey, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rattan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sickmier, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Jean, D. J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">From fragment screening to <i>In Vivo</i> efficacy: optimization of a series of 2-aminoquinolines as potent inhibitors of beta-site amyloid precursor protein cleaving enzyme 1 (BACE1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5836</span><span class="NLM_x">–</span> <span class="NLM_lpage">5857</span><span class="refDoi"> DOI: 10.1021/jm200544q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200544q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20k&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5836-5857&author=Y.+Chengauthor=T.+C.+Juddauthor=M.+D.+Bartbergerauthor=J.+Brownauthor=K.+Chenauthor=R.+T.+Fremeauauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=B.+Jordanauthor=V.+Liauthor=P.+Lopezauthor=S.+W.+Louieauthor=Y.+Luoauthor=K.+Michelsenauthor=T.+Nixeyauthor=T.+S.+Powersauthor=C.+Rattanauthor=E.+A.+Sickmierauthor=D.+J.+St.+Jeanauthor=R.+C.+Wahlauthor=P.+H.+Wenauthor=S.+Wood&title=From+fragment+screening+to+In+Vivo+efficacy%3A+optimization+of+a+series+of+2-aminoquinolines+as+potent+inhibitors+of+beta-site+amyloid+precursor+protein+cleaving+enzyme+1+%28BACE1%29&doi=10.1021%2Fjm200544q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20kR"><div class="casContent"><span class="casTitleNuber">20k</span><div class="casTitle"><span class="NLM_cas:atitle">From Fragment Screening to In Vivo Efficacy: Optimization of a Series of 2-Aminoquinolines as Potent Inhibitors of Beta-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE1)</span></div><div class="casAuthors">Cheng, Yuan; Judd, Ted C.; Bartberger, Michael D.; Brown, James; Chen, Kui; Fremeau, Robert T.; Hickman, Dean; Hitchcock, Stephen A.; Jordan, Brad; Li, Vivian; Lopez, Patricia; Louie, Steven W.; Luo, Yi; Michelsen, Klaus; Nixey, Thomas; Powers, Timothy S.; Rattan, Claire; Sickmier, E. Allen; St. Jean, David J.; Wahl, Robert C.; Wen, Paul H.; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5836-5857</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Using fragment-based screening of a focused fragment library, 2-aminoquinoline 1 was identified as an initial hit for BACE1.  Further SAR development was supported by X-ray structures of BACE1 cocrystd. with various ligands and mol. modeling studies to expedite the discovery of potent compds.  These strategies enabled us to integrate the C-3 side chain on 2-aminoquinoline 1 extending deep into the P2' binding pocket of BACE1 and enhancing the ligand's potency.  We were able to improve the BACE1 potency to subnanomolar range, over 106-fold more potent than the initial hit (900 μM).  Further elaboration of the phys. properties of the lead compds. to those more consistent with good blood-brain barrier permeability led to inhibitors with greatly improved cellular activity and permeability.  Compd. 59 showed an IC50 value of 11 nM on BACE1 and cellular activity of 80 nM.  This compd. was advanced into rat pharmacokinetic and pharmacodynamic studies and demonstrated significant redn. of Aβ levels in cerebrospinal fluid (CSF).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLRGyUyxO1fLVg90H21EOLACvtfcHk0lj8SjEcZJtuYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsFSksrk%253D&md5=fa0f2b9b7524a1c3b75e162801f54d90</span></div><a href="/servlet/linkout?suffix=cit20k&amp;dbid=16384&amp;doi=10.1021%2Fjm200544q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200544q%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DJordan%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DV.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DLouie%26aufirst%3DS.%2BW.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DNixey%26aufirst%3DT.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DRattan%26aufirst%3DC.%26aulast%3DSickmier%26aufirst%3DE.%2BA.%26aulast%3DSt.%2BJean%26aufirst%3DD.%2BJ.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DFrom%2520fragment%2520screening%2520to%2520In%2520Vivo%2520efficacy%253A%2520optimization%2520of%2520a%2520series%2520of%25202-aminoquinolines%2520as%2520potent%2520inhibitors%2520of%2520beta-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%25201%2520%2528BACE1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5836%26epage%3D5857%26doi%3D10.1021%2Fjm200544q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Ginman, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viklund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malmstroem, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blid, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emond, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forsblom, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lake, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sehgelmeble, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sterky, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindgren, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faelting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gravenfors, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahm, F.</span><span> </span><span class="NLM_article-title">Core refinement toward permeable β secretase (BACE-1) inhibitors with low hERG activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4181</span><span class="NLM_x">–</span> <span class="NLM_lpage">4205</span><span class="refDoi"> DOI: 10.1021/jm3011349</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3011349" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4181-4205&author=T.+Ginmanauthor=J.+Viklundauthor=J.+Malmstroemauthor=J.+Blidauthor=R.+Emondauthor=R.+Forsblomauthor=A.+Johanssonauthor=A.+Kersauthor=F.+Lakeauthor=F.+Sehgelmebleauthor=K.+J.+Sterkyauthor=M.+Berghauthor=A.+Lindgrenauthor=P.+Johanssonauthor=F.+Jeppssonauthor=J.+Faeltingauthor=Y.+Gravenforsauthor=F.+Rahm&title=Core+refinement+toward+permeable+%CE%B2+secretase+%28BACE-1%29+inhibitors+with+low+hERG+activity&doi=10.1021%2Fjm3011349"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20l&amp;dbid=16384&amp;doi=10.1021%2Fjm3011349&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3011349%26sid%3Dliteratum%253Aachs%26aulast%3DGinman%26aufirst%3DT.%26aulast%3DViklund%26aufirst%3DJ.%26aulast%3DMalmstroem%26aufirst%3DJ.%26aulast%3DBlid%26aufirst%3DJ.%26aulast%3DEmond%26aufirst%3DR.%26aulast%3DForsblom%26aufirst%3DR.%26aulast%3DJohansson%26aufirst%3DA.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DLake%26aufirst%3DF.%26aulast%3DSehgelmeble%26aufirst%3DF.%26aulast%3DSterky%26aufirst%3DK.%2BJ.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DLindgren%26aufirst%3DA.%26aulast%3DJohansson%26aufirst%3DP.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DFaelting%26aufirst%3DJ.%26aulast%3DGravenfors%26aufirst%3DY.%26aulast%3DRahm%26aufirst%3DF.%26atitle%3DCore%2520refinement%2520toward%2520permeable%2520%25CE%25B2%2520secretase%2520%2528BACE-1%2529%2520inhibitors%2520with%2520low%2520hERG%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4181%26epage%3D4205%26doi%3D10.1021%2Fjm3011349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Tamura, Y.; Suzuki, S.; Tada, Y.; Yonezawa, S.; Fujikoshi, C.; Matsumoto, S.; Kooriyama, Y.; Ueno, T.</span><span> </span><span class="NLM_article-title">Preparation of aminodihydrothiazine derivatives as BACE1 inhibitors</span>. PCT Int. Appl. WO 2008133274,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Tamura&author=S.+Suzuki&author=Y.+Tada&author=S.+Yonezawa&author=C.+Fujikoshi&author=S.+Matsumoto&author=Y.+Kooriyama&author=T.+Ueno&title=Preparation+of+aminodihydrothiazine+derivatives+as+BACE1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20m&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTamura%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520aminodihydrothiazine%2520derivatives%2520as%2520BACE1%2520inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Suzuki, Y.; Motoki, T.; Kaneko, T.; Takaishi, M.; Ishida, T.; Takeda, K.; Kita, Y.; Yamamoto, N.; Khan, A.; Dimopoulos, P.</span><span> </span><span class="NLM_article-title">Preparation of condensed aminodihydrothiazine derivatives as inhibitors of β-site APP-cleaving enzyme 1 (BACE1)</span>. PCT Int. Appl. WO 2009091016,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=Y.+Suzuki&author=T.+Motoki&author=T.+Kaneko&author=M.+Takaishi&author=T.+Ishida&author=K.+Takeda&author=Y.+Kita&author=N.+Yamamoto&author=A.+Khan&author=P.+Dimopoulos&title=Preparation+of+condensed+aminodihydrothiazine+derivatives+as+inhibitors+of+%CE%B2-site+APP-cleaving+enzyme+1+%28BACE1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20n&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSuzuki%26aufirst%3DY.%26atitle%3DPreparation%2520of%2520condensed%2520aminodihydrothiazine%2520derivatives%2520as%2520inhibitors%2520of%2520%25CE%25B2-site%2520APP-cleaving%2520enzyme%25201%2520%2528BACE1%2529%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Mandal, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, J. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leach, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grzelak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terracina, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuvelkar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favreau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Orth, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buevich, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Voigt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kazakevich, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKittrick, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9331</span><span class="NLM_x">–</span> <span class="NLM_lpage">9345</span><span class="refDoi"> DOI: 10.1021/jm301039c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301039c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9331-9345&author=M.+Mandalauthor=Z.+Zhuauthor=J.+N.+Cummingauthor=X.+Liuauthor=C.+Stricklandauthor=R.+D.+Mazzolaauthor=J.+P.+Caldwellauthor=P.+Leachauthor=M.+Grzelakauthor=L.+Hydeauthor=Q.+Zhangauthor=G.+Terracinaauthor=L.+Zhangauthor=X.+Chenauthor=R.+Kuvelkarauthor=M.+E.+Kennedyauthor=L.+Favreauauthor=K.+Coxauthor=P.+Orthauthor=A.+Buevichauthor=J.+Voigtauthor=H.+Wangauthor=I.+Kazakevichauthor=B.+A.+McKittrickauthor=W.+Greenleeauthor=E.+M.+Parkerauthor=A.+W.+Stamford&title=Design+and+validation+of+bicyclic+iminopyrimidinones+as+beta+amyloid+cleaving+enzyme-1+%28BACE1%29+inhibitors%3A+conformational+constraint+to+favor+a+bioactive+conformation&doi=10.1021%2Fjm301039c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Validation of Bicyclic Iminopyrimidinones As Beta Amyloid Cleaving Enzyme-1 (BACE1) Inhibitors: Conformational Constraint to Favor a Bioactive Conformation</span></div><div class="casAuthors">Mandal, Mihirbaran; Zhu, Zhaoning; Cumming, Jared N.; Liu, Xiaoxiang; Strickland, Corey; Mazzola, Robert D.; Caldwell, John P.; Leach, Prescott; Grzelak, Michael; Hyde, Lynn; Zhang, Qi; Terracina, Giuseppe; Zhang, Lili; Chen, Xia; Kuvelkar, Reshma; Kennedy, Matthew E.; Favreau, Leonard; Cox, Kathleen; Orth, Peter; Buevich, Alexei; Voigt, Johannes; Wang, Hongwu; Kazakevich, Irina; McKittrick, Brian A.; Greenlee, William; Parker, Eric M.; Stamford, Andrew W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9331-9345</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of our observation that the biaryl substituent of iminopyrimidinone 7 must be in a pseudoaxial conformation to occupy the contiguous S1-S3 subsites of BACE1, we have designed a novel fused bicyclic iminopyrimidinone scaffold intended to favor this bioactive conformation.  Strategic incorporation of a nitrogen atom in the new constrained ring allowed us to develop SAR around the S2' binding pocket and ultimately resulted in analogs with low nanomolar potency for BACE1.  In particular, optimization of the prime side substituent led to major improvements in potency by displacement of two conserved water mols. from a region near S2'.  Further optimization of the pharmacokinetic properties of this fused pyrrolidine series, in conjunction with facile access to a rat pharmacodynamic model, led to identification of compd. 43, which is an orally active, brain penetrant inhibitor that reduces Aβ40 in the plasma, CSF, and cortex of rats in a dose-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprlJsgY-3wuLVg90H21EOLACvtfcHk0lhpwZ9KHhkyNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktb%252FP&md5=6fd0bc5ac847ded7e235939594d4b20d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm301039c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301039c%26sid%3Dliteratum%253Aachs%26aulast%3DMandal%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DCumming%26aufirst%3DJ.%2BN.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMazzola%26aufirst%3DR.%2BD.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DLeach%26aufirst%3DP.%26aulast%3DGrzelak%26aufirst%3DM.%26aulast%3DHyde%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DQ.%26aulast%3DTerracina%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DKuvelkar%26aufirst%3DR.%26aulast%3DKennedy%26aufirst%3DM.%2BE.%26aulast%3DFavreau%26aufirst%3DL.%26aulast%3DCox%26aufirst%3DK.%26aulast%3DOrth%26aufirst%3DP.%26aulast%3DBuevich%26aufirst%3DA.%26aulast%3DVoigt%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DKazakevich%26aufirst%3DI.%26aulast%3DMcKittrick%26aufirst%3DB.%2BA.%26aulast%3DGreenlee%26aufirst%3DW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DDesign%2520and%2520validation%2520of%2520bicyclic%2520iminopyrimidinones%2520as%2520beta%2520amyloid%2520cleaving%2520enzyme-1%2520%2528BACE1%2529%2520inhibitors%253A%2520conformational%2520constraint%2520to%2520favor%2520a%2520bioactive%2520conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9331%26epage%3D9345%26doi%3D10.1021%2Fjm301039c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martenyi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith LaBell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greg Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Friedrich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Citron, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span> </span><span class="NLM_article-title">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">16507</span><span class="NLM_x">–</span> <span class="NLM_lpage">16516</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.3647-11.2011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1523%2FJNEUROSCI.3647-11.2011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22090477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2011&pages=16507-16516&author=P.+C.+Mayauthor=R.+A.+Deanauthor=S.+L.+Loweauthor=F.+Martenyiauthor=S.+M.+Sheehanauthor=L.+N.+Boggsauthor=S.+A.+Monkauthor=B.+M.+Mathesauthor=D.+J.+Mergottauthor=B.+M.+Watsonauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=E.+Smith+LaBellauthor=C.+R.+Gonzalesauthor=M.+Nakanoauthor=S.+S.+Jheeauthor=M.+Yenauthor=L.+Ereshefskyauthor=T.+D.+Lindstromauthor=D.+O.+Calligaroauthor=P.+J.+Cockeauthor=D.+Greg+Hallauthor=S.+Friedrichauthor=M.+Citronauthor=J.+E.+Audia&title=Robust+central+reduction+of+amyloid-%CE%B2+in+humans+with+an+orally+available%2C+non-peptidic+%CE%B2-secretase+inhibitor&doi=10.1523%2FJNEUROSCI.3647-11.2011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22aR"><div class="casContent"><span class="casTitleNuber">22a</span><div class="casTitle"><span class="NLM_cas:atitle">Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor</span></div><div class="casAuthors">May, Patrick C.; Dean, Robert A.; Lowe, Stephen L.; Martenyi, Ferenc; Sheehan, Scott M.; Boggs, Leonard N.; Monk, Scott A.; Mathes, Brian M.; Mergott, Dustin J.; Watson, Brian M.; Stout, Stephanie L.; Timm, David E.; LaBell, Elizabeth Smith; Gonzales, Celedon R.; Nakano, Masako; Jhee, Stanford S.; Yen, Mark; Ereshefsky, Larry; Lindstrom, Terry D.; Calligaro, David O.; Cocke, Patrick J.; Hall, D. Greg; Friedrich, Stuart; Citron, Martin; Audia, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">16507-16516</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">According to the amyloid cascade hypothesis, cerebral deposition of amyloid-β peptide (Aβ) is crit. for Alzheimer's disease (AD) pathogenesis.  Aβ generation is initiated when β-secretase (BACE1) cleaves the amyloid precursor protein.  For more than a decade, BACE1 has been a prime target for designing drugs to prevent or treat AD.  However, development of such agents has turned out to be extremely challenging, with major hurdles in cell penetration, oral bioavailability/metabolic clearance, and brain access.  Using a fragment-based chem. strategy, we have generated LY2811376 [(S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine], the first orally available non-peptidic BACE1 inhibitor that produces profound Aβ-lowering effects in animals.  The biomarker changes obtained in preclin. animal models translate into man at doses of LY2811376 that were safe and well tolerated in healthy volunteers.  Prominent and long-lasting Aβ redns. in lumbar CSF were measured after oral dosing of 30 or 90 mg of LY2811376.  This represents the first translation of BACE1-driven biomarker changes in CNS from preclin. animal models to man.  Because of toxicol. findings identified in longer-term preclin. studies, this compd. is no longer progressing in clin. development.  However, BACE1 remains a viable target because the adverse effects reported here were recapitulated in LY2811376-treated BACE1 KO mice and thus are unrelated to BACE1 inhibition.  The magnitude and duration of central Aβ redn. obtainable with BACE1 inhibition positions this protease as a tractable small-mol. target through which to test the amyloid hypothesis in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqns_TvT2bZrVg90H21EOLACvtfcHk0lhpwZ9KHhkyNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFaksL7F&md5=8f21f91ebd77e5fcf8b58b51c73a1a6b</span></div><a href="/servlet/linkout?suffix=cit22a&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3647-11.2011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3647-11.2011%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DMartenyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DSmith%2BLaBell%26aufirst%3DE.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DYen%26aufirst%3DM.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DGreg%2BHall%26aufirst%3DD.%26aulast%3DFriedrich%26aufirst%3DS.%26aulast%3DCitron%26aufirst%3DM.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26atitle%3DRobust%2520central%2520reduction%2520of%2520amyloid-%25CE%25B2%2520in%2520humans%2520with%2520an%2520orally%2520available%252C%2520non-peptidic%2520%25CE%25B2-secretase%2520inhibitor%26jtitle%3DJ.%2520Neurosci.%26date%3D2011%26volume%3D31%26spage%3D16507%26epage%3D16516%26doi%3D10.1523%2FJNEUROSCI.3647-11.2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gustavsson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ploeger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cebers, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bueters, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of alzheimer disease</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">287</span><span class="NLM_x">, </span> <span class="NLM_fpage">41245</span><span class="NLM_x">–</span> <span class="NLM_lpage">41257</span><span class="refDoi"> DOI: 10.1074/jbc.M112.409110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1074%2Fjbc.M112.409110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23048024" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=41245-41257&author=F.+Jeppssonauthor=S.+Eketj%C3%A4llauthor=J.+Jansonauthor=S.+Karlstr%C3%B6mauthor=S.+Gustavssonauthor=L.-L.+Olssonauthor=A.-C.+Rades%C3%A4terauthor=B.+Ploegerauthor=G.+Cebersauthor=K.+Kolmodinauthor=B.-M.+Swahnauthor=S.+von+Bergauthor=T.+Buetersauthor=J.+F%C3%A4lting&title=Discovery+of+AZD3839%2C+a+potent+and+selective+BACE1+inhibitor+clinical+candidate+for+the+treatment+of+alzheimer+disease&doi=10.1074%2Fjbc.M112.409110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22bR"><div class="casContent"><span class="casTitleNuber">22b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of AZD3839, a Potent and Selective BACE1 Inhibitor Clinical Candidate for the Treatment of Alzheimer Disease</span></div><div class="casAuthors">Jeppsson, Fredrik; Eketjaell, Susanna; Janson, Juliette; Karlstroem, Sofia; Gustavsson, Susanne; Olsson, Lise-Lotte; Radesaeter, Ann-Cathrine; Ploeger, Bart; Cebers, Gvido; Kolmodin, Karin; Swahn, Britt-Marie; von Berg, Stefan; Bueters, Tjerk; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">41245-41257</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Site amyloid precursor protein cleaving enzyme 1 (BACE1) is one of the key enzymes involved in the processing of the amyloid precursor protein (APP) and formation of amyloid β peptide (Aβ) species.  Because cerebral deposition of Aβ species might be crit. for the pathogenesis of Alzheimer disease, BACE1 has emerged as a key target for the treatment of this disease.  Here, the authors report the discovery and comprehensive preclin. characterization of AZD3839, a potent and selective inhibitor of human BACE1.  AZD3839 was identified using fragment-based screening and structure-based design.  In a concn.-dependent manner, AZD3839 inhibited BACE1 activity in a biochem. fluorescence resonance energy transfer (FRET) assay, Aβ and sAPPβ release from modified and wild-type human SH-SY5Y cells and mouse N2A cells as well as from mouse and guinea pig primary cortical neurons.  Selectivity against BACE2 and cathepsin D was 14 and >1000-fold, resp.  AZD3839 exhibited dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate.  Pharmacokinetic/pharmacodynamic analyses of mouse and guinea pig data showed a good correlation between the potency of AZD3839 in primary cortical neurons and in vivo brain effects.  These results suggest that AZD3839 effectively reduces the levels of Aβ in brain, CSF, and plasma in several preclin. species.  It might, therefore, have disease-modifying potential in the treatment of Alzheimer disease and related dementias.  Based on the overall pharmacol. profile and its drug like properties, AZD3839 has been progressed into Phase 1 clin. trials in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoi56XzYm8WhLVg90H21EOLACvtfcHk0lhKmBWAXIkSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslGjs7fE&md5=dd328c2e0b3de730de30f1e249f2403e</span></div><a href="/servlet/linkout?suffix=cit22b&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M112.409110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M112.409110%26sid%3Dliteratum%253Aachs%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3DGustavsson%26aufirst%3DS.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DPloeger%26aufirst%3DB.%26aulast%3DCebers%26aufirst%3DG.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DBueters%26aufirst%3DT.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520AZD3839%252C%2520a%2520potent%2520and%2520selective%2520BACE1%2520inhibitor%2520clinical%2520candidate%2520for%2520the%2520treatment%2520of%2520alzheimer%2520disease%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D41245%26epage%3D41257%26doi%3D10.1074%2Fjbc.M112.409110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">May, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willis, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowe, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dean, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monk, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocke, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audia, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boggs, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borders, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brier, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calligaro, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ereshefsky, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erickson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gevorkyan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">James, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jhee, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Komjathy, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathes, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martényi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stout, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Timm, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaught, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winneroski, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mergott, D. J.</span><span> </span><span class="NLM_article-title">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">1199</span><span class="NLM_x">–</span> <span class="NLM_lpage">1210</span><span class="refDoi"> DOI: 10.1523/JNEUROSCI.4129-14.2015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1523%2FJNEUROSCI.4129-14.2015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=25609634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2015&pages=1199-1210&author=P.+C.+Mayauthor=B.+A.+Willisauthor=S.+L.+Loweauthor=R.+A.+Deanauthor=S.+A.+Monkauthor=P.+J.+Cockeauthor=J.+E.+Audiaauthor=L.+N.+Boggsauthor=A.+R.+Bordersauthor=R.+A.+Brierauthor=D.+O.+Calligaroauthor=T.+A.+Dayauthor=L.+Ereshefskyauthor=J.+A.+Ericksonauthor=H.+Gevorkyanauthor=C.+R.+Gonzalesauthor=D.+E.+Jamesauthor=S.+S.+Jheeauthor=S.+F.+Komjathyauthor=L.+Liauthor=T.+D.+Lindstromauthor=B.+M.+Mathesauthor=F.+Mart%C3%A9nyiauthor=S.+M.+Sheehanauthor=S.+L.+Stoutauthor=D.+E.+Timmauthor=G.+M.+Vaughtauthor=B.+M.+Watsonauthor=L.+L.+Winneroskiauthor=Z.+Yangauthor=D.+J.+Mergott&title=The+potent+BACE1+inhibitor+LY2886721+elicits+robust+central+A%CE%B2+pharmacodynamic+responses+in+mice%2C+dogs%2C+and+humans&doi=10.1523%2FJNEUROSCI.4129-14.2015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22cR"><div class="casContent"><span class="casTitleNuber">22c</span><div class="casTitle"><span class="NLM_cas:atitle">The potent BACE1 inhibitor LY2886721 elicits robust central Aβ pharmacodynamic responses in mice, dogs, and humans</span></div><div class="casAuthors">May, Patrick C.; Willis, Brian A.; Lowe, Stephen L.; Dean, Robert A.; Monk, Scott A.; Cocke, Patrick J.; Audia, James E.; Boggs, Leonard N.; Borders, Anthony R.; Brier, Richard A.; Calligaro, David O.; Day, Theresa A.; Ereshefsky, Larry; Erickso, Jon A.; Gevorkyan, Hykop; Gonzales, Celedon R.; James, Douglas E.; Jhee, Stanford S.; Komjathy, Steven F.; Li, Linglin; Lindstrom, Terry D.; Mathe, Brian M.; Martenyi, Ferenc; Sheehan, Scott M.; Stout, Stephanie L.; Timm, David E.; Vaught, Grant M.; Watson, Brian M.; Winneroski, Leonard L.; Yang, Zhixiang; Mergott, Dustin J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1199-1210, 12 pp.</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">BACE1 is a key protease controlling the formation of amyloid β, a peptide hypothesized to play a significant role in the pathogenesis of Alzheimer's disease (AD).  Therefore, the development of potent and selective inhibitors of BACE1 has been a focus of many drug discovery efforts in academia and industry.  Herein, we report the nonclin. and early clin. development of LY2886721, a BACE1 active site inhibitor that reached phase 2 clin. trials in AD.  LY2886721 has high selectivity against key off-target proteases, which efficiently translates in vitro activity into robust in vivo amyloid β lowering in nonclin. animal models.  Similar potent and persistent amyloid β lowering was obsd. in plasma and lumbar CSF when single and multiple doses of LY2886721 were administered to healthy human subjects.  Collectively, these data add support for BACE1 inhibition as an effective means of amyloid lowering and as an attractive target for potential disease modification therapy in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDDFLhcsiUDLVg90H21EOLACvtfcHk0lhKmBWAXIkSGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXit1Oit78%253D&md5=7e16cc00767a8af4da7dd17b6e40e8f5</span></div><a href="/servlet/linkout?suffix=cit22c&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.4129-14.2015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.4129-14.2015%26sid%3Dliteratum%253Aachs%26aulast%3DMay%26aufirst%3DP.%2BC.%26aulast%3DWillis%26aufirst%3DB.%2BA.%26aulast%3DLowe%26aufirst%3DS.%2BL.%26aulast%3DDean%26aufirst%3DR.%2BA.%26aulast%3DMonk%26aufirst%3DS.%2BA.%26aulast%3DCocke%26aufirst%3DP.%2BJ.%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DBoggs%26aufirst%3DL.%2BN.%26aulast%3DBorders%26aufirst%3DA.%2BR.%26aulast%3DBrier%26aufirst%3DR.%2BA.%26aulast%3DCalligaro%26aufirst%3DD.%2BO.%26aulast%3DDay%26aufirst%3DT.%2BA.%26aulast%3DEreshefsky%26aufirst%3DL.%26aulast%3DErickson%26aufirst%3DJ.%2BA.%26aulast%3DGevorkyan%26aufirst%3DH.%26aulast%3DGonzales%26aufirst%3DC.%2BR.%26aulast%3DJames%26aufirst%3DD.%2BE.%26aulast%3DJhee%26aufirst%3DS.%2BS.%26aulast%3DKomjathy%26aufirst%3DS.%2BF.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DLindstrom%26aufirst%3DT.%2BD.%26aulast%3DMathes%26aufirst%3DB.%2BM.%26aulast%3DMart%25C3%25A9nyi%26aufirst%3DF.%26aulast%3DSheehan%26aufirst%3DS.%2BM.%26aulast%3DStout%26aufirst%3DS.%2BL.%26aulast%3DTimm%26aufirst%3DD.%2BE.%26aulast%3DVaught%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DB.%2BM.%26aulast%3DWinneroski%26aufirst%3DL.%2BL.%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DMergott%26aufirst%3DD.%2BJ.%26atitle%3DThe%2520potent%2520BACE1%2520inhibitor%2520LY2886721%2520elicits%2520robust%2520central%2520A%25CE%25B2%2520pharmacodynamic%2520responses%2520in%2520mice%252C%2520dogs%252C%2520and%2520humans%26jtitle%3DJ.%2520Neurosci.%26date%3D2015%26volume%3D35%26spage%3D1199%26epage%3D1210%26doi%3D10.1523%2FJNEUROSCI.4129-14.2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Neumann, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueeger, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Machauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veenstra, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lueoend, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tintelnot-Blomley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laue, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beltz, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogg, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frieauff, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimshek, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staufenbiel, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, L. H.</span><span> </span><span class="NLM_article-title">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span> <span class="citation_source-journal">Mol. Neurodegener.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">44</span><span class="refDoi"> DOI: 10.1186/s13024-015-0033-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1186%2Fs13024-015-0033-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=26336937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&pages=44&author=U.+Neumannauthor=H.+Rueegerauthor=R.+Machauerauthor=S.+J.+Veenstraauthor=R.+M.+Lueoendauthor=M.+Tintelnot-Blomleyauthor=G.+Laueauthor=K.+Beltzauthor=B.+Voggauthor=P.+Schmidauthor=W.+Frieauffauthor=D.+R.+Shimshekauthor=M.+Staufenbielauthor=L.+H.+Jacobson&title=A+novel+BACE+inhibitor+NB-360+shows+a+superior+pharmacological+profile+and+robust+reduction+of+amyloid-%CE%B2+and+neuroinflammation+in+APP+transgenic+mice&doi=10.1186%2Fs13024-015-0033-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22dR"><div class="casContent"><span class="casTitleNuber">22d</span><div class="casTitle"><span class="NLM_cas:atitle">A novel BACE inhibitor NB-360 shows a superior pharmacological profile and robust reduction of amyloid-β and neuroinflammation in APP transgenic mice</span></div><div class="casAuthors">Neumann, Ulf; Rueeger, Heinrich; Machauer, Rainer; Veenstra, Siem Jacob; Lueoend, Rainer M.; Tintelnot-Blomley, Marina; Laue, Grit; Beltz, Karen; Vogg, Barbara; Schmid, Peter; Frieauff, Wilfried; Shimshek, Derya R.; Staufenbiel, Matthias; Jacobson, Laura H.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurodegeneration</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">44/1-44/15</span>CODEN:
                <span class="NLM_cas:coden">MNOEAZ</span>;
        ISSN:<span class="NLM_cas:issn">1750-1326</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Alzheimer's disease (AD) is the most common form of dementia, the no. of affected individuals is rising, with significant impacts for healthcare systems.  Current symptomatic treatments delay, but do not halt, disease progression.  Genetic evidence points to aggregation and deposition of amyloid-β (Aβ) in the brain being causal for the neurodegeneration and dementia typical of AD.  Approaches to target Aβ via inhibition of γ-secretase or passive antibody therapy have not yet resulted in substantial clin. benefits.  Inhibition of BACE1 (β-secretase) has proven a challenging concept, but recent BACE1inhibitors can enter the brain sufficiently well to lower Aβ.  However, failures with the first clin. BACE1 inhibitors have highlighted the need to generate compds. with appropriate efficacy and safety profiles, since long treatment periods are expected to be necessary in humans.  Results: Treatment with NB-360, a potent and brain penetrable BACE-1 inhibitor can completely block the progression of Aβ deposition in the brains of APP transgenic mice, a model for amyloid pathol.  We furthermore show that almost complete redn. of Aβ was achieved also in rats and in dogs, suggesting that these findings are translational across species and can be extrapolated to humans.  Amyloid pathol. may be an initial step in a complex pathol. cascade; therefore we investigated the effect of BACE-1 inhibition on neuroinflammation, a prominent downstream feature of the disease.  NB-360 stopped accumulation of activated inflammatory cells in the brains of APP transgenic mice.  Upon chronic treatment of APP transgenic mice, patches of gray hairs appeared.  Conclusions: In a rapidly developing field, the data on NB-360 broaden the chem. space and expand knowledge on the properties that are needed to make a BACE-1 inhibitor potent and safe enough for long-term use in patients.  Due to its excellent brain penetration, reasonable oral doses of NB-360 were sufficient to completely block amyloid-β deposition in an APP transgenic mouse model.  Data across species suggest similar treatment effects can possibly be achieved in humans.  The reduced neuroinflammation upon amyloid redn. by NB-360 treatment supports the notion that targeting amyloid-β pathol. can have beneficial downstream effects on the progression of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGquJLgu8zl8_LVg90H21EOLACvtfcHk0ljasFuavEcUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xls1Sls7o%253D&md5=728407859709d7de57d68bfdc374fe85</span></div><a href="/servlet/linkout?suffix=cit22d&amp;dbid=16384&amp;doi=10.1186%2Fs13024-015-0033-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13024-015-0033-8%26sid%3Dliteratum%253Aachs%26aulast%3DNeumann%26aufirst%3DU.%26aulast%3DRueeger%26aufirst%3DH.%26aulast%3DMachauer%26aufirst%3DR.%26aulast%3DVeenstra%26aufirst%3DS.%2BJ.%26aulast%3DLueoend%26aufirst%3DR.%2BM.%26aulast%3DTintelnot-Blomley%26aufirst%3DM.%26aulast%3DLaue%26aufirst%3DG.%26aulast%3DBeltz%26aufirst%3DK.%26aulast%3DVogg%26aufirst%3DB.%26aulast%3DSchmid%26aufirst%3DP.%26aulast%3DFrieauff%26aufirst%3DW.%26aulast%3DShimshek%26aufirst%3DD.%2BR.%26aulast%3DStaufenbiel%26aufirst%3DM.%26aulast%3DJacobson%26aufirst%3DL.%2BH.%26atitle%3DA%2520novel%2520BACE%2520inhibitor%2520NB-360%2520shows%2520a%2520superior%2520pharmacological%2520profile%2520and%2520robust%2520reduction%2520of%2520amyloid-%25CE%25B2%2520and%2520neuroinflammation%2520in%2520APP%2520transgenic%2520mice%26jtitle%3DMol.%2520Neurodegener.%26date%3D2015%26volume%3D10%26spage%3D44%26doi%3D10.1186%2Fs13024-015-0033-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Rombouts, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tresadern, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delgado, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martínez-Lamenca, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Gool, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">García-Molina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso de Diego, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oehlrich, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prokopcova, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alonso, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Austin, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghys, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Brandt, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surkyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Cleyn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alexander, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macdonald, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moechars, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gijsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trabanco, A. A.</span><span> </span><span class="NLM_article-title">1,4-Oxazine β-secretase 1 (BACE1) inhibitors: from hit generation to orally bioavailable brain penetrant leads</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">8216</span><span class="NLM_x">–</span> <span class="NLM_lpage">8235</span><span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01101</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=8216-8235&author=F.+J.+Romboutsauthor=G.+Tresadernauthor=O.+Delgadoauthor=C.+Mart%C3%ADnez-Lamencaauthor=M.+Van+Goolauthor=A.+Garc%C3%ADa-Molinaauthor=S.+A.+Alonso+de+Diegoauthor=D.+Oehlrichauthor=H.+Prokopcovaauthor=J.+M.+Alonsoauthor=N.+Austinauthor=H.+Borghysauthor=S.+Van+Brandtauthor=M.+Surkynauthor=M.+De+Cleynauthor=A.+Vosauthor=R.+Alexanderauthor=G.+Macdonaldauthor=D.+Moecharsauthor=H.+Gijsenauthor=A.+A.+Trabanco&title=1%2C4-Oxazine+%CE%B2-secretase+1+%28BACE1%29+inhibitors%3A+from+hit+generation+to+orally+bioavailable+brain+penetrant+leads&doi=10.1021%2Facs.jmedchem.5b01101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22eR"><div class="casContent"><span class="casTitleNuber">22e</span><div class="casTitle"><span class="NLM_cas:atitle">1,4-Oxazine β-Secretase 1 (BACE1) Inhibitors: From Hit Generation to Orally Bioavailable Brain Penetrant Leads</span></div><div class="casAuthors">Rombouts, Frederik J. R.; Tresadern, Gary; Delgado, Oscar; Martinez-Lamenca, Carolina; Van Gool, Michiel; Garcia-Molina, Aranzazu; Alonso de Diego, Sergio A.; Oehlrich, Daniel; Prokopcova, Hana; Alonso, Jose Manuel; Austin, Nigel; Borghys, Herman; Van Brandt, Sven; Surkyn, Michel; De Cleyn, Michel; Vos, Ann; Alexander, Richard; Macdonald, Gregor; Moechars, Dieder; Gijsen, Harrie; Trabanco, Andres A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8216-8235</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">1,4-Oxazines are presented, which show good in vitro inhibition in enzymic and cellular BACE1 assays.  We describe lead optimization focused on reducing the amidine pKa while optimizing interactions in the BACE1 active site.  Our strategy permitted modulation of properties such as permeation and esp. P-glycoprotein efflux.  This led to compds. which were orally bioavailable, centrally active, and which demonstrated robust lowering of brain and CSF Aβ levels, resp., in mouse and dog models.  The amyloid lowering potential of these mols. makes them valuable leads in the search for new BACE1 inhibitors for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHVm9JF2kNa7Vg90H21EOLACvtfcHk0ljasFuavEcUyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsFWktL3L&md5=d3563a26a17a1c86c45a4f99b18be251</span></div><a href="/servlet/linkout?suffix=cit22e&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01101%26sid%3Dliteratum%253Aachs%26aulast%3DRombouts%26aufirst%3DF.%2BJ.%26aulast%3DTresadern%26aufirst%3DG.%26aulast%3DDelgado%26aufirst%3DO.%26aulast%3DMart%25C3%25ADnez-Lamenca%26aufirst%3DC.%26aulast%3DVan%2BGool%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Molina%26aufirst%3DA.%26aulast%3DAlonso%2Bde%2BDiego%26aufirst%3DS.%2BA.%26aulast%3DOehlrich%26aufirst%3DD.%26aulast%3DProkopcova%26aufirst%3DH.%26aulast%3DAlonso%26aufirst%3DJ.%2BM.%26aulast%3DAustin%26aufirst%3DN.%26aulast%3DBorghys%26aufirst%3DH.%26aulast%3DVan%2BBrandt%26aufirst%3DS.%26aulast%3DSurkyn%26aufirst%3DM.%26aulast%3DDe%2BCleyn%26aufirst%3DM.%26aulast%3DVos%26aufirst%3DA.%26aulast%3DAlexander%26aufirst%3DR.%26aulast%3DMacdonald%26aufirst%3DG.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DGijsen%26aufirst%3DH.%26aulast%3DTrabanco%26aufirst%3DA.%2BA.%26atitle%3D1%252C4-Oxazine%2520%25CE%25B2-secretase%25201%2520%2528BACE1%2529%2520inhibitors%253A%2520from%2520hit%2520generation%2520to%2520orally%2520bioavailable%2520brain%2520penetrant%2520leads%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D8216%26epage%3D8235%26doi%3D10.1021%2Facs.jmedchem.5b01101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judd, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, T. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartberger, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, R. T.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fremeau, R. T.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harried, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minatti, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, V. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vargas, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wahl, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whittington, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zheng, X. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span> </span><span class="NLM_article-title">An orally available BACE1 inhibitor that affords robust CNS Aβ reduction without cardiovascular liabilities</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">210</span><span class="NLM_x">–</span> <span class="NLM_lpage">215</span><span class="refDoi"> DOI: 10.1021/ml500458t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500458t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22f&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=210-215&author=Y.+Chengauthor=J.+Brownauthor=T.+C.+Juddauthor=P.+Lopezauthor=W.+Qianauthor=T.+S.+Powersauthor=J.+J.+Chenauthor=M.+D.+Bartbergerauthor=K.+Chenauthor=R.+T.+Dunnauthor=O.+Epsteinauthor=R.+T.+Fremeauauthor=S.+Harriedauthor=D.+Hickmanauthor=S.+A.+Hitchcockauthor=Y.+Luoauthor=A.+E.+Minattiauthor=V.+F.+Patelauthor=H.+M.+Vargasauthor=R.+C.+Wahlauthor=M.+M.+Weissauthor=P.+H.+Wenauthor=R.+D.+Whiteauthor=D.+A.+Whittingtonauthor=X.+M.+Zhengauthor=S.+Wood&title=An+orally+available+BACE1+inhibitor+that+affords+robust+CNS+A%CE%B2+reduction+without+cardiovascular+liabilities&doi=10.1021%2Fml500458t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22fR"><div class="casContent"><span class="casTitleNuber">22f</span><div class="casTitle"><span class="NLM_cas:atitle">An Orally Available BACE1 Inhibitor That Affords Robust CNS Aβ Reduction without Cardiovascular Liabilities</span></div><div class="casAuthors">Cheng, Yuan; Brown, James; Judd, Ted C.; Lopez, Patricia; Qian, Wenyuan; Powers, Timothy S.; Chen, Jian Jeffrey; Bartberger, Michael D.; Chen, Kui; Dunn, Robert T.; Epstein, Oleg; Fremeau, Robert T.; Harried, Scott; Hickman, Dean; Hitchcock, Stephen A.; Luo, Yi; Minatti, Ana Elena; Patel, Vinod F.; Vargas, Hugo M.; Wahl, Robert C.; Weiss, Matthew M.; Wen, Paul H.; White, Ryan D.; Whittington, Douglas A.; Zheng, Xiao Mei; Wood, Stephen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">210-215</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">BACE1 inhibition to prevent Aβ peptide formation is considered to be a potential route to a disease-modifying treatment for Alzheimer's disease.  Previous efforts in our lab. using a combined structure- and property-based approach have resulted in the identification of aminooxazoline xanthenes as potent BACE1 inhibitors.  Herein, we report further optimization leading to the discovery of inhibitor 15 as an orally available and highly efficacious BACE1 inhibitor that robustly reduces CSF and brain Aβ levels in both rats and nonhuman primates.  In addn., compd. 15 exhibited low activity on the hERG ion channel and was well tolerated in an integrated cardiovascular safety model.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbH-0fLNUlbrVg90H21EOLACvtfcHk0lgUIxhR_i9Osg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFyhtLzI&md5=bd8e5a33d06a51646873c4c43d01b003</span></div><a href="/servlet/linkout?suffix=cit22f&amp;dbid=16384&amp;doi=10.1021%2Fml500458t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500458t%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DJudd%26aufirst%3DT.%2BC.%26aulast%3DLopez%26aufirst%3DP.%26aulast%3DQian%26aufirst%3DW.%26aulast%3DPowers%26aufirst%3DT.%2BS.%26aulast%3DChen%26aufirst%3DJ.%2BJ.%26aulast%3DBartberger%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DDunn%26aufirst%3DR.%2BT.%26aulast%3DEpstein%26aufirst%3DO.%26aulast%3DFremeau%26aufirst%3DR.%2BT.%26aulast%3DHarried%26aufirst%3DS.%26aulast%3DHickman%26aufirst%3DD.%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26aulast%3DLuo%26aufirst%3DY.%26aulast%3DMinatti%26aufirst%3DA.%2BE.%26aulast%3DPatel%26aufirst%3DV.%2BF.%26aulast%3DVargas%26aufirst%3DH.%2BM.%26aulast%3DWahl%26aufirst%3DR.%2BC.%26aulast%3DWeiss%26aufirst%3DM.%2BM.%26aulast%3DWen%26aufirst%3DP.%2BH.%26aulast%3DWhite%26aufirst%3DR.%2BD.%26aulast%3DWhittington%26aufirst%3DD.%2BA.%26aulast%3DZheng%26aufirst%3DX.%2BM.%26aulast%3DWood%26aufirst%3DS.%26atitle%3DAn%2520orally%2520available%2520BACE1%2520inhibitor%2520that%2520affords%2520robust%2520CNS%2520A%25CE%25B2%2520reduction%2520without%2520cardiovascular%2520liabilities%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D210%26epage%3D215%26doi%3D10.1021%2Fml500458t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit22g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Butler, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barreiro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vajdos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parris, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varghese, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lira, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buzon, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dutra, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez-Alsina, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogilvie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atchison, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzales, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span> </span><span class="NLM_article-title">Discovery of a series of efficient, centrally efficacious BACE1 inhibitors through structure-based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">2678</span><span class="NLM_x">–</span> <span class="NLM_lpage">2702</span><span class="refDoi"> DOI: 10.1021/jm501833t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501833t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22g&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=2678-2702&author=C.+R.+Butlerauthor=M.+A.+Brodneyauthor=E.+M.+Beckauthor=G.+Barreiroauthor=C.+E.+Nolanauthor=F.+Panauthor=F.+Vajdosauthor=K.+Parrisauthor=A.+H.+Vargheseauthor=C.+J.+Helalauthor=R.+Liraauthor=S.+D.+Doranauthor=D.+R.+Riddellauthor=L.+M.+Buzonauthor=J.+K.+Dutraauthor=L.+A.+Martinez-Alsinaauthor=K.+Ogilvieauthor=J.+C.+Murrayauthor=J.+M.+Youngauthor=K.+Atchisonauthor=A.+Robshawauthor=C.+Gonzalesauthor=J.+Wangauthor=Y.+Zhangauthor=B.+T.+O%E2%80%99Neill&title=Discovery+of+a+series+of+efficient%2C+centrally+efficacious+BACE1+inhibitors+through+structure-based+drug+design&doi=10.1021%2Fjm501833t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22gR"><div class="casContent"><span class="casTitleNuber">22g</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a Series of Efficient, Centrally Efficacious BACE1 Inhibitors through Structure-Based Drug Design</span></div><div class="casAuthors">Butler, Christopher R.; Brodney, Michael A.; Beck, Elizabeth M.; Barreiro, Gabriela; Nolan, Charles E.; Pan, Feng; Vajdos, Felix; Parris, Kevin; Varghese, Alison H.; Helal, Christopher J.; Lira, Ricardo; Doran, Shawn D.; Riddell, David R.; Buzon, Leanne M.; Dutra, Jason K.; Martinez-Alsina, Luis A.; Ogilvie, Kevin; Murray, John C.; Young, Joseph M.; Atchison, Kevin; Robshaw, Ashley; Gonzales, Cathleen; Wang, Jinlong; Zhang, Yong; O'Neill, Brian T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2678-2702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The identification of centrally efficacious β-secretase (BACE1) inhibitors for the treatment of Alzheimer's disease (AD) has historically been thwarted by an inability to maintain alignment of potency, brain availability, and desired absorption, distribution, metab., and excretion (ADME) properties.  In this paper, the authors describe a series of truncated, fused thioamidines that are efficiently selective in garnering BACE1 activity without simultaneously inhibiting the closely related cathepsin D or neg. impacting brain penetration and ADME alignment, as exemplified by I.  Upon oral administration, these inhibitors exhibit robust brain availability and are efficacious in lowering central Amyloid β (Aβ) levels in mouse and dog.  In addn., chronic treatment in aged PS1/APP mice effects a decrease in the no. and size of Aβ-derived plaques.  Most importantly, evaluation of I in a 2-wk exploratory toxicol. study revealed no accumulation of autofluorescent material in retinal pigment epithelium or histol. findings in the eye, issues obsd. with earlier BACE1 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpiNT62AGyml7Vg90H21EOLACvtfcHk0lgh-d-YfrQdpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtVSjtro%253D&md5=ac2a6fd661f7e9fd8b925deffd5e1010</span></div><a href="/servlet/linkout?suffix=cit22g&amp;dbid=16384&amp;doi=10.1021%2Fjm501833t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501833t%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DC.%2BR.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBarreiro%26aufirst%3DG.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DPan%26aufirst%3DF.%26aulast%3DVajdos%26aufirst%3DF.%26aulast%3DParris%26aufirst%3DK.%26aulast%3DVarghese%26aufirst%3DA.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DLira%26aufirst%3DR.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DBuzon%26aufirst%3DL.%2BM.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DMartinez-Alsina%26aufirst%3DL.%2BA.%26aulast%3DOgilvie%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%2BC.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DAtchison%26aufirst%3DK.%26aulast%3DRobshaw%26aufirst%3DA.%26aulast%3DGonzales%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26atitle%3DDiscovery%2520of%2520a%2520series%2520of%2520efficient%252C%2520centrally%2520efficacious%2520BACE1%2520inhibitors%2520through%2520structure-based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D2678%26epage%3D2702%26doi%3D10.1021%2Fjm501833t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Swahn, B.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolmodin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karlström, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Söderman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holenz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sundström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turek, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kihlström, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slivo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andersson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pyring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotticci, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Öhberg, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogar, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Kieseritzky, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergh, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, L.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georgievska, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span> </span><span class="NLM_article-title">Design and synthesis of β-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of β-amyloid peptides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9346</span><span class="NLM_x">–</span> <span class="NLM_lpage">9361</span><span class="refDoi"> DOI: 10.1021/jm3009025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9346-9361&author=B.-M.+Swahnauthor=K.+Kolmodinauthor=S.+Karlstr%C3%B6mauthor=S.+von+Bergauthor=P.+S%C3%B6dermanauthor=J.+Holenzauthor=S.+Bergauthor=J.+Lindstr%C3%B6mauthor=M.+Sundstr%C3%B6mauthor=D.+Turekauthor=J.+Kihlstr%C3%B6mauthor=C.+Slivoauthor=L.+Anderssonauthor=D.+Pyringauthor=D.+Rotticciauthor=L.+%C3%96hbergauthor=A.+Kersauthor=K.+Bogarauthor=F.+von+Kieseritzkyauthor=M.+Berghauthor=L.-L.+Olssonauthor=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=B.+Georgievskaauthor=F.+Jeppssonauthor=J.+F%C3%A4lting&title=Design+and+synthesis+of+%CE%B2-site+amyloid+precursor+protein+cleaving+enzyme+%28BACE1%29+inhibitors+with+in+vivo+brain+reduction+of+%CE%B2-amyloid+peptides&doi=10.1021%2Fjm3009025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23aR"><div class="casContent"><span class="casTitleNuber">23a</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides</span></div><div class="casAuthors">Swahn, Britt-Marie; Kolmodin, Karin; Karlstroem, Sofia; von Berg, Stefan; Soederman, Peter; Holenz, Joerg; Berg, Stefan; Lindstroem, Johan; Sundstroem, Marie; Turek, Dominika; Kihlstroem, Jacob; Slivo, Can; Andersson, Lars; Pyring, David; Rotticci, Didier; Oehberg, Liselotte; Kers, Annika; Bogar, Krisztian; Bergh, Margareta; Olsson, Lise-Lotte; Janson, Juliette; Eketjaell, Susanna; Georgievska, Biljana; Jeppsson, Fredrik; Faelting, Johanna</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9346-9361</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The evaluation of a series of aminoisoindoles as β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and the discovery of a clin. candidate drug for Alzheimer's disease, (S)-32 (I, AZD3839), are described.  The improvement in permeability properties by the introduction of fluorine adjacent to the amidine moiety, resulting in in vivo brain redn. of Aβ40, is discussed.  Due to the basic nature of these compds., they displayed affinity for the human ether-a-go-go related gene (hERG) ion channel.  Different ways to reduce hERG inhibition and increase hERG margins for this series are described, culminating in (S)-16 (II) and (R)-41 (III) showing large in vitro margins with BACE1 cell IC50 values of 8.6 and 0.16 nM, resp., and hERG IC50 values of 16 and 2.8 μM, resp.  Several compds. were advanced into pharmacodynamic studies and demonstrated significant redn. of β-amyloid peptides in mouse brain following oral dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox062OT8a6ubVg90H21EOLACvtfcHk0lgh-d-YfrQdpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1OmtL%252FM&md5=da7685d90f56449caa77b6e6393e0a7d</span></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fjm3009025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009025%26sid%3Dliteratum%253Aachs%26aulast%3DSwahn%26aufirst%3DB.-M.%26aulast%3DKolmodin%26aufirst%3DK.%26aulast%3DKarlstr%25C3%25B6m%26aufirst%3DS.%26aulast%3Dvon%2BBerg%26aufirst%3DS.%26aulast%3DS%25C3%25B6derman%26aufirst%3DP.%26aulast%3DHolenz%26aufirst%3DJ.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DLindstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSundstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DTurek%26aufirst%3DD.%26aulast%3DKihlstr%25C3%25B6m%26aufirst%3DJ.%26aulast%3DSlivo%26aufirst%3DC.%26aulast%3DAndersson%26aufirst%3DL.%26aulast%3DPyring%26aufirst%3DD.%26aulast%3DRotticci%26aufirst%3DD.%26aulast%3D%25C3%2596hberg%26aufirst%3DL.%26aulast%3DKers%26aufirst%3DA.%26aulast%3DBogar%26aufirst%3DK.%26aulast%3Dvon%2BKieseritzky%26aufirst%3DF.%26aulast%3DBergh%26aufirst%3DM.%26aulast%3DOlsson%26aufirst%3DL.-L.%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DGeorgievska%26aufirst%3DB.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520%25CE%25B2-site%2520amyloid%2520precursor%2520protein%2520cleaving%2520enzyme%2520%2528BACE1%2529%2520inhibitors%2520with%2520in%2520vivo%2520brain%2520reduction%2520of%2520%25CE%25B2-amyloid%2520peptides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9346%26epage%3D9361%26doi%3D10.1021%2Fjm3009025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woltering, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wostl, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mauser, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayweg, A. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers-Evans, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humm, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krummenacher, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muser, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnider, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergadano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banner, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hochstrasser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuglstatter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">David-Pierson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polara, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narquizian, R.</span><span> </span><span class="NLM_article-title">β-Secretase (BACE1) Inhibitors with high in vivo efficacy suitable for clinical evaluation in Alzheimer’s disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">3980</span><span class="NLM_x">–</span> <span class="NLM_lpage">3995</span><span class="refDoi"> DOI: 10.1021/jm400225m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400225m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3980-3995&author=H.+Hilpertauthor=W.+Gubaauthor=T.+J.+Wolteringauthor=W.+Wostlauthor=E.+Pinardauthor=H.+Mauserauthor=A.+V.+Maywegauthor=M.+Rogers-Evansauthor=R.+Hummauthor=D.+Krummenacherauthor=T.+Muserauthor=C.+Schniderauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Bergadanoauthor=D.+W.+Bannerauthor=R.+Hochstrasserauthor=A.+Kuglstatterauthor=P.+David-Piersonauthor=H.+Fischerauthor=A.+Polaraauthor=R.+Narquizian&title=%CE%B2-Secretase+%28BACE1%29+Inhibitors+with+high+in+vivo+efficacy+suitable+for+clinical+evaluation+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fjm400225m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">β-Secretase (BACE1) Inhibitors with High in Vivo Efficacy Suitable for Clinical Evaluation in Alzheimer's Disease</span></div><div class="casAuthors">Hilpert, Hans; Guba, Wolfgang; Woltering, Thomas J.; Wostl, Wolfgang; Pinard, Emmanuel; Mauser, Harald; Mayweg, Alexander V.; Rogers-Evans, Mark; Humm, Roland; Krummenacher, Daniela; Muser, Thorsten; Schnider, Christian; Jacobsen, Helmut; Ozmen, Laurence; Bergadano, Alessandra; Banner, David W.; Hochstrasser, Remo; Kuglstatter, Andreas; David-Pierson, Pascale; Fischer, Holger; Polara, Alessandra; Narquizian, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">3980-3995</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An extensive fluorine scan of 1,3-oxazines revealed the power of fluorine(s) to lower the pKa and thereby dramatically change the pharmacol. profile of this class of BACE1 inhibitors.  The CF3 substituted oxazine 89, a potent and highly brain penetrant BACE1 inhibitor, was able to reduce significantly CSF Aβ40 and 42 in rats at oral doses as low as 1 mg/kg.  The effect was long lasting, showing a significant redn. of Aβ40 and 42 even after 24 h.  In contrast to 89, compd. 1b lacking the CF3 group was virtually inactive in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmoKRrAxxHErVg90H21EOLACvtfcHk0li1JoiCCLMzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtVymuro%253D&md5=e5d311d1c8fecfaed043d3a0bf16c168</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1021%2Fjm400225m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400225m%26sid%3Dliteratum%253Aachs%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DGuba%26aufirst%3DW.%26aulast%3DWoltering%26aufirst%3DT.%2BJ.%26aulast%3DWostl%26aufirst%3DW.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DMauser%26aufirst%3DH.%26aulast%3DMayweg%26aufirst%3DA.%2BV.%26aulast%3DRogers-Evans%26aufirst%3DM.%26aulast%3DHumm%26aufirst%3DR.%26aulast%3DKrummenacher%26aufirst%3DD.%26aulast%3DMuser%26aufirst%3DT.%26aulast%3DSchnider%26aufirst%3DC.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DBergadano%26aufirst%3DA.%26aulast%3DBanner%26aufirst%3DD.%2BW.%26aulast%3DHochstrasser%26aufirst%3DR.%26aulast%3DKuglstatter%26aufirst%3DA.%26aulast%3DDavid-Pierson%26aufirst%3DP.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DPolara%26aufirst%3DA.%26aulast%3DNarquizian%26aufirst%3DR.%26atitle%3D%25CE%25B2-Secretase%2520%2528BACE1%2529%2520Inhibitors%2520with%2520high%2520in%2520vivo%2520efficacy%2520suitable%2520for%2520clinical%2520evaluation%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3980%26epage%3D3995%26doi%3D10.1021%2Fjm400225m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wilcken, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmermann, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lange, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joerger, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boeckler, F. M.</span><span> </span><span class="NLM_article-title">Principles and applications of halogen bonding in medicinal chemistry and chemical biology</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">1363</span><span class="NLM_x">–</span> <span class="NLM_lpage">1388</span><span class="refDoi"> DOI: 10.1021/jm3012068</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3012068" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=1363-1388&author=R.+Wilckenauthor=M.+O.+Zimmermannauthor=A.+Langeauthor=A.+C.+Joergerauthor=F.+M.+Boeckler&title=Principles+and+applications+of+halogen+bonding+in+medicinal+chemistry+and+chemical+biology&doi=10.1021%2Fjm3012068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology</span></div><div class="casAuthors">Wilcken, Rainer; Zimmermann, Markus O.; Lange, Andreas; Joerger, Andreas C.; Boeckler, Frank M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1363-1388</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Halogen bonding has been known in material science for decades, but until recently, halogen bonds in protein-ligand interactions were largely the result of serendipitous discovery rather than rational design.  In this Perspective, we provide insights into the phenomenon of halogen bonding, with special focus on its role in drug discovery.  We summarize the theor. background defining its strength and directionality, provide a systematic anal. of its occurrence and interaction geometries in protein-ligand complexes, and give recent examples where halogen bonding has been successfully harnessed for lead identification and optimization.  In light of these data, we discuss the potential and limitations of exploiting halogen bonds for mol. recognition and rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjholHfNZ9kbVg90H21EOLACvtfcHk0li1JoiCCLMzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1GrurfJ&md5=81ba024e4427fac3e7af0a4cd330909c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm3012068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3012068%26sid%3Dliteratum%253Aachs%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DZimmermann%26aufirst%3DM.%2BO.%26aulast%3DLange%26aufirst%3DA.%26aulast%3DJoerger%26aufirst%3DA.%2BC.%26aulast%3DBoeckler%26aufirst%3DF.%2BM.%26atitle%3DPrinciples%2520and%2520applications%2520of%2520halogen%2520bonding%2520in%2520medicinal%2520chemistry%2520and%2520chemical%2520biology%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D1363%26epage%3D1388%26doi%3D10.1021%2Fjm3012068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Rochin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurbain, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serneels, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fort, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leblanc, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marks, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Strooper, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raposo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Niel, G.</span><span> </span><span class="NLM_article-title">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">110</span><span class="NLM_x">, </span> <span class="NLM_fpage">10658</span><span class="NLM_x">–</span> <span class="NLM_lpage">10663</span><span class="refDoi"> DOI: 10.1073/pnas.1220748110</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1073%2Fpnas.1220748110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=23754390" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2013&pages=10658-10663&author=L.+Rochinauthor=I.+Hurbainauthor=L.+Serneelsauthor=C.+Fortauthor=B.+Wattauthor=P.+Leblancauthor=M.+S.+Marksauthor=B.+De+Strooperauthor=G.+Raposoauthor=G.+van+Niel&title=BACE2+processes+PMEL+to+form+the+melanosome+amyloid+matrix+in+pigment+cells&doi=10.1073%2Fpnas.1220748110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">BACE2 processes PMEL to form the melanosome amyloid matrix in pigment cells</span></div><div class="casAuthors">Rochin, Leila; Hurbain, Ilse; Serneels, Lutgarde; Fort, Cecile; Watt, Brenda; Leblanc, Pascal; Marks, Michael S.; De Strooper, Bart; Raposo, Graca; van Niel, Guillaume</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">10658-10663,S10658/1-S10658/7</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Amyloids are often assocd. with pathol. processes such as in Alzheimer's disease (AD), but can also underlie physiol. processes such as pigmentation.  Formation of pathol. and functional amyloidogenic substrates can require precursor processing by proteases, as exemplified by the generation of Aβ peptide from amyloid precursor protein (APP) by beta-site APP cleaving enzyme (BACE)1 and γ-secretase.  Proteolytic processing of the pigment cell-specific Melanocyte Protein (PMEL) is also required to form functional amyloid fibrils during melanogenesis, but the enzymes involved are incompletely characterized.  Here we show that the BACE1 homolog BACE2 processes PMEL to generate functional amyloids.  BACE2 is highly expressed in pigment cells and Bace2-/- but not Bace1-/- mice display coat color defects, implying a specific role for BACE2 during melanogenesis.  By using biochem. and morphol. analyses, combined with RNA silencing, pharmacol. inhibition, and BACE2 overexpression in a human melanocytic cell line, we show that BACE2 cleaves the integral membrane form of PMEL within the juxtamembrane domain, releasing the PMEL luminal domain into endosomal precursors for the formation of amyloid fibrils and downstream melanosome morphogenesis.  These studies identify an amyloidogenic substrate of BACE2, reveal an important physiol. role for BACE2 in pigmentation, and highlight analogies in the generation of PMEL-derived functional amyloids and APP-derived pathol. amyloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLBEney5KFyLVg90H21EOLACvtfcHk0li1JoiCCLMzEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFejs7rK&md5=3deb3f80dca6a32748aa6fe2e50c2df1</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1220748110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1220748110%26sid%3Dliteratum%253Aachs%26aulast%3DRochin%26aufirst%3DL.%26aulast%3DHurbain%26aufirst%3DI.%26aulast%3DSerneels%26aufirst%3DL.%26aulast%3DFort%26aufirst%3DC.%26aulast%3DWatt%26aufirst%3DB.%26aulast%3DLeblanc%26aufirst%3DP.%26aulast%3DMarks%26aufirst%3DM.%2BS.%26aulast%3DDe%2BStrooper%26aufirst%3DB.%26aulast%3DRaposo%26aufirst%3DG.%26aulast%3Dvan%2BNiel%26aufirst%3DG.%26atitle%3DBACE2%2520processes%2520PMEL%2520to%2520form%2520the%2520melanosome%2520amyloid%2520matrix%2520in%2520pigment%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2013%26volume%3D110%26spage%3D10658%26epage%3D10663%26doi%3D10.1073%2Fpnas.1220748110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Esterházy, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stützer, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rechsteiner, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Döbeli, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilpert, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matile, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prummer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lieske, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boehm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marselli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosco, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerr-Conte, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aebersold, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spinas, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Migliorini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoffel, M.</span><span> </span><span class="NLM_article-title">BACE2 is a β cell-enriched protease that regulates pancreatic β cell function and mass</span> <span class="citation_source-journal">Cell Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">365</span><span class="NLM_x">–</span> <span class="NLM_lpage">377</span><span class="refDoi"> DOI: 10.1016/j.cmet.2011.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1016%2Fj.cmet.2011.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=21907142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2011&pages=365-377&author=D.+Esterh%C3%A1zyauthor=I.+St%C3%BCtzerauthor=H.+Wangauthor=M.+P.+Rechsteinerauthor=J.+Beauchampauthor=H.+D%C3%B6beliauthor=H.+Hilpertauthor=H.+Matileauthor=M.+Prummerauthor=A.+Schmidtauthor=N.+Lieskeauthor=B.+Boehmauthor=L.+Marselliauthor=D.+Boscoauthor=J.+Kerr-Conteauthor=R.+Aebersoldauthor=G.+A.+Spinasauthor=H.+Mochauthor=C.+Miglioriniauthor=M.+Stoffel&title=BACE2+is+a+%CE%B2+cell-enriched+protease+that+regulates+pancreatic+%CE%B2+cell+function+and+mass&doi=10.1016%2Fj.cmet.2011.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Bace2 Is a β Cell-Enriched Protease that Regulates Pancreatic β Cell Function and Mass</span></div><div class="casAuthors">Esterhazy, Daria; Stuetzer, Ina; Wang, Haiyan; Rechsteiner, Markus P.; Beauchamp, Jeremy; Doebeli, Heinz; Hilpert, Hans; Matile, Hugues; Prummer, Michael; Schmidt, Alexander; Lieske, Nora; Boehm, Bernhard; Marselli, Lorella; Bosco, Domenico; Kerr-Conte, Julie; Aebersold, Ruedi; Spinas, Giatgen Andreia; Moch, Holger; Migliorini, Cristiano; Stoffel, Markus</div><div class="citationInfo"><span class="NLM_cas:title">Cell Metabolism</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-377</span>CODEN:
                <span class="NLM_cas:coden">CMEEB5</span>;
        ISSN:<span class="NLM_cas:issn">1550-4131</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: Decreased β cell mass and function are hallmarks of type 2 diabetes.  Here we identified, through a siRNA screen, beta site amyloid precursor protein cleaving enzyme 2 (Bace2) as the sheddase of the proproliferative plasma membrane protein Tmem27 in murine and human β cells.  Mice with functionally inactive Bace2 and insulin-resistant mice treated with a newly identified Bace2 inhibitor both display augmented β cell mass and improved control of glucose homeostasis due to increased insulin levels.  These results implicate Bace2 in the control of β cell maintenance and provide a rational strategy to inhibit this protease for the expansion of functional pancreatic β cell mass.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrNmw-BllVxx7Vg90H21EOLACvtfcHk0lj4y-sd9_LARQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtFGltbbM&md5=489e20b2d997eb0cbaff195819e35d64</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.cmet.2011.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cmet.2011.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DEsterh%25C3%25A1zy%26aufirst%3DD.%26aulast%3DSt%25C3%25BCtzer%26aufirst%3DI.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DRechsteiner%26aufirst%3DM.%2BP.%26aulast%3DBeauchamp%26aufirst%3DJ.%26aulast%3DD%25C3%25B6beli%26aufirst%3DH.%26aulast%3DHilpert%26aufirst%3DH.%26aulast%3DMatile%26aufirst%3DH.%26aulast%3DPrummer%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%26aulast%3DLieske%26aufirst%3DN.%26aulast%3DBoehm%26aufirst%3DB.%26aulast%3DMarselli%26aufirst%3DL.%26aulast%3DBosco%26aufirst%3DD.%26aulast%3DKerr-Conte%26aufirst%3DJ.%26aulast%3DAebersold%26aufirst%3DR.%26aulast%3DSpinas%26aufirst%3DG.%2BA.%26aulast%3DMoch%26aufirst%3DH.%26aulast%3DMigliorini%26aufirst%3DC.%26aulast%3DStoffel%26aufirst%3DM.%26atitle%3DBACE2%2520is%2520a%2520%25CE%25B2%2520cell-enriched%2520protease%2520that%2520regulates%2520pancreatic%2520%25CE%25B2%2520cell%2520function%2520and%2520mass%26jtitle%3DCell%2520Metab.%26date%3D2011%26volume%3D14%26spage%3D365%26epage%3D377%26doi%3D10.1016%2Fj.cmet.2011.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">He, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyons, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bleasby, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hafey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salituro, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, W.</span><span> </span><span class="NLM_article-title">Utility of unbound plasma drug levels and P glycoprotein transport data in prediction of central nervous system exposure</span> <span class="citation_source-journal">Xenobiotica</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">687</span><span class="NLM_x">–</span> <span class="NLM_lpage">693</span><span class="refDoi"> DOI: 10.1080/00498250903015402</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1080%2F00498250903015402" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2009&pages=687-693&author=H.+Heauthor=K.+A.+Lyonsauthor=X.+Shenauthor=Z.+Yaoauthor=K.+Bleasbyauthor=G.+Chanauthor=M.+Hafeyauthor=X.+Liauthor=S.+Xuauthor=G.+M.+Salituroauthor=L.+H.+Cohenauthor=W.+Tang&title=Utility+of+unbound+plasma+drug+levels+and+P+glycoprotein+transport+data+in+prediction+of+central+nervous+system+exposure&doi=10.1080%2F00498250903015402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F00498250903015402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00498250903015402%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DH.%26aulast%3DLyons%26aufirst%3DK.%2BA.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DBleasby%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DHafey%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DSalituro%26aufirst%3DG.%2BM.%26aulast%3DCohen%26aufirst%3DL.%2BH.%26aulast%3DTang%26aufirst%3DW.%26atitle%3DUtility%2520of%2520unbound%2520plasma%2520drug%2520levels%2520and%2520P%2520glycoprotein%2520transport%2520data%2520in%2520prediction%2520of%2520central%2520nervous%2520system%2520exposure%26jtitle%3DXenobiotica%26date%3D2009%26volume%3D39%26spage%3D687%26epage%3D693%26doi%3D10.1080%2F00498250903015402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riddell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos-Korcsok, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bales, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robshaw, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tseng, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barricklow, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osgood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Neill, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodney, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pettersson, M.</span><span> </span><span class="NLM_article-title">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">342</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">–</span> <span class="NLM_lpage">375</span><span class="refDoi"> DOI: 10.1124/jpet.112.192625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1124%2Fjpet.112.192625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22562771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=342&publication_year=2012&pages=366-375&author=Y.+Luauthor=D.+Riddellauthor=E.+Hajos-Korcsokauthor=K.+Balesauthor=K.+M.+Woodauthor=C.+E.+Nolanauthor=A.+E.+Robshawauthor=L.+Zhangauthor=L.+Leungauthor=S.+L.+Beckerauthor=E.+Tsengauthor=J.+Barricklowauthor=E.+H.+Millerauthor=S.+Osgoodauthor=B.+T.+O%E2%80%99Neillauthor=M.+A.+Brodneyauthor=D.+S.+Johnsonauthor=M.+Pettersson&title=Cerebrospinal+fluid+amyloid-%CE%B2+%28A%CE%B2%29+as+an+effect+biomarker+for+brain+A%CE%B2+lowering+verified+by+quantitative+preclinical+analyses&doi=10.1124%2Fjpet.112.192625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">Cerebrospinal fluid amyloid-β (Aβ) as an effect biomarker for brain Aβ lowering verified by quantitative preclinical analyses</span></div><div class="casAuthors">Lu, Yasong; Riddell, David; Hajos-Korcsok, Eva; Bales, Kelly; Wood, Kathleen M.; Nolan, Charles E.; Robshaw, Ashley E.; Zhang, Liming; Leung, Louis; Becker, Stacey L.; Tseng, Elaine; Barricklow, Jason; Miller, Emily H.; Osgood, Sarah; O'Neill, Brian T.; Brodney, Michael A.; Johnson, Douglas S.; Pettersson, Martin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">342</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">366-375</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease.  For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain.  However, this presumption is challenged by the lack of quant. understanding of the relationship between brain and CSF Aβ lowering.  In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quant. modeling of preclin. data for numerous BACEi, GSI, and GSM across multiple species.  Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacol. relevant range, with excellent consistency across mechanisms and species.  As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically.  Meanwhile, we have been able to reproduce the dose-dependent sepn. between brain and CSF effect profiles using simulations.  We further discuss the implications of our findings to drug discovery and development with regard to preclin. PK/PD characterization and clin. prediction of Aβ lowering in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0fekVpcL50rVg90H21EOLACvtfcHk0lgygBZo1_LEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVOru7vN&md5=65443990fd05b2244ce611e91629341e</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.112.192625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.112.192625%26sid%3Dliteratum%253Aachs%26aulast%3DLu%26aufirst%3DY.%26aulast%3DRiddell%26aufirst%3DD.%26aulast%3DHajos-Korcsok%26aufirst%3DE.%26aulast%3DBales%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DK.%2BM.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLeung%26aufirst%3DL.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DTseng%26aufirst%3DE.%26aulast%3DBarricklow%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DE.%2BH.%26aulast%3DOsgood%26aufirst%3DS.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DB.%2BT.%26aulast%3DBrodney%26aufirst%3DM.%2BA.%26aulast%3DJohnson%26aufirst%3DD.%2BS.%26aulast%3DPettersson%26aufirst%3DM.%26atitle%3DCerebrospinal%2520fluid%2520amyloid-%25CE%25B2%2520%2528A%25CE%25B2%2529%2520as%2520an%2520effect%2520biomarker%2520for%2520brain%2520A%25CE%25B2%2520lowering%2520verified%2520by%2520quantitative%2520preclinical%2520analyses%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D342%26spage%3D366%26epage%3D375%26doi%3D10.1124%2Fjpet.112.192625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Janson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eketjäll, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tunblad, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeppsson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesäter, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fälting, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Visser, S. A. G.</span><span> </span><span class="NLM_article-title">Population PKPD modeling of BACE1 inhibitor-induced reduction in Aβ levels in vivo and correlation to in vitro potency in primary cortical neurons from mouse and guinea pig</span> <span class="citation_source-journal">Pharm. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">670</span><span class="NLM_x">–</span> <span class="NLM_lpage">683</span><span class="refDoi"> DOI: 10.1007/s11095-013-1189-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1007%2Fs11095-013-1189-y" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2014&pages=670-683&author=J.+Jansonauthor=S.+Eketj%C3%A4llauthor=K.+Tunbladauthor=F.+Jeppssonauthor=S.+Von+Bergauthor=C.+Nivaauthor=A.-C.+Rades%C3%A4terauthor=J.+F%C3%A4ltingauthor=S.+A.+G.+Visser&title=Population+PKPD+modeling+of+BACE1+inhibitor-induced+reduction+in+A%CE%B2+levels+in+vivo+and+correlation+to+in+vitro+potency+in+primary+cortical+neurons+from+mouse+and+guinea+pig&doi=10.1007%2Fs11095-013-1189-y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=10.1007%2Fs11095-013-1189-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11095-013-1189-y%26sid%3Dliteratum%253Aachs%26aulast%3DJanson%26aufirst%3DJ.%26aulast%3DEketj%25C3%25A4ll%26aufirst%3DS.%26aulast%3DTunblad%26aufirst%3DK.%26aulast%3DJeppsson%26aufirst%3DF.%26aulast%3DVon%2BBerg%26aufirst%3DS.%26aulast%3DNiva%26aufirst%3DC.%26aulast%3DRades%25C3%25A4ter%26aufirst%3DA.-C.%26aulast%3DF%25C3%25A4lting%26aufirst%3DJ.%26aulast%3DVisser%26aufirst%3DS.%2BA.%2BG.%26atitle%3DPopulation%2520PKPD%2520modeling%2520of%2520BACE1%2520inhibitor-induced%2520reduction%2520in%2520A%25CE%25B2%2520levels%2520in%2520vivo%2520and%2520correlation%2520to%2520in%2520vitro%2520potency%2520in%2520primary%2520cortical%2520neurons%2520from%2520mouse%2520and%2520guinea%2520pig%26jtitle%3DPharm.%2520Res.%26date%3D2014%26volume%3D31%26spage%3D670%26epage%3D683%26doi%3D10.1007%2Fs11095-013-1189-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Tai, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ozmen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flohr, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakob-Roetne, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caruso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimm, H. P.</span><span> </span><span class="NLM_article-title">The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat</span> <span class="citation_source-journal">J. Pharmacokinet. Pharmacodyn.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">237</span><span class="refDoi"> DOI: 10.1007/s10928-012-9246-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1007%2Fs10928-012-9246-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=22481485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=1%3ACAS%3A528%3ADC%252BC38XnvFOmtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2012&pages=227-237&author=L.+M.+Taiauthor=H.+Jacobsenauthor=L.+Ozmenauthor=A.+Flohrauthor=R.+Jakob-Roetneauthor=A.+Carusoauthor=H.+P.+Grimm&title=The+dynamics+of+A%CE%B2+distribution+after+%CE%B3-secretase+inhibitor+treatment%2C+as+determined+by+experimental+and+modelling+approaches+in+a+wild+type+rat&doi=10.1007%2Fs10928-012-9246-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28cR"><div class="casContent"><span class="casTitleNuber">28c</span><div class="casTitle"><span class="NLM_cas:atitle">The dynamics of Aβ distribution after γ-secretase inhibitor treatment, as determined by experimental and modelling approaches in a wild type rat</span></div><div class="casAuthors">Tai, Leon M.; Jacobsen, Helmut; Ozmen, Laurence; Flohr, Alexander; Jakob-Roetne, Roland; Caruso, Antonello; Grimm, Hans-Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacokinetics and Pharmacodynamics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-237</span>CODEN:
                <span class="NLM_cas:coden">JPPOAH</span>;
        ISSN:<span class="NLM_cas:issn">1567-567X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibition of the enzyme(s) that produce the Amyloid beta (Aβ) peptide, namely BACE and γ-secretase, is considered an attractive target for Alzheimer's disease therapy.  However, the optimal pharmacokinetic-pharmacodynamic modeling method to describe the changes in Aβ levels after drug treatment is unclear.  In this study, turnover models were employed to describe Aβ levels following treatment with the γ-secretase inhibitor RO5036450, in the wild type rat.  Initially, Aβ level changes in the brain, cerebral spinal fluid (CSF) and plasma were modeled as sep. biol. compartments, which allowed the estn. of a compd. IC 50 and Aβ turnover.  While the data were well described, the model did not take into consideration that the CSF pool of Aβ most likely originates from the brain via the CSF drainage pathway.  Therefore, a sep. model was carried out, with the assumption that CSF Aβ levels originated from the brain.  The optimal model that described the data involved two brain Aβ 40 sub-compartments, one with a rapid turnover, from which CSF Aβ 40 is derived, and a second quasi-static pool of ∼20%.  Importantly, the estd. in vivo brain IC 50 was in a good range of the in vitro IC 50 (ratio, 1.4).  In conclusion, the PK/PD models presented here are well suited for describing the temporal changes in Aβ levels that occur after treatment with an Aβ lowering drug, and identifying physiol. parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrM6gomsyyrKbVg90H21EOLACvtfcHk0lgygBZo1_LEyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XnvFOmtrY%253D&md5=ab4fdf450464626408ae92585d14f778</span></div><a href="/servlet/linkout?suffix=cit28c&amp;dbid=16384&amp;doi=10.1007%2Fs10928-012-9246-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10928-012-9246-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DL.%2BM.%26aulast%3DJacobsen%26aufirst%3DH.%26aulast%3DOzmen%26aufirst%3DL.%26aulast%3DFlohr%26aufirst%3DA.%26aulast%3DJakob-Roetne%26aufirst%3DR.%26aulast%3DCaruso%26aufirst%3DA.%26aulast%3DGrimm%26aufirst%3DH.%2BP.%26atitle%3DThe%2520dynamics%2520of%2520A%25CE%25B2%2520distribution%2520after%2520%25CE%25B3-secretase%2520inhibitor%2520treatment%252C%2520as%2520determined%2520by%2520experimental%2520and%2520modelling%2520approaches%2520in%2520a%2520wild%2520type%2520rat%26jtitle%3DJ.%2520Pharmacokinet.%2520Pharmacodyn.%26date%3D2012%26volume%3D39%26spage%3D227%26epage%3D237%26doi%3D10.1007%2Fs10928-012-9246-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Van Maanen, E.; Van Steeg, T.; Michener, M. S.; Savage, M. J.; Kennedy, M. E.; Kleijn, H. J.; Stone, J.; Danhof, M.</span><span> </span><span class="NLM_article-title">Systems pharmacology analysis of the amyloid cascade enables the identification of an Aβ<sub>42</sub> oligomer pool</span>.  <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span>DOI: <span class="refDoi"> DOI: 10.1124/jpet.115.230565</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=10.1124%2Fjpet.115.230565" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;key=26826190" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=E.+Van+Maanen&author=T.+Van+Steeg&author=M.+S.+Michener&author=M.+J.+Savage&author=M.+E.+Kennedy&author=H.+J.+Kleijn&author=J.+Stone&author=M.+Danhof&title=Systems+pharmacology+analysis+of+the+amyloid+cascade+enables+the+identification+of+an+A%CE%B242+oligomer+pool&doi=10.1124%2Fjpet.115.230565"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28d&amp;dbid=16384&amp;doi=10.1124%2Fjpet.115.230565&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.115.230565%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BMaanen%26aufirst%3DE.%26atitle%3DSystems%2520pharmacology%2520analysis%2520of%2520the%2520amyloid%2520cascade%2520enables%2520the%2520identification%2520of%2520an%2520A%25CE%25B242%2520oligomer%2520pool%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2016%26doi%3D10.1124%2Fjpet.115.230565" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0','PDB','5hd0'); return false;">PDB: 5hd0</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g','PDB','4h3g'); return false;">PDB: 4h3g</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu','PDB','5hdu'); return false;">PDB: 5hdu</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv','PDB','5hdv'); return false;">PDB: 5hdv</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx','PDB','5hdx'); return false;">PDB: 5hdx</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz','PDB','5hdz'); return false;">PDB: 5hdz</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5','PDB','5he5'); return false;">PDB: 5he5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he7','PDB','5he7'); return false;">PDB: 5he7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4','PDB','5he4'); return false;">PDB: 5he4</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i36"><a href="/doi/suppl/10.1021/acs.jmedchem.5b01995">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_57536"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.5b01995">10.1021/acs.jmedchem.5b01995</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Synthetic procedures for preparation of the pyrimidine reagents used to make compounds <b>8</b>–<b>25</b>, the synthesis of compound <b>8</b>, procedures for incubation of compound <b>6</b> with CYP3A4 in the presence and absence of glutathione, methods for determination of rhesus monkey plasma, CSF and cortical Aβ<sub>40</sub>, Aβ<sub>42</sub>, and sAPPβ levels, and methods for determination of cynomolgus monkey CSF and cortical Aβ<sub>40</sub> levels (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_001.pdf">PDF</a>)</p></li><li><p class="inline">(<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_001.pdf">jm5b01995_si_001.pdf (520.07 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.5b01995/suppl_file/jm5b01995_si_002.csv">jm5b01995_si_002.csv (1.59 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates for BACE1/inhibitor complexes will be deposited at the Protein Data Bank. Authors will release the atomic coordinates and experimental data upon article publication. PDB codes: <b>6</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hd0">5hd0</a>; <b>7</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4h3g">4h3g</a>; <b>8</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdu">5hdu</a>; <b>11</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdv">5hdv</a>; <b>15</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdx">5hdx</a>; <b>16</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5hdz">5hdz</a>; <b>17</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he5">5he5</a>; <b>23</b>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=5he4">5he4</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.5b01995&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.5b01995%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2016.59.issue-7%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.5b01995" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679965da9c31248d","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
